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The association between tobacco smoking and a 
form of amblyopia has been recognised for over one hundred 
years» The disease characteristically affects elderly men 
affects both eyes unequally and does not progress to complete 
blindness# The patient typicall has poor vision both for 
near and distance* bentro-caecal scotomas larger for colour 
than white targets in the field of vision and an acquired 
colour blindness of each eye. Recent additions to the 
world literature on the subject have postulated an abnormality 
of the vitamin B12 cyanide relationship as being the underlying 
aetiological feature and that tobacco amblyopia is a member 
of a group of diseases which includes Leber’s hereditary 
optic atrophy* the optic neuropathy of pernicious anaemia, 
the optic neuropathy of diabetes and some forms of tropical 
nutritional amblyopia.
This study reports the findings in 65 patients 
diagnosed as suffering from tobacco amblyopia which have been 
collected over a period of three years in the Western Regional 
Hospital Board area. The patients showed, a marked reduction 
in visual acuity by the time they have reported for treatment.
It was found that the duration of symptoms did not influence 
the initial visual acuity but those patients who cam© under 
treatment early Imd the greatest improvement in visual acuity 
The Farnsworth Munsell Hundred Hue test was chosen as one of 
the major parameters evaluating new patients prior to and 
whilst on therapy* As the Hundred Hue test error scores 
obtained in the untreated tobacco amblyopes were higher than 
previously recorded analyses, an investigation to establish 
the validity of such error scores was carried out. It was 
found that with error scores above 600 it was better to take 
the average of several readings rather than the result of one 
test. In untreated tobacco amblyopia the Farnsworth îtoieell 
Hundred Hue test result correlated well with visual acuity, 
and tended to do so with patient ago* #i©re was no 
aignificant correlation between the Farnsworth Munsell Hundred 
Hue teat result and duration of symptoms, serum vitamin B12 
concentration, or serum folate concentration* The incidence 
of the disease increases in a positive manner with age, reaching 
a peak in the ?0*80 years age group. The mean duration of 
symptoms prior to seeking advice was 6 months and it was 
found that age played no part in deteriBining when a patient 
presented for treatment*
Patienta were examined for evidence of avitaminosis 
B12 by having serological estimations of vitamin B12 and 
estimations of vitamin B12 absorption carried out, Serum 
vitamin B12 concentrations were found to be lower in tobacco 
amblyopia than in the general smoking and non-smoking 
populations. The serum vitamin BX2 concentration correlated 
well with tobacco consumption, the Schilling test less well so, 
and the %lose absorption test poorly so. In the untreated 
tobacco amblyope the serum folate concentration tended to 
correlate with tobacco consumption. Patients with tobacco 
amblyopia in the presence of frank Addisonian Pernicious 
toaemia exhibited higher aenam folate concentrations than 
those patients without pernicious anaemia.
As cyanide is Volatile investigations into its 
metabolism ie to be directed to its detoxication products 
namely thiooyaWte, Although tobacco amblyopes smoko more 
tobacco than non-amblyopic subjects, their serum thiocyanate 
concentrations are lower than those of non-amblyopic smokers 
and tend to resemble the concentrat3.ons found in non-smokers. 
These reduced concentrations, on treatment with hydroxocobalamln, 
tend to revert towards the hi#ier concentrations found in the
non-amblyopic smokers. Associated m t h  this rise in the 
blood there is an increased excretion of thiocyanate in the 
urine. A si{piifleant negative correlation was found to esixt 
between the plasma cyanide and the serum vitamin B12 
concentrations and between the plasma thiocyanate and the renal 
clearance of thiocyanate in untreated tobacco amblyopia.
The keystone in therapy up till 10 years ago had 
been abstinence from the tobacco habit. With the growing 
awareness of the part played by malnutrition in this disease, 
preparetiohs of vitamin B12 were used in this analysis* Of 
the two preparations used, hydroxocobalamin was quickly found 
to be superior to qyanocobalamin. The mean period that patients 
remained under observation was nineteen months* The majority 
(40 in number) had a visual acuity of 6/12 (Snellen) or better. 
Of the fifteen patients who had a poor restoration of vision, 
four were undergoing their second attack of the disease* The 
progress of the disease whilst on. therapy was also observed by 
following the alteration in colour discrimination. It was 
found that the Farnsworth Munsell Hundred Hue test results 
fitted an exponential curve equation.
The rat© of improvement in uncomplicated tobacco 
amblyopia treated with hydroxocobalamln was as good as that 
treated by abstinence from tobacco•
Leber’s Hereditary Optic Atrophy is mi inherited 
disease which primarily attacks the young adult* Abnormalities 
in cyanide detoxication products, similar to those found in 
tobacco amblyopia, were found in such patients* These 
changes underwent similar alteration on treatment with 
hydroxooobalamin as had been demonstrated in tobacco amblyopia 
and were associated with Improvement in visual acuity and 
visual field*
The ocular features of patients suffering from the 
optic neuropathy of pernicious anaemia who smoked, were 
identical to those found in patients suffering from tobacco 
amblyopia* Accordingly, it is Alt that the diagnosis of 
optic neuropathy of pernicious anaemia be reserved for those 
non-smoking pernicious anaemia patients, Three case histories 
are examined which reveal the superiority of hydroxocobalamin 
therapy over cyanoêobalamln in this condition* In one 
patient the visual defect commenced after treatment with
cyanooobalamiîi for the haematological disorder had been 
continued for some time.
It is difficult in the light of present knowledge 
to explain the rise in thiocyanate concentrations in body 
fluids following a hydroxocobalamin therapy, unless a hitherto 
unknoim mechanism sited in the kidney is postulated. It 
would seem that the principle biochemical defect in tobacco 
amblyopia would lie in the preparation of a suitable sulphur 
donor. In the preparation of such a donor coenzyme vitamin 
B12 is essential.
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It ia imivamally recognised that tobaooo mblyopie 
ie a clieoase, almost oxelueively, of the elderly pipe amohlmg 
œle. It la the impreealoti that, although # m  tohaoeo 
ooneumption has steadily risen ainoe the turn of the century,
the reported, number of oaaea of W W o a o  amblyopia has fallen* 
This ia in contrast to the .parallelism accorded to % e  alleged 
cigare tte  smoking ^  lung cancer relationsMp*- Assuming th a t 
the imcidanoe of tobacco amblyopia line apparently gone down 
while exposure to  its presumed aotiologio agent has risen, 
other contributory explanations must be sought,
%#%y does only a small proportion of pip© smokers 
develop the disease? \Ûmt factors cause the disease and how 
do they alter with treatment? An attempt to answer these 
questions# using the in-patient and out*patient data of a 
study into the clinical feature© of the disease, is contained 
in this thesis, the data been arranged under the 
following headings!-
1. â historical background,
2# Ml analyeis of the means to determine the presence 
and severity of the disease, (Ophthalmclogloal
investigation),
4
5* Kutrltionul faotors*
4*, flue tox ic  facto r in  tobacco*
5* the m&ponm to therapy*
6* Leber’ 8 Hereditary Optio Atrophy* Optic Neuropathy 
of Pornloioma Anaemia*
7* Oouolueloaa*
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Chapter I# Hiatorioal Background
Tobacco amblyopia ie a disease of the elderly 
pipe-smoking male* Females may also contract the disease
if sufficiently exposed to the toxic agent* Characteristii 
*Gaily the disease is bilateral, but unequally distributed 
between the two eyes* The. visual acuity is depressed and 
a glittering mist obscures objects except when viewed in 
twilight* A oentro-oaeoal scotoma, larger for colours than 
white, is present in the field of vision, and is$.acoompanied 
by an acquired colour blindness*
Tobaooo amblyopia may be associated with a variety 
of systemic diseases, in particular diabetes, pernicious 
anaemia and digestive disorders* This has led to the 
belief tiiat such patients are more liable to tobacco 
amblyopia because of a deficiency in an essential substance*
The keystone in treatment of tobacco amblyopia 
has been abstinence from the tobacco habit and has been in 
vogue from the last century* Over the past thirty years
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however, the importance of malnutrition has been stressed 
by various authors, in particular of dafioienoy in vitamin 
B12*
Within the past eight years much new work has 
postulated the probable aetiology as being a disturbance in 
the cyanide - vitamin B12 relationship* This has led to the 
proposal that tobacco amblyopia is a member of a group of 
diseases which includes Leber’s Hereditary Optic Atrophy, 
the Optic Neuropathy of Pernicious Anaemia, the Optic 
Neuropathy of Diabetes, and some forms of Tropical Nutritional 
Amblyopia, and in each of which a disturbance of the above 
relationship is present*
Chapter II* QphthalmologioaX Investigation
In this chapter the ophthalmic methods of 
investigating the visual loss found to accompany tobacco 
amblyopia are dealt with*
By the time they report for treatment the patients 
have a marked reduction in visual acuity, oentro-caeoal 
scotomas in the field of vision for each eye, and a gross
mpact in oolom? disojriraination feeing present. The 
teation of ayaptome did not influence the initial visual 
acuity, but those patiente who came mder treatment early 
had the greatest improvement in visual acuity#
The Farnsworth îteisell 100 Hue tent u m  chosen as 
one of the major parameters in evaluating individual patients 
prior to# and whilst on tîierapy. As the 100 Hue test error 
soores obtained in the untreated tofeaooo amblyopes were 
higher than previously recorded analyses, mi investigation 
to establish the validity of suoh error soores was carried 
out.
In untreated tobaooo amblyopia the Famswortii 
Munsell 100 Hue test result correlated well with visual 
acuity and tended to do so with patient age. There was no 
aignifieant correlation between the Itensworth Mimsell 
Hundred Hue test result and duration of symptoms, serum 
vitamin Bl2 oonoentratipn or serum folate oonoentration*
The incidence of the disease inoreaaes in a 
positive manner with age, reaohing a peak in the 70-80
years age group# thereafter declining in frequency. The
0
mean duration of symptoms prior to seeking advice was 6 
months and it was found that age played no pari in detersiaining 
when a patient presented for treatment#
Chanter III* Nutritional Factors»
In this chapter attention has been concentrated on 
the detection of avitasiinosis B12 and the relationship of the 
findings to tobacco oonsumption* The patients were examined 
for coincident disease, serological examinations were carried 
out for total vitamin B12 and folate concentrations of the 
blood* Igxamlnation into vitamin il2 absorption were carried 
out on the patients on an in-patient basis* Liver function 
tests were performed to screen the patients for defective 
hepatic storage Of vitamin B12»
Serum v itamin B12 concentrations were found to be 
lower in tobacco amblyopia than in the general smoking and 
non-smoking populations. The serum vitamin B12 concentration 
correlated well with tobacco consumption, the Schilling test 
less well BO, and the Xylose absorption test poorly so#
The serum folate concentration was also investigated
and a significant proportion of the patients exhibited low 
concentration© of folate* In the untreated tobacco amblyope 
the serum folate concentration tended to correlate with tobacco 
consumption. Patienta with tobacco amblyopia in the presence 
of frank Addisonian Pernicious Maemia exhibited higher serum 
folate concentrations than those patients without pernicious 
anaemia. Age played no part in determining the serum folate 
concentra tion »
er IV'* The Toxic Factor in Tobacco*
In this chapter the presence of cyanide in tobacco 
smoke and its metabolic effects are reviewed. As cyanide is 
volatile investigation of its metabolism has to be directed 
to its detoxication products* Attention has been concentrated 
on thiocyanate levels in the blood and urine*
Although tobacco amblyopes smoke more tobacco than 
non-amblyopio subjects, their serum thiocyanate concentrations 
are lower than those of non-arablyopic smokers and tend to 
resemble the concentrations found in non-smokers. These 
reduced concentrations, on treatment with hydroxocobalamin, 
tend to revert towards the higher oonoentrations found, in the
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mon-aia.1>lyopl0 smokers* Associated with this rise in the 
blood there la am inoroaasd excretion of thlqoyamete 1b the 
urime and in some patients a diureals oooura* The negative 
relationship between eerm vitamin BIB oonaentration and 
urinary thlooyanato exoration, and the positive relationship 
between plasma cyanide and plasma thiocyanate found by earlier 
workers in healthy smokers were not confirmed in patients 
suffering from tobacco amblyopia, Only a tendency towards 
aucli relationships was observed* A signifloant negative 
correlation was fomd to exist between the plasma cyanide 
and the serum vitamin B12 concentrations, and between the 
plasma thiooyanat© and the renal clearance of thiocyanate in 
untreated tobacco amblyopia#
The keystone in therapy, up till 10 years ago, for 
patients with tobacco amblyopia had been abstinence from 
the tobacco habit; in addition, vasodiXatory drugs and 
etryehnino had been used with doubtful Buceeee* With the 
growing ewarenees of the part played by. malnutrition in this 
disease I preparations of vitamin B12 were used in this analysis. 
Of the two preparations used, hydroxocobalafin was quickly
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foimd to be superior to oymoeobulamin and all patients 
ultimately cam© to be treated with the better droif*
The mean period that patients remained wider 
observation was nineteen months, with a range from five 
montha to thirty five months* fhe majority (40 in number) 
had a visual acuity of 6/l2 or batter after the period cf 
follmt up. fen patiente became lost from tlie mialyml# by 
reason of default or death* Of the fifteen patients who had 
a poor restoration of vialon, four wore undergoing tlioir 
seoond attaok of the-disease*
The progress of the disease whilst on tliorapy was 
also observed by following the alteration in colour 
discrimination# It was found that the remits fitted an 
exponential ourve equation* By this mems the rate of 
Impmvemmt in colour discrimination was compared in tobacco 
amblyopia complicated by pernicious anaemia, pre-perniciouo' 
anaemia, and diabetes# The rate of improvement in 
mieoMplloated tcbacoo amblyopia treated by hydroxocofealamin 
was equally good as that treated by abstinence from tobacco#
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Leher’ s Hereditary Optic Atmphy is an inherited 
digeaee which primarily attacks the young adult, both eye# 
being affaotad and resulting in a aerioue viaual defect# 
âbnoraalltiaa in cyanide detoxiaation product©, elmllar to 
thoee found in tohaooo aTaMyopia, were found in auoh patients, 
These changea undorwmt similar alteration after treatment 
with hydroxoGobalamln, ae had been demonotrated in tobaoeo 
amblyopia# The ocular feature© of patiente oufferlng from 
the optio neuropathy of pernioioiia maemia who emoked, were 
Identical to those found in patienta suffering from tohaooo 
amblyopia# âeoordlngly. It la felt that the diagnosis of 
optlo neuropathy of parnioloua anaemia he reserved for #oae 
mon-amoklng pernicious anaemia patients who have visual eigne 
and symptoms# " Three came histories are examined which 
reveal the superiority of liydroxooohalamln therapy over 
oyanoQObalamin in this condition# In one patient the visual 
defect oommenoed after traatjaent with cymoaobalwin for the 
haematologioal defect had been continued for acme time#
An oaeurreno© not previously reported in the literature*
13
Oonoluaicaa
in this chapterf the evidence in favour of a 
ctletnrhanoe in the vitamin BlB/oygmide relationship, as the 
hsaio factor in the production of tobacco amblyopia, 1# 
collected and examined# In the maim sttch a dieturhance 
leada to a failure of the detoxloation of cyanide to 
thiocyanate, by its mien with sulphur-* It ie difficult in 
the light of present toowledgo to explain the rise in 
thiocyanate eoncentratione in body fluids following on 
hydroxoooMlamin therapy, unleee a hitherto unWwwn meohaniam 
cited in the kidney is postulated# Such a mechanism is 
outlined#
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o m r œ  i.
HxaroiüAii moKORomp
fhe term toxic amblyopia is generally ueed. to 
designate condition© to which visual losa results from the 
absorption of exogenous poison or endogenously elaborated 
toxins* As a group these poisons have features in common# 
1?hey involve the ganglion cells or optic nerve fibres of 
the sub chiasmal portion of the visual pathway# #ie 
visual disturbance is bilateral and, on the whole, the . 
defect is not permanent# fhe common group has an affinity 
for the papillo macular neiva fibre bundle resulting in a 
central, or centro-»oaeeal scotoma, and may be accompanied 
by a peripheral neuropathy# In this group are found 
tobacco, methyl and ethyl alcohol, lead, carbon disulphide 
and inorganic arsenical compounds* In the less common 
group, the visual defect takes the fozrm of a peripheral 
contraction of the visual field while peripheral neuropathy 
is unusual* fh© quinoline group of drugs act in this way.
Tobacco amblyopia is the most common type of 
toxic amblyopia met with in Western Burope today. It 
constitutes a clinical entity which affects mainly the pipe
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smoking middle-aged male# and ie oharaoteMsed by a 
bilateral impairment of central vision with the development, 
in the eentro-eaeoal area of the visual field, of depressed 
sensitivity to red and green stimuli, without ophthalmosoopio 
changes* (Buka Bilder 19# )
Ton ^ i*aefe (186$) recognised progressive amblyopia 
with oontraotad field, and curable amblyopia with full field 
and central scotoma* He considered that excessive 
indulgence in alcohol, much smoking of strong cigars, 
irregular sleep and over use of the eyes might act singly, 
but m m  often acted together in producing amblyopia# leber 
(I86f) exm*ined the colour sense and found a central defect. 
He considered that in many cases smoking was a factor in the 
production of central scotomata. Burster (I069) had found 
patients with a central scotoma who improved when tobacco 
moklng was avoided, and in 18?1 he recorded the value of 
using a rad object on a black background in testing for the 
never failing central scotoma in amblyopia from abuse of 
nicotine and spirits*
Although Beer (181?) is credited with the first 
recorded description of tobacco amblyopia, it is quite 
possible that Tenner (18§0) ms referring to tMse cases
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that are novt called tobacco amblyopia# in hi© treatise 
on tohaooo, l^okengîia (IB50) had repeatedly hinted hie 
ouepioions that tohaaoo was a cause of amaurosis# and in the 
4th edition of "Biseasee of the Bye*' ' (IB54) he mentioned a 
oaso of amaurosis that improved on giving up tohaoeo without 
other treatment* He further oonaldered that one of the 
best proofs of tohaoco being a cause of amaurosis mn  in the 
great Improvement of vision that ensued on givii^ up the use 
of the poison*
hfmtenhaoh (189#) employed the term "Tobacco 
Amblyopia" to express retrobulbar neuritis of the optio nerve 
with a central colour scotoma# followed by optic nerve atrophy 
m d  occurring in those addicted to the exoeceivo use of 
tobacco* Hhthoff (1886) and Qroenouw (18# )  regarded 
retrobulbar neuritis and toxic amblyopia as different diseases 
in spite of the seemingly identical findings* Accordi% to 
Hhthoff retrobulbar neuritis is distinguished frm toxic 
amblyopia by the extent of #%e scotoma* Early observers 
noted that toWccc amblyopia was almost exclusively a male 
disease (Halson 1880 mid lyle 190$), and was very rare in 
women (Berry 1884, Bales 1887, Gunn 1887, Oossu 1# 3, %her
l # 7e and Traquair 1928)* Hhtoff (Ifll) warned that one 
should not assume a special predisposition in men, since
17
women wore algo affected when sufficiently exposed to 
tobacco as was found In female tobaooo workers by legge 
(1922).
Virtually all authorities are ageeed that tobacco 
amblyopia ia a disease of the middle-aged male beetween the 
ages of #-60 years (lelaon 1880, lamaay 1895, %le IgOg,
Bar 1906, tîaher 1927a 1 Traquair 1950, Mille 1934* Oreeves 
1936, liambreain and Boliopena 194^ m d  Heaton et aX 1958), 
being rare before the age of 30 years (Groenouw 1892) though 
fraquair (1930) repeated its ooourrenoe in the 20*8 ami Usher 
(1927a) in the teens* The incidence declines after the age 
of 60 years (Oromouw 1892) though Traquair (1930) and 
Seaton et al (1958) reported it» ooourreaco in patients of 
60 years and older* Bowling (1908) extensively Investigated 
legro tobacco workers and conoludad that this race had an 
immunity to tobacco amblyopia* This work hm not been 
confirmed or disproved*, hopes (I9OO) stated that tobacco 
amblyopia was m  exceptional disease in -Bpaniards and Oubans 
but this was eubsequently disproved (finlay 1901)* Van den 
loeve (1927) stated that he had never seen cases of tobacco 
amblyopia in Holland and believed that it did not occur there, 
though he could offer no reason why*
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Gromouw (I892) stated that all of the usual 
foma of using tobaooo may load to tohsooo amblyopia | 
bmutenbaoh (1898) was oonvlmoed that tobaooo must he smoked 
to produoa the disorder# Boggart (1959) reported a ease f^om 
the use of snuff and Ohisholm (1S90) itm- chewing tohaoco# 
Tobaooo amblyopia mm  common in patients who smoked tofeaooo 
as cigars or pipes, usually strong tobacco and pipe smoking 
was the commonest cause, (Grseves 19)6, Beislman 1951 
Boggart 1959)^  Billie (1934) had never seen the disease 
from cigarette smoking, hut EVsns (1959) » Oohen (1959)'*
Smith (1959) and Heaton et al (1958) had* Beiehman (1951) 
suggested that a possible explanation of the different 
incidence rates of tobacco amblyopia in pipe and cigarette 
smoking may lie in the different routes of absorption of the 
toxic agent# In pipe smoking the agent was swallowed 
causing a slow upset of gastric function with resulting 
metabolic derangement whioh in turn might produce the lesion 
of tobacco amblyopia#
It ie agreed that prolonged exposure to tobacco 
is necessary to produce tobacco amblyopia (Galezowski 1683, 
Mettleship IBS?, Ohieholm 1#90, Bmmsoy 1695$ Heaton et al 
1950, Boggart 1959)* Ohioholm (1890) had never seen tobacco 
amblyopia from tobacco use of less than 10 years and all but
19
om of the patienta of Heaton et al (1958) had emoked for JO 
yeare or more# Hettleshlp (1887) recorded the dieeaae after one 
year* $ emoklmg# Gmevee (19J6) and Heaton at al (1956) found 
that the absolute amount of tobacco was not a determining factor, 
m  there is no demonstrable relationship between thia and the 
onset of the disease#
In men Berry (IBS?) found that one ounce to half a 
pound or more weekly was the quantity smoked by ease» of amblyopia, 
The disease le seen from time to time in those who have smoked 
surprisingly email qumtities of 'tobacoo# Siioh oases have been 
recorded by Hales (186?), Berry (IBS?), lîaberahon (ISSS), de 
Boh'weinitîs (19OO) end others# Chisholm (IBB?) recorded a case 
that smoked only half a cigar daily# It frequently made hie 
patient sick and'he had been persevering for years to acquire 
the habit of smoking#
The onset of tobacco amblyopia has been described as 
sudden, rapid or abrupt (llartrMge 1886) or slow, gradual or 
insidious. (Ramsay 1895». Byle 1905» B.owling 1908, Eambresin and 
Schepene 19#)* The earlier observers tended to emphasise the 
rapidity and the later observers the slowness of onset# According 
to some observers failure of eight in tobacco amblyopia progreeaed
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rapidly for a time .and then remained relatively stationary 
(lettleship IBS?) or progreaaiva (l»yle 1905$ Bowling IgOS), 
Most authors are in agreement that tobadoo amblyopia never 
progressed to complete loam of sight (ïlhthoff 1080, Berry 
1S02| Traquair 1930) though Marshall and Seiler (1942) found 
that tobacco amblyopia accounted for 0#124# of blind 
registrations#
The prognosis is generally favourable if the patient 
gives up smoking and comm under early treatment (Hamasy 1895$ ■ 
Bowling 1908, Traqualr 19J0)# Griffith (1687) from M s  study 
of oases, concluded that there was a tendency for recovery 
to take place even without complete discontinuance of the 
toxic agent. Speedy recoveries were marked in those who 
gave up tobacco completely# Of his 65 examples of tobacco 
amblyopia, 27 patients- completely recovered their sight 
(18 complete abstinence emd 9 almost complete), 24 partially 
recovered their sight (II complete abstinence), II remained 
stationary (5 complete abstinence), 5 became worse (I complete 
abstinence), Somewhat similar results were found by Evans 
(1939) ^ out of 551 23 recovered fully their sight, 27 had 
partial recovery, 5 no recovery# Oarroll (1937-44) found 
that patients on adequate diets made partial or complete
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recovery, in spite of their continued and unabated m e  of 
tobacco and/or alcohol# He claimed hie résulta wero m  good 
a# any previous oeriea Including those in which the patienta 
abstained from smoking# If the patient with tobacco amblyopia 
dieaontinned smoking hia vision usually improved but if he 
oontimied to smoke and take large doeee of vitamin B complex 
and a well balanced diet there would be improvement over a 
period of months (Ofarroll 1956).
time for recovery has been variously described 
as rapid (Euata 1925) or* slow (Oreovea 193^)I not earlier 
than 2 months (Berry 18$?), J-42 months in 50& of patients 
(Griffith 1887), 2-10 months (llambreaiE and Hohopens 1946}# 
Bidden (1936) stated that recovery may take up to 2 years - 
longer than was usually considered* Berry (1887) noticed 
that there was a latent period t#ter treatment was commenced 
before appreciable change occurred mad fraquair (1930) 
noticed that vision, in some oases, became worse before 
Improvement set in, after smoking was stopped# Berry (1887) 
noted that relapses were rare, Gunn (1887) end Bales (188?) 
had not mmi a recurrence though lîettleahlp (1887) had 
encountered a relapse#
According to Croenouw (1892) the typical cases
were fotmd in middle-aged men who were heavy smoker# m d  
eonemmed alcohol. The general condition wa# dietnrbed with, 
laok of appetite, insomnia, constipation and a feeling of 
fatigue and dépression# A# daaoribed by Traquair (igJO) the 
patient wan ueually a man of about 50 years whose eight had 
been falling for several weeks or months. There was a smell 
of stale tobaooo about him# ihere may be tremor of the 
hands# The vision failure was worse for near vision and 
identity of oolours# The vision was better at dusk than in 
bright daylight. Oooasionally a silvery mist surrounded any 
object looked at. The symptoms same on gradually and without 
any exciting cause* In general, there appeared to be little 
or no oharaoteristlo ophthalmoscopie findings, (Mettleship 
and Edmund IBSJ, Traquair 1930» Oarroll 1935» Hambresin and 
Bchepona 1946), although pallor of the temporal half or 
quadrant of the optio dies had been observed (Groenouw 1892, 
Traquair 1930$'8arroll 1935)• Persistent and marked miosis 
had. been noticed (Osle^owski 1ÛS3) and had been used to 
differentiate tobaooo amblyopia from alcoholic amblyopia in 
which the pupils were said to be dilated B.M.d# i»744 (1879)
Diminution of visual acuity was one of the 
characteristic signs of tobacco amblyopia (QalezowBki 1883). 
There was conspicuous disproportion between distant vision
which was almost momml im moat oaoea, sad olosa vision 
which showed pronounced deterioration (fraquair 1930)* Aa 
long ae the aootoma had not attacked the fixation point, 
the vision remained good in tohaooo amblyopia# When the 
fixation point m m  affected, the decrease in the visual acuity 
could he rapid {flamhreein and Hohepens 1946)#
The visual field defect has been variously 
deeeribed as central (leher 1069, Galeaowoki 1883, Comior 
1890, Bedgee 1957) and oentro-oaeeal (fraquair 1930, Oarroll 
1935» ieatoii et al 1958) in which the defeot for colour was 
larger than that far white, m d  of the colours that for red 
and green being larger than that for blue (hyle 1905)#
Heaton at si (1958) eryetalliaed the literature in the 
following criteria#-
(1) The patient muet be a smoker*
(2) A oentro-oaeoal eootoma must be preaent#
(3) Thia sootoiaa must be horizontally oval and 
most readily detected by a reduced-, stimulus#
(4) The defect for csolour must be larger than that 
for white#
(5) The scotoma must be bilateral though not 
■ necessarily equal on the two «idee#
Pathological changes in tobacco amblyopia or
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tobacco-nleohol amblyopia had been thought to involve either 
the oiroulatory or the neural elements of the sye, or both, 
although in actual examination, it va» exoeptlonal to find 
auoh change© (%le 1947)# Hietopathologio findings have 
been reported in detail (Bameleobn 188Ê, Haoh© 1887*93# Biroh-^  
IlirsohfeM 1902# Victor and Bryfus 1965)* Wordworth (I863) 
stated that only one pathologic condition was seen - namely 
white atrophy of the optic nerve»# Bach© (18Û7) considered 
that the generally valid anatomic haaie of tobacco amblyopia 
was the partial degeneration of the optic nerve tract and 
degeneration of the papillo-macular fasciculus* Hue! (1096) 
claimed that the central scotoma of tobacco amblyopia was the 
result of macular disease and not an interstitial neuritis 
of the optic nerve* Mille (1934) considered the idea that 
only the maculopapillary bundle of nerves is affected seemed 
beet established clinically# Grosnouv (1892) favn:a?ed the 
view that the primary site of tobacco amblyopia vac to be 
found in the optic nerve and not in the chiasm» or optic 
tract# byle (IgOg) believed that the amblyopia was centred 
on a primary degeneration of the ganglion cells of the retina 
in the neighbourhood of the macula lutes with a secondary 
degeneration of the neive fibres arising from the cells* 
Victor and Bryfue (1965) took the opposite view* The 
interstitial changes noted were considered to be an
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accompaniment of the degenerative process in the optic 
nerve itaeif, Sohieok (X9Û3) and Bar (1906) supported the 
view of Parsons (1901) that the action of nicotine in tobacco 
amblyopia was in part vascular# causing vasoconstriction of 
the arterioles, which explained the selection of the macular 
region with its unique vascular supply, Bohieok (1903) felt 
that the nerve fibres which maintain the retinal centre were 
unfavourably situated in the axial part of the optic nerve 
and therefore were liable to reflect nutritional disturbances# 
earlier than the fibres located in the periphery of nerve, 
Thus# tobacco was said to act on the nerve i)y way of a
chronic nutritional disturbance* Several authors had noted 
that the vision in tobacco amblyopia was improved by 
vasodilators and had considered that this supported the 
hypothesis that tobacco amblyopia was due to vascular spasm 
in the visual pathway (Oordos and Harrington 1935# Duggan 
1935*37)• Carroll (1957) challenged this as he had no 
success with sodium nitrate. It would appear that the 
lesion in tobacco mablyopia was primarily nervous rather 
than vascular (Gunn I930) and although the factor of vaso 
spasm could not be excluded# it is probably not of very 
great importance (Evans 1939)* Sohepens (1946) suggested 
that tobacco amblyopia began with an enlargement of normal
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angioscotomata particularly in the centro-oaecal regions* 
Heusohueler (1928) summed up the theories proposed to explain 
tobacco amblyopiaI-
(l) Primary interstitial inflammation of the papillo- 
macular bundle with predominating localisations in 
the optic canal and subsequent compression of nerve 
fibres by the newly formed tissue (ïïhthoff Igll). 
Primary lesion in the vasal system consisting of 
inflammation and thickening of the walls# often the 
phenomenon of endararltis (Sohieok I903).
(3) Primary degeneration of the nerve fibres of the 
papillo-macular bundle with secondary and simultaneout 
lesions of the ganglion cells of the macular region 
(Palen I9O6)#
(4) A primary lesion of the centre of the retina with 
secondary ascending degeneration of Ihe papille- 
macular bimdl© (Roenne I910)*
He further concluded that none was satisfactory*
parsons (1901) considered that the action of 
nicotine (or# rather of the unknown cause of tobacco amblyopia) 
was two-fold; (l) vascular# causing vaso-constriction of the 
arterioles; (2) paralytic upon the synapsis either of the
2?
eone fibres# of the cone bipolars# or of both, and Fisher
(1901) felt that nicotine was directly toxic to the ganglion 
cells of the retina* Ramsay (1S95) wrote "as far as my own 
observations go, all oases of tobaooo amblyopia when recovery 
is Incomplete will sooner or later exhibit peripheral 
contraction of the visual field» " These observations suggested 
that parts of the retina m â  optic nerve other thm those 
connected with the papillo**maoular bundle of nerve fibres 
were involved, though in some cases the nerve fibres even in 
the papillo#macular bundle were irregularly affected* Doyne 
(1SS9) auggeeted that tobacco might have a toxic influence on 
a îjypotîiotioal substance in the retina analogous to the visual 
pwple, degenerating it m d  causing retinal exhaustion, which 
shows itself in the failure of the more delicate colour sense* 
The exhaustion naturally takes place at # e  point of greatest 
retinal activity and where the light is proportionately 
stronger, the rays being more accurately focussed* Sohanz 
(1920) held the opinion that in toxic mblyopia the retina 
was damaged by light while the poisonous substances acted as 
sensitising agents*
Recent experimental and clinical evidence both 
suggest that there is sme connection between tîie metabolism 
of Vitamin B12 and that of cyanide, and that smoking, which is
associa tat with a high cyanide Intake (Burgeon General U.S# 
1964# Darby and Wiloon 1967) may adversely affect Vitamin B12 
metabolism (Boxer and Biokarde 1952# Woke# and Piocard 1955» 
Braekkan et al 1957» Wbkee 1958# 8ml# I96I» Smith et al IgëJ» 
Smith 1964$ Smith and Duokett I965# llatthewa et al 1965, Wllaon 
and Matthew# 1966» hlndatrand et al I966» Smith and Fonilkee 
1966)* The hypotheale that intereonneeted diaturhanoea of 
eyanide/Vitamin BIB metaholim may W  concerned in the 
pathogenesi# of tobacco amblyopia» the retrobulbar neuritis of 
pemicioue anaemia» Baber’e hereditary optic atropiiy» and 
certain tropical neurological syndrome# apparently aaeooiatei 
with a high cyanide intake itm tropical pulses such as 
cassava» is supported by Smith (1961)» Wilson (196$^)» 
Montgomery (1965)# Wilson and hangman (1966)» Monekoaso and 
Wilson (1966)» Freeman (196?)» Chisholm at &1 (l967)»Foulda 
et al (196s a»b# and a)» M m e l l  et al (19#)» and Osimtokim 
et ml (1969).
29
ES$ÏGâ$M.
Til© material far tliio manusorlpt m m  obtained from 
iAi& out-iiatient and in-patlont investigationa oarritkl out ou 
65 patlontw auffer&ng from tobaooo amblyopia, oolleotad o v w  
a period of J yearn# The patlmte warn referred from 
Ophtbalmologio&I ol&mlea In tb# area of the woet&BA Regional 
Hospital Board of SGotlaad, prinolpally from Glasgow and Ita 
Immediate eurrou&&&&ga,
Being tb# criteria of Heaton at al (1958) &# & 
guide the diagaoole wae oo&flrmeâ on the finding of bilateral 
depree&lo# of viaiou, m  sotuirei defeot of colour vielom, aad 
omtro-oaeml defooto in the field of vision, oemrrlmg in a 
amoklng eubjeot#
The patient ega ranged .from 46*84 yearn, all but 
m m  were male and their tobaaco eoneumptlou lay in the range 
0*5*? ozs# per week# The patiente wore informed that it 
wae not neceoaary to alter #mlr moking habit but five 
patie&te elected to abetalm from cmw#dhr&4MM& tbie was their
w #
la general, the patlmtc eought medical advice
after itoir visual symptom» had h em present for (> months 
or so, by which time the visual lose of both eyes was 
substantial. A number of the patients were ill due to 
ooinoiient disease and # 1» %m& categorised after 
investigation. In a few the coincident disease was # e  
reason for seeking medical advice and they had the visual 
complaint subseqmntly categorised*
Information about a patient’s direct vision can 
be obtained by examining his f om sense or visual acuity# 
his colour sense and his light sense* By examining his 
field of vision information is gained about his indirect 
vision* fhe patiente in this analysis of tobacco amblyopia 
had assessments of tWir visual acuity, colour vision and 
fields of .vision carried m t  to confirm the diagnosis and 
at intervale whilst on treatment*
As the disease process does not effect the eyes 
equally# the visual acuity is not equally depressed in 
tobacco amblyopia. According to #ie majority of observera# 
vision is poor in sunshine# but improves in the evening 
or in suMued lighting* (tielson 1880# Groenouw 1892#
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ïïarman 1904# Traquair 1930# Oarroll 1935). Thia la due 
to the glimmering mist which cover© all objecta, being 
removed with twilight mid allowing contours to become 
aharper, Hirachler (1071) claimed that this was ao only 
for large objecta and did not apply to reading*
fho distance visual acuity was estimated 
subjectively by mean» of Snellen’e teat iype at 6 metres 
(Snellen U62)* In each case the visual acuity recorded 
was the beet visual acuity with a spectacle correction*,
The near vision was similarly estimated using 
tlie notation laid, down by the Faculty of Ophthalmologists 
(baw 1951-52). Examination of the best distance visual 
acuity obtained from the 65 pairs of eyes, showed that in 
only 22 was the visual acuity of the right equal to th.at of 
the left, in 10 the visual acuity of the right was better than 
that of the left, and in 25 it was worse* Thu© confirming 
the unequal visual loss in this disease# As four of the 
left eyes were amblyopic from other causes (5 from long 
standing squint, 1 from a central retinal artery occlusion) 
and, as no improvement in vision could be expected in them, 
the rigîit eye of all patients was selected for all visual 
compa,risoBs*
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The viauaX aouity'(Bncllen) was converted to 
percentage visual acuity (Ridley 1959)*' The visual acuity 
in untraatecl tobacco amblyopia was found to be within the 
range 1*5 - 100^ with a mean at 18^ (equivalent to a 
visual acuity of 6/j6 Snellen)* Of the 65 patients 21 had 
a Visual acuity of 6/24 or better and 44 ^ visual acuity 
of 6/36 or worse* The Improvament in vigual acuity with 
therapy is dealt with In the ©setion on treatment#
The near vision results were similarly transposed 
into the percentage visual acuity scale* The range for 
the right eye was 8^  - 64^ with a mean at 20*?5# which I0 ■ 
equivalent to 11$ at a standard reading distance of 15 
inches or 3i oms* The disproportion alluded to by 
classical writers between distance and near vision was not 
aonfisnaed (t « 0*5?I n ^ 116; p> 0*1)#
The OolQur Sense
The colour sense can be tested by various methods 
some of which give only a rough estimate, while others are 
a very sensitive index* The methods are as follows*- 
(a) Colour Wamlm?
%  thia means a subjects ability to name correctly
3)
or incorrectly test colours will reveal gross defects of 
colour vision. Inability to distinguish one primary 
colour from another is termed gross colour confusion.
(h) Paéudo-iaoohroroatio Plates or Oonfusion Charts* 
These plates made up of coloured dots in which 
the baokgrotmd colour differs from that of the figure (he 
it a number or symbol). These plates have been 
deliberately constructed so that the background and figure 
coloui's lie at different points m  a known confusion asds 
for one of the congenital dichromats* See Fig 2» By 
presenting a series of appropriate plates, a patient can 
be quickly screened for the four congenital colour 
defioienoies* The plates that are available are after 
the pattern of Stilling (l88j), Bvorine (1955)$ Hardy- 
Band-Bittler (1955)$ Ishihara (1959)$ and the Tokyo Medical 
College (1957) •
(c) Pigment Matching Tests.
These test a subject’s ability to discriminate 
between colours which differ only by a small amount when 
viewed under a constant illumination. The Farnsworth- 
Hansel1 100 Hue test (Farnsworth 1945) i© a refined and 
Useful member of this group. The test enables a 
qualitative as well as a quantitative estimation of the 
colour defect to be carried out (Orone I96I)*
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for %he kmmn. eongonitaX oolow #feote. %n the ©entrai 
area le ehown tko looi for tîio F.M* 100 Hue caps and the 
Rumbere refer to cap numbere* (After hekmBkt 196©)#
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(a) ^
tests a m  oarrisd out m  an anomaXosoops 
after the pattern usei W  BageX (190?) > or Fiokted and 
bakowskl (X9#0)# fha subjeot views a halved aperture* 
one half containing the test speotml oolonr* the other is 
controlled by the testes* Is is required to moke a colour 
match by varying the proportions of two other spectral 
colours which can balance the test colour at \momk 
proportions* % e  Wagel anomaloscope tests for red«*green 
colour defects (l#e* Frotsn and Deutan)# and the Fiokford*^ 
ilcolson anomaloscope for red^§rcen.| yellow^hlue - (Sletartan) 
and green#hlue (fritan) defects* fhis is a delicate 
method of assesament which requires considorahle experience 
In its use before the Interpretation of the results are 
meaningful*
Defective colour vision is acquired hy patients 
b o m  with a potentially normal colour vision syatem which 
has failed to reach maturity or has deteriorated after 
reaching maturity» because of local ocular disease» 
ayatemic disease or the toxic effect of ayateojically 
aâmiïiictcred drugs* *Bie extent of the acquired colour 
defect is unequally distributed between the ey#s and each 
eye must therefore be tested separately* A typical
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dysohromatopsia develops from normal triohromatio vision 
though an abnormal triohromatio stage before dlchromatie 
vision is reaohedi further extension of the process will 
lead to monoohromatlsm and eventual blindness* Pseudo-- 
isochromatic plates are of little value in detecting the 
relatively early triohromatio stage which can be detected 
by the Famsworth-wMunsell 100 Hue test or by anomaloscope 
tests*
Disease processes affecting the neuro^sensory 
or conductive layers of the retina will if severe enough 
lead to blindness* bees severe disease will degrade visual 
function In a variety of ways including the development 
of an acquired dysohromatopsia* #us lesions of the 
neuro-sensory retina by and large» result in a loss of 
colour discrimination in the yellow^blue» or violet blue- 
green» and lesions of the conductive layers in the red-green 
areas of the spectrum respectively* (Koellner 1912»
Cox i960, Verriest I96;)*
The Oolour Sense in fobaoao Amblyopia
One of the dia^iostio criteria of this condition 
is the finding, in the centro*#caecal area of the field of
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vision» of depressed Bensitivity to red and green stimuli* 
Aooompenyiug this is a aubjeotive tiisturhanoe of colour 
diaarimlnation which traditionally reveals itself by the 
confusion of gold and silver coins, or today, hetwem 
copper and cupro-*niohel* Qalejsoweki {IBBJ)' w&s first to 
draw attention to the subjective colour defect in tobacco 
amblyopia arid ©roenouw (I0f2) pointed out that this acquired 
dyacîiromatopsia differed from tlmt of the congenital 
diohromst* In more recent times Riddell (1936) observed 
that with treatment the colour sense in tobacco amblyopia 
took much longer to return to nomal levels, if at all, than 
did visual acuity* Box (i960), Francois and Terriest (1961) 
Saraux et al (I966), Bouniq and Cfoaoaa (1966), observed that 
the dyechrcmatopsia found in tobacco amblyopia had features 
in common with other toxic amblyopias#
Of the teats available for investigating the 
colour aenae, the Famstwrth Mmmall 100 Hue Tost was found 
the most useful in the investigation of the tobacco 
amblyopia patients* fhe test conaiets of a graded series 
of 05 coloured caps mmtigéâ in four boxes# The patient 
la required to arrange the colour caps into a regular colour 
series between fixed end caps# He is presented with the
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oolourad caps arranged in a etaoclard rmdem fashion*
Bach cap Is mimhered on its reverse aide* The patient* 0 
arrangement of the caps is recorded on a chart, (fig 2.» 2) » 
and deviationa from the normal arrangement are soon 
apparent* As the caps are numbered, the error of m y  
particular cap is obtained by summing # w  differences 
between the cap number of the cap in question and the cap 
mmber x^ hioh comes before, and the cap which comes after 
it* If the patient’s arrangement is normal the minimal 
aiTor score for any cap ia 2# Two is accordingly 
deducted from Individual cap scores and the sum of these 
individual error acores gives the total raw score* The 
individual emror score ■ of the cap# may also be expressed 
graphically as the patients profile*' (Fig*^, 2)#
fhia teat was originally deaigïied as a binocular 
test, for the screening of youthful subjects for congenital 
colour defect, end a time limit of 2 minutes was placed 
for the completion of each box* This routine required 
amendment fbr the investigation of the dysclwrnatDpsla of 
tobacco amblyopia* Booh eye was examined separately, and 
no time limit wae set for the completion of each box as 
the patients being tested were elderly# many had defective
5 4 10 12 9
2 I J( »  i, 7
3 3 3 3 3 4 5 7
13 11 18 17 20 19
X  ^  14 15 16 X  >«f ^  21
6 5 4 3 3 4 4 3 3
Piguw ^  g. ' Showiflg Bpeoimen Farnsworth Hwnsall 100 
Hue caloiûation sa& profile»
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vlelom and had dlffloulty in manipulating the oape# 
Standard artlfioiai illumination waa provided by a îlubble 
Verl ?idl oabinet wMoh provided artificial dayli^it 
illumination with a colour t#%p#):atur# K with an
intensity of 1200 *1290 Imc at the teat cape» thus 
oonforaiing with l#Bè 950 part one (19^7)4
The materials used in thie teat come from all 
parte of the ootom circle and hue diaorimination near the - 
centre of the colour epaoe can be tested in all diraotions* 
O m  o f the great merits of the Farnsworth Mtmsell 100 Hue 
test is that elements suitable for detecting colour 
confusion om  also be used for detesting the variations in 
colour clisorlmination existing among triohromatio observers, 
(Hg« ^  %)# to be able to measure these variations tasks 
presented for discrimination must inelude small oolour 
differenees ( a  B) suoh as are found In this tost* whore 
A B  between suooessive oaps is of the order 2*5 
units (ifetion Bureau of Stmdards). The task hero may 
be considered analogous to visual aouity testing (Wmwaki 
I9G8)# Subjests with aomto colour discrimination will 
arrange the % olour series” in each box within the two 
end lim its  oorreotly, tliLOse with lessor discrim ination
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will accumulate ”error scores" which are a ipcssure of the 
degree of displacement from the ideal arrangement.
Terriast (196)) demonstrated that in normal 
healthy subjects the error score of the Farnsworth Himsell 
100 Hue test increased in a positive manner with age* after 
20 years of age* (Fig# 2# ?)♦ ^his was in agreement with 
the earlier finding of Imkowski (1958) who described 
distinct phases in the normal development of colour vision* 
Colours are perceived and discriminated most accurately 
between the ages of 16 and )5 years* After 55 years there 
is a rapid deterioration in ability for fine colour 
discrimination* Hed*green discrimination is least affected 
by age* but yellow#b?.ue and violet blne*#green discrimination 
may deteriorate from as early as the JOth year* lakowski 
(1962) produced evidence that these observed deteriorations 
in colour discrimination were due to retinal rather than 
pre*retinal changes#
Bach patient performed the Farnsworth Munsell 
100 Hue test on more than one occasion prior to the 
commencement of treatment* The error score for the right 
eye of each patient is presented in this analysis. For 
the 65 patients* prior to treatment the erxror score lay in
RAW
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Figaro 2^  3* Mean B'arnavortîî îteaall 100 Mae taat error 
aoore in normol patienta rolateA to age, (after Carriest 
1964) and showing the upper 95th par oant limit*
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the mmge with a mean et Ab a group
theme error eooree are mmoh higher them, preirioualy 
reoorêeâ aumlyaea Verriaet (196^ ) mi norfaaXe^  Kimiear 
(19^5) on diahetioB, Xakowokl m%à Davenport (i960) on 
ohlorogulne treated arthrltioa: and aomo doubt meat be 
oaat on the validity of sooroa above 1OÔ0 which can be 
achieved %' randomizing the cape# à %plcal Farnaworth . 
Munaell'. 1#, Hue profile ie «hown in Fig# gj 4#
' ' -In order to invoatigate the validity of the 
teat at. high error eo&re# m  investigation wma carried' out 
into the change- In error soore on two teats and- on multiple 
teating#;
(1) CommrWon of t M  W W m  let and gnd
teat .and initial error j^ core#
03 patienta were selected at random and tea ted* 
Theae patients included examples of tobacco amblybpia# ■ 
heber* e hereditary optic atrophyt macular degeneration^ 
squint, glaucoma and endocrine diaeaee* One eye at random 
from each patient use reteated after 24 hourG*
The relevant figures ore contained in table 1
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* 1»
\,J 0 0  Hue Test 
TOBACCO AMBLYOPIA
figure 2j 4* Anarohio profile in Tobaooo Amblyopia, but 
with preponderance of error in the red-green areae.
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M L S  2,1.
CHANGE IN  100 HUE ERROR SCORE ON TWO TESTS WITH IN ITIAL ERROR SCORE
GROUP 0 - 200 201 - 400 401 - 600 601 -  800 801+
NUMBER
IN GROUP 18 19 14 18 14
MEAN CHANGE - 15 +  0.31 - 9 , 4  -  9 - 53
STANDARD
DEVIATION ±49 ±56 ± 76.5 ± 141 ± 166
95 PERCENTAGE ± 96. 04 ± 109.76 ± 149. 94 ± 276. 36 ± 325. 36
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and figure 2^  5* As crni be seem lu Figure ^  5# at error 
eooree above 601 there appears to be a trend towards 
spoutaueeme Improvement on retesting* However, the mean 
change in error score In this group m  in each of the other 
groups is not aIgulflearntly different from the expected 
value of zero (60I#B00; t «* 0*27, n *» 17# P>0*1î 000+1 
t 1*19, u ^ 13, p> 0*1)*.
With increasing initial error score however* there 
is an imreaeed scatter of remit»* the inoreaee in variance 
being statistically oignlfioant only for teste at erkOr score» 
of over 600* (601^a0C% W m 2*B7, p<0*0g; 001+* F « 3*90, 
p<O,05)* fhero is no. evidmoe to support the premise that 
repetition of the teat improves performance.
From these figures one can deduce by how much the 
error score at each particular level must change to be
regarded as a aignifioant alteration in the result of the 
teat* fhi» is illustrated in Figure £, 6* Here the 95# 
range about the mean is shown* A cimnge In error score 
lying outside theae limits would Imve m one in twenty 
probability of arising by chance and would therefore be 
significant# Fox* example, with mi initial error score of 
130, on retest a score of 39 would be a significant
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CHANGE in RM. 100-HUE ERROR SCORE on 2 TESTS, 
with INITIAL ERROR SCORE (83 eyes)
Change in 100-hue 
Error Score
300
IMPROVEMENT
150 -
0 - —
150 -
+ WORSENING
300
200 400 800 1000600
INITIAL P.M. 100-HUE SCORE
figure 5.. M e m  ehmga in the ftoBell 100
Hue te&t error score on 2 teste with tm indication of 
variance oompored wi# initial error score*
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CHANGE in RM. 100-HUE ERROR SCORE on 2 TESTS, 
with initial Error Score, showing 95th Percentile Limits (sseyes).
500 -1
400  -
300 -
IMPROVEMENT
200 -
100 -
50 -
50 - 
100 -
200 -
+ WORSENING
3 0 0 -
400 -
500
200 400 600 800 1000
INITIAL P.M. 1 0 0 -HUE SCORE
Flgtirm 6# Compwiaon o f eh&mge in  the
Mmeell 100 Hue teat m  U m  teeta, v?ith iBitiaX e-x;vow
eoore, mid ehoving the 95 aent limite qf the varianoe*
improvement ÿ or a aoore of 251» a signifioant deterioration j 
similarly at an initial error soore of 700, a fall to 415» 
or an inorease to 967 would be significant*
4 comparison between age and change in error score 
and between age and error soore variance for this group of 
patients showed no significant relationships in either case 
(fable 2.1 2, and Hgure 2, 7) *
Table 2,2#
CHANGE IN 100 HUE SCORE ON TWO TESTS WITH AGE
AGE GROUP ( YEARS ) 30 31-45 46-60 61-75 76 +
NUMBER 10 11 14 30 18
MEAN CHANGE IN  
ERROR SCORE - 7.5 + 9.45 - 72 - 35.6 +  38.05
STANDARD DEVIATION ± 78. 96 ± 75.4 ± 142. 6 ± 260. 8 ± 108.2
go
Change in 100-hue 
Error Score
300
CHANGE in RM. 100-HUE ERROR SCORE 
on 2 TESTS, with AGE (83 eyes)
150 -
150 ■
+
300
IMPROVEMENT
WORSENING
— I—
30
—T-
45 60 75 100
AGE in YEARS
Figure 7. Coapaïlaon of oliange in the Parneworth 
Munaell Hundred Hue teat aoora in two teats, with age, îhe 
mean of ohange and variance are shown*
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(2) 
Table 2,5,
RESULTS OF MULTIPLE TESTING
PATIENT 1 2 6 7 8 9
NUMBER 
OF TESTS 6 9 10 10 10 10 6 10
AVERAGE
SCORE 43.6 157.44 184.75 274.8 520.5 602.7 686.5 696.3 785
STANDARD 
DEVIATION ± 11.76 18.25 29.5 42.6 47.45 59.2 60.14 54.6 95
Th© variance about the moane in figure 2, 5 in
made up ef 2 oomponeute * the inter-obeerver error and. the 
intrawobeerver error» To eetablieh whether "familiarity" 
with the toot had any bearing on the test result, patients 
from each éP^ oup except thoae with error ocorea over 800 wore 
selected for intonolvo toatiug owr a space of 2**3 doye»
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INTRA-OBSERVER ERROR Compared with 
ERROR SCORE (9 patients)
Variance
120
90 -
60 -
30 -
0 200 400 600 800
AVERAGE ERROR SCORE
^*0* -Intra ** obriorvatlonaX for the Farnsworth
MimaoXl lOD Hue teat# (r 0*915 n » ?? 0*001)*
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In these teats the same eye was m m i m â  ou each oooasiou*
For this analysis the aoatter of the results about the mean 
error soore was useâ* The results are shown In table £t )#
In no ease was there any inclieatien that repetition influenoeâ 
the patient*B performance.
à comparison of the average error score with the 
error soore varianee for each patient# shows a significant 
positive relationship (r # ###1, n # 7, p < 0*001)» (Figure 
2# S)« As this variance is a measure of the tatra observer 
error# it can be seen that this quantity increases with error 
score* The difference between this variance and the variance 
found on two tests is a meaanre of the inter observer error# 
1.0» error inherent in the test. This also inoreaees with 
error score.
fhie comparison was possible in 64 patients# 1 
patient in the saris© had abstained from smoking prior to 
the first outpatient oonanltatlon and was therefore excluded, 
à positive correlation between patient age m ü  the Farnsworth
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Ago in Years
AGE and F.-M. 100 HUE ERROR SCORE
in UNTREATED TOBACCO AMBLYOPIA
90 n
80 -
7 0 -
• #
6 0 -
r = 0-325
0-01>p>0'001
50-
300 500 700 900 1100 1300
F.-M. 100 Hue Error Score
9* Gomparlaon hetwoen age in yeara/'emâ' the 
Pamaworth U m B ù ll 100 Mme teat error aoore la mtreated 
totoaaao amblyopia# (r «» a 68$ O*O01<p <0#01)#
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ïteisell Hundred Hue teet result was obtained in untreated 
tobacco amblyopia which was significant (r *» 0*525$ 
n « 62| p ffi»<0*0l)* (Figure^, 9)#
2• Comparison of ?#M* 100 Hue error soore and visual acuity 
in untreated tOobaoco Amblyopia*
%is comparison was possible in 64 patients* A 
positive correlation was, obtained which was significant 
(r ea 0*4^S| n « 625 p ««<O*O0D* fh© visual acuity ^ in 
this comparison was ©stressed as a percentage taking 6/6 
Snellen as lOC^ after Hidley (1959) (Figure 10)*
3 • Comparison of f *M* 100 Hue error soore and duration 
of symptoms in untreated Tobacco Amblyonia*
The comparison was carried out on 5I patients whose 
duration of symptoms was definite* A positive correlation 
between these 2 factors was obtained which was just 
significant* (r *# 0*242$ ni*» 49; 0*3>p>0*05)* Thus
patient® with a long history of visual disturbance tended 
to give a poor result on odour vision testing*
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VISUAL ACUITY and F .-M . 100 HUE ERROR SCORE
in UNTREATED TOBACCO AMBLYOPIA
percentage 
Visual Acuity
25 -
50 -
75 - r = 0 -402
p= 0-001
100
12501000 1500750250 500
Figure 10* Oompurleon between fereantaga visual acuity 
and Faraawortb fômaell 100 Hue teat error eoore in untreated 
tobacco amblyopia# (r «« 0*402; u # p < 0*001),
4* gomcarlBom of 100 Hue error acore and serum vitamin 
B12 oonoeatration in imtreated tobaoQo mblyepla*
fhia gomparlaoa waa carried out on 60 patients*
A positive correlation was obtained but this proved not to be
significant* (r » 0*l6l| n * 58; p > 0*l)*
5* Qomoarison of F%M* 100 Hue error soore and serum folate
concentration in untreated tobaooo amblyonia*
This comparison was carried out on patients*
A positive correlation was obtained which proved not to be 
significant* (r « 0*166; n *« 49; p> 0#l)*
The Field of Vision*
The investigation of a patient*® indirect vision is 
carried out by examining his field of vision* This can be 
accomplished by several meansi*
1* Kinetic. Examination of üeld bf Vision*.
(a) The confrontation test is simple and easily applied* In
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its execution the obsemrer teats the range of the patient*® 
field of vielOB by that of his mn* The ohaerver and patient 
ait opposite each other at about one metre apart# a hand or 
test object Is introduced in the mid plane between opposite 
eyea# %#en the test object cornea into view the position is 
noted. The test û m  be repeated in as many meridians as 
neceeeary* It 1# of value in examining the field of vision 
In. children,
(b) à well established method of delineating the field of 
vision accurately is by perimetry* The perimeter consists of 
a half sphere# or rotatable arc revolving around a pivot in 
order to teat varimîs meridians* fhe arc of the circle is 
approximately concentric with the retina* The patient with 
one eye occluded# fixes a stationary central mark at a distance 
of § of a metre* The test object is moved in from # e  
periphery until it ie seen* By using teat objects of 
variable else and colour#but of fixed lumlnmce# and with e 
oonstont background illumination# the boundaries of those 
areas of the retina just semitlv# to the given tWeshold 
a m  determined, The linm joining points of equal 
sensitivity ere called isopters* (Groencuw 1093)*
(o) %  using a somewhat similar teclmiqu# the central area
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of the visual field {2(P aro’uud fixation point) oan be 
mrMfThirnl m  the tangent soreon %  oampimetry* The patient 
site from the soreen at m e  metro or two metres distance*
Th.0 ooroen over which the toot objecte are moved is flat# 
and m  the mode of projection ie taii^ iontial# a certEîin 
arnomit of magnification of the defecta ocmiro which la not 
30 in perimetry* The central# oeatr<.>**oaeoal and Mind 
apot areas can bo itnveatigatod very aoenrately by tills moons*
II* .Po:^ lT%etry
Quantitative Perlmtry (Bair 1940* %rmo 1952) 
or light sense perimetry (Sloan 1939) or static |>orim0try 
( Fraïikcnhauser and Schmidt 1950) la carried out by moacuring
tlio va ria tion  o f luminance o f the tos t object to  'produce 
recognition at a serloa o f fixed locations in  the f ie ld  o f 
vision* The entire  vicua l fie ld  oan foe explored from the 
contre to periphery in e  m m W r  of d iffe re n t meridians# and 
by nsing a mnios o f tost objecte o f d if forent oiiîo ono oan 
accurately raeasnra both the density and extent o f a ecotoma,
The apparatus conolots o f a I'iemi-aphoricol bool* Tho 
patient*a eye le located 33 oontiiaotroc tmm this sphere* The
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baokgazoimct, Illumination of the howl is variable# and generally 
an illiminatlon of lOaeh I0 used (l ash « 100 n lux)* By 
means of neutral filters the illumination of the teat object 
can be reduced by 80 equidistant logaritiimlo stages from, 
iOOOasb to 0*00001asb* The light threshold is measured at 
2^ intervals along any given meridian and gives sections 
across the ’^ island” of Traquair (1930)* (Figure 2# ll)&
The Field of Vision in Tobacco Amblyouia*
Though a central scotoma for colours (Red and Green) 
was found in tobacco amblyopia and tpbacco^aloohol amblyopia 
by beber (1869)# Galezowskl (1683) and Connor (iGgO)* most 
authors have described the typical scotoma as para**oentral 
(Oroenouw 1893# Byle I905, Boyne 1922 and others)# Tracxuair 
(1930) emphasised that the scotoma was in fact centre#caecal 
and not central# The scotoma developed by extension from the 
nasal side of the blind spot and was uniform in character.
It was ovoid In shape and contained nuclei of maximum density 
(lambresin and Sohepens 194& end Heaton et al 1958)*
Byle (1903) showed that central vision for green 
was affected first# red later and blue last. Oarroll (1935)
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Leuchtdichte: Farbe: Durchm.: 
asb X  ^ m ln  IMeridian: —|—Name: Dal.:
a LAPriifp.: VIsus:
FIxlerp.:
Umfeld:
Dlagn.:
Korn:
asb
0,32
100
IIS
ISO
SOD(30
320
«0300
•to100
1000
M g u m - II#  Ite a a l s ta tio  perim etry o M rt aeme# the 
horizontal meridian and outtirig aaroais W t h  the
fixation point and the blind epot#
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foimd dentro'-'oaeoal eootomae» that for red being larger thaâ 
that for bine) and Heaton et al (195B) ohowetî that the eoototna 
was bilateral) larger for oolonr than white# and aocompanled 
hy a temporal conatrietion for oolour#
ïihrane (1959) found th# following distribution of
scotomata* oonfluent with the blind spot in 71; half way 
between blind spot and fixation point in 18$ maximum central 
In 0* Boxmi<x ^nd Coeoae (1966) found almost an equal 
distribution between central and centrooacioal aootomae* 
According to Hhthoff (1886) the margin of the scotoma in the 
most severe cases may enoroaoh into the periphery of the field 
and de Schweinitz (1922) found tWt the periphery of the field 
of vision was not always intact and defects could bo found 
if the tests were carried out under diminished illumination# 
lîambrosln and Schepene (1949) held the view that the scotoma 
of tobaooo amblyopia and that of tho hereditary optic atrophy 
were similar a,îxd they raised the question that the aetiology 
of both conditions was similar#
The patiente in this analysis had examinations 
of their field of vision carried out by campimotry «md static 
perimetry#
#' RA
M  RA
ytgure 12* Cai^lmetzy abowine typloal oant»o-o«»o«l 
sootona and atatio parlmatqr chart of uatroatsd tobacco 
amblyopia (upper pair). Alteration in both oampimetry and 
,tatic periaatiy after three months treatment with 
hydroxooobalamin (lower pair), shaded area indicates extent 
of deviation from normal*
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(a) î5xamination of tho oenWai area of the field of vision 
revealed topical oentro*saeoal soatomas before eaoh eye in 
wMoh the defect for colour was larger than that for white*
In most patients the scotoma extended some way frm the 
blind spot towards the fixation point# and in some# included 
the fixation point* Figure 12 shows a typioal example*
(b) The types of defect detected by static perimetry fell 
into 2 main categories and were similar to those described 
by %ingirian and Hivara (1965)* The first type of defect 
is a relatively uniform slope and was present on examination 
of 8 eyes# the second is similar but the slope is interupted 
by a tooth or spike in the juxta caecal area and was present 
in 52 eyes out of a total of 60 ©yes examined by this method* 
In all the cases examined the nasal margin of the defect 
extended beyond the fixation point for a variable distance 
into the nasal field# even in these oases who retained gsod 
visual acuity*
The response to therapy can be demonstrated by 
static perimetry and Mlson (1969) followed patients suffering 
from tobacco amblyopia, treated with hydroxooobalamin by 
recording the change in field area* A typical example of
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the field defect recorded by kimetio and static perimetry 
before and after several months #erapy with liydroxooobalamin 
la shown in Figure £#> 12*
f’atient .in fohapeo Mhlyonia* ' '
All the 65 patients were smokers j 5Î pipe onjy# 3 
oigarettee only end g$ both* there were 64 male patients 
and I female* the mean age of this group was &fi 9*1 year©, 
with a range of 46 * §4 years# 47 of the patients (ahofut §) 
were of retirai age or older, hut # e  greatest ineiienoe lay 
in the 60^80 years age group* (âs shown in table 2| 4)#
This is higher than the previously recorded inoidenoeai 
maximum incidence in the $0*s recorded by %her (1927a) and 
Traqpalr (1938)#
However, when the figures are related to the 
percentage of # e  male population in these age ^mups the 
incidence is fcmd to be maximal in the 70#80 years age group*
*In this analysis the figures for the 1961 census for 
Glasgow were used* The proportion of males in each age group 
was compared, aa a ratio Tobacco amblyopia/census* The
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résulta are contaimed in tabla 4 and figure 13 and 
refer only te the male fatieiits*
Table 2# 4# 
Age Group 40*49 50*59 60*69 70-79 80+ Total
lUBbara# 2 18 28 24 4 64
Percentage 3.1s 18.72 34.32 37,44 6,24
1961 Q m m m
Hatio M a. 
(Zeamœ
12,3#
0.85
18.4%&
1.5
7.56^  3.44f^
4,54 10,88
0.94#
6.64
The proportion of emoÿimg to mon#smoking males hae 
been examined by Todd (1966) who found on over all inoidenoe 
for all ages of 72# smoker# in 1961 mà  68# in 1963, hat 
indicated a. falling inoidence by age# A study carried out 
by Brett and Benjamin (1968) on an industrial population 
revealed an inoidence of 68## smoker# of #%om l#ÿ# were 
pipe smoker##, Boll and Hill (1964) found 13#2# of dootora 
were pipe amokers* and the Tobacco Hesemzch Cornell 3*4# of 
the general population (Todd 1966)# Hnfortuaately, these 
published statistics do not show the incidence of smokers, 
by decades* above the age of 60 years#
Wore the scatter of tobacco m*blyopla patients
10-88
6-64
5-
4-54
1-5
025
50 60 70
Age in Years
90
ïi'lgîure 13, Xnoidenoe of tobacco amblyopia with age, 
as indicated by the ratio of percentage of patients in 
experimental gronp to actual percentage of population in 
the same age groups.
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evenly distributed with age the ratio 1'ofeaooo Amblyopia/ 
censuo would be the same in all age groupe* ïho results 
not only oonfim that tobaeco mbXjropia is a disease of the 
elderlyI but also illustrate that the inoidenoe of the disease 
inoreased xjith age up till 00 years* thereafter declining#
l^om the figures in this analysis it is evident 
that the inoidènoe of the disease in the 70 year olds is 45 
times as common than in 40 year olds*
Duration of Symptoms*
The duration of visual symptoms prior to seeking
medical advio© was known acouratoly in 55 patients and lay
within the rang© 1 • 24 months with a mean at 6 months*
4*5 months* Patients whose symptoms were present for an
indefinite period have been excluded* Patients over the
age of 65 years were as likely to report for treatment earlier
or later than 6 months as were patients younger than 65*
Patients 65 years Visual symptoms Visual symptoms 
or younger < 6 months for 6 months
or more
14 9
Patients older than
65 years 18 I4
(x n 0*111 n «* 55; p 0*95)
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Thus age played no part in determining when a patient 
reported for advioe*
Visual Aouity and duration of symntoma in untreated
A comparison between duration of symptoms and the 
percentage visual acuity yielded a correlation which was not 
significant (r » 0#085; n * 55; p^ Q.l)* Thus length of 
illness did not appear to materially affect the extent to 
which the visual acuity was lost*
Duration of Evmotoms and Visual Outcome*
The effect of duration of symptoms on the visual 
outcome is dealt with on page 146 where it is demonstrated 
that the earlier the patient presents for advice the more 
likely that the outcome will be favourable*
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c m p T m  III,
It ha© been obvloiw to all obaervero that the 
majority of tobaooo ueere do not develop tobaooo amblyopia 
ovm when not in perfect health, EutcMnaon (1075*07)»
BaXea (1807) n W  Tm q w i r  (ifJO) postulated an individual 
inherited ouaoeptihillty to tobaoeo In patients showing 
tobaooo amblyopia* General ill health (Balae 1007, fraqmair 
1930 m â  Erlmeky 1934), and psyohio shook (fmqualr 1930* 
llarnbresim mid Bohepens 1946) have been mentioned m  
precipitating oauees. Hutritional dietnrbancee have been 
blamed for am inoreaaed emeoeptlbility to toxio amblyopia,
In particular e vitmmln defioimoy, although Carroll 
(1935*56), Carroll and ^anklln (1936) did not oonaldei? 
tobaoGo amblyopia purely the remit of a defloieney state*
The aetiologie factor of vitamin Jldefioienoy in the 
amblyopia of tobacco or alcohol habituée ban been suggested 
by Duggen (1935), Gottlieb (I941) end Groess (1930)* but 
olinical trials have not convincingly ehowi that tobacco 
amblyopia ie oaueed by vitamin B complex deficiency 
(Heaton at al 1950)#
n
Battler (3,925)® Bach teg; (1920), Baohtes mid 
Burtsohor (19H0), fraqiiair (1950)# llambresin and Bohepons 
(1946) m d  Grosz (1949), 3mv@ proaaiited atatistioal evidence 
pointing to an laoreaee in the imiûmo 0 of tobacco amblyopia 
during wartime, partiomlarly in eoumtriea suffering from 
food eearoltiee* There appears little doubt that the 
inoreae© in tehaoco amblyopia during the 1914*1913 and 
1959*1945 World Ware w%& due to nutritional faotore rather 
than by change in the degree or manner of tobacco use*
Carroll (1935) reported that the OSF in ten oases 
of tobacco amblyopia was essentially normal* Be 
Bchweinitz and Msall (1903) studied the blood, urine, 
faeooa and stomach contents and reported evidence of an 
upset in digestion and metabolism* Lelshm&n (1951) foimd 
a high Incidence of hypochlorhydrla and achlorhydria in 
tobacco amblyopia* Heaton et ul (1953) found a 
©ignlfioantly low level of B12 in serum In tobacco amblyopia* 
They further pointed out that mmw workers have noted the 
Importaniba of nutrition and general state of the patient 
with tobacco amblyopia*
Carroll (1935) felt tlnat there were other factors
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in tîie and pmgree» ni tobacco amblyopia other than
tobaooo and alcohol# He allowed patiente to oontinue to 
emoke and oomeme alcohol while rmiintaining them on a high 
vitamin diet eupplemented by yeast, whe$%t*#rm, ood*liver 
oil, and liver extract injeotiome. fhe euooesa of M s  
therapy is reflected in the rate of recovery which is as 
good as in any previous survey in which the patients had 
abstained from tobaooo#
Inj^lnenpo of. AlObhol# _
Widely divergent views have b e m  expressed 
cGuoeming the influence of alcohol in the produotion of 
tobacco mblyopia*. ■ On # e  other hand, there are those who 
deollne to Hntchinson^a view (1876) that total abstainers 
from stimulants are more liable to suffer than others and 
that on the whole, alcohol eounteraots tobaooo. Thus# 
Berry (188?) held that alcohol more probably oounteraots 
than abets the poisoning which gives rise to the amblyopia, 
and Gunn (IBB?) believed that total abstainers are probably 
pemliarly apt to get toxic amblyopia from a oomparatively 
small amoimt of the poison#
de SOhweinlts (ifOO) stated that alcohol was not
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antegoEistio to toWooo but# in fact, predisposed to 
tobaooo amblyopia by producing a chronic dyspepsia* 
Aooordimg to bhthoff (lB86#lgai) aldohoi alone in excess 
will cause the oliaioal picture of toxic amblyopia*
The following relationships between tobacco and 
alcohol in the production of the amblyopia have been 
suggested#*
(1) Both alcohol m û  tobacco are causative agents,
(2) Either "agmt alone is capable of causing the 
dieeaae, although usually free indulgence in alcohol is 
associated with heavy smoking# (llamaay 1^9% Parsons I90I# 
hyle 1905» do Sohweinltz W 7 #  lyle 1947 and Maxwell 1953)*
(3) The ' influence of alcohol in the production 
of tobacco alcohol amblyopia is secondary or doubtful 
(Traquair IflO) since the amblyopia is observed in non# 
drinkers# but not in non#smokers# (ieltlaship 10B7, 
lanibreain and Bchepens 1946). fobaooo*aleohol amblyopia 
improve# wiien smoking is stopped even though the patient 
continues to drink (Berry 1##2 and llvans 1939).
(4) Alcohol indirectly forme the toxic effect of 
tobacco on the eye (Bemy IBi?# Gunn 1887# Mettleship 1887 
and Heaton at al 199f)-*' Oarroll (1935^) believed that
increased susoeptiMIity of the patient was a far more 
important factor than the amount of tohaoco or alcohol 
oonaumed# Aa a rule, neither tobacco or alcohol directly 
affect the eye, unless the substances have first attacked 
the general health (Krimsky 1934), & view which supports
the bel&af that cîironic retrobulbar neuritis is a true 
deficiency disee,ee#, -
The alcohol intake of the present group was 
assessed in 55 of the patients| 16 patients abstained from 
alcohol, 18 occasionally took alcohol, and 21 had a daily 
intake of alcohol* The alcohol consumption of 8 patients 
was considered heavy, but in only 3 of this group did the 
visual improvement reach 6/9 (Snellen) with treatment*
Of the 13 moderate drinkers 5 (38*4^) and of the 16 teetotal 
patients 10 (62*5^) achieved a visual improvement to 6/9 
(Snellen), or better during the period of treatment* It 
would seem that the alcohol consumption influenced the 
outcome* However, it was found that those patients who 
dranic heavily also smoked heavily#*
Heavy drinkers mean tobacco consumption 3*68 oae per week* 
Moderate drinkers mean tobacco consumption 2*6 oz# per week 
Abstainers from alcohol mean tobacco consumption 2*5 02s•
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per week*
' It was felt that alcohol ployed little if any 
part im the aoureo of the illmeee*
Vitamin B12* '
Binoe oyanooohalamin was isolated by Bmith (19#) 
and the eubaequent elucidation of its etruatura m â  that of 
various analogues, there lim been oonaidorable interest in 
their biological roaotione* Vitamin B12 is a group of 
oompounde, each of which ie a complex porphyrin derivative • 
eontaining-a tervalent cobalt atom lltifced to a nucleotide# '
A nomenclature of the mbmbere of the Vltaniin B12 group# 
based on the nature of the nucleotide oemposltion has been 
proposed# in whièh the term Oobalamin i# reserved for those 
qompounds in which the nucleotide contains # e  Imse 5*6, 
dimethylben&imidasole »
The six qowordinsto valenoiee of the cobalt atom 
are satisfied by the four nitrogen atoms of the tetrapyrrol, 
a nitrogen atom of the nucleotide; the sixth'valency is 
taken up by cyanide in the case of cyanocobalmin (figure* 3,1)
T6
NHg'GO'CH, CHgCHg'CO'NHg
NHo'CO'CH,
Co— N
CH^ — NH'CO'CHg'CHg
CH-CH
CHg-CO-NHg
CHg'GHg'CO'NHg
Figuro ^  1# lîoleoular configuration of Cyanooot)alamin 
(5» 6* BimothylfeonsaimMaaoIooljamldo Cyanide)*
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by a lorn Im and by
S#d#oxyadmaayl in co^enssya© B12# the mamfaotnre of 
vitamin B12 le baaed on its diraot miorobiologioal eyntbeei# 
by Strmtomyoes oliyaosna. or %oill^a^ me^therinm# It in 
also obtained m  a by^^rodnot of antiMotlo mmfaotnre 
(Johnson and Todd 195?) ♦
Although oyanooobalamin was isolated from animal 
liver 60 the anti-^fernloious amimia faotor$ it has been 
enbseqnently shown that ocMen^yme BX2 is the major analogue 
in the livor (Toohey and Barker I96I)# aeoounting for 80# 
of the vitamin B12 analo#es# and is considered to be the 
active principle of vitamin B12 in the body*
1# J
The oarbm«#to#eobal t bond by mem%s of whioh the 
9*demyadenosyl group is attaohed to the cobamide moiety in 
oo^A^emyme B12, aoeomts for the unique properties of tMs 
analogue* This bond may be split by the action of visible 
light, acid or oymide (Weisabaoh et al I960)* ïïndor 
Bummhin conditimw# light oauaes homely tic cleavage of 
the carbon^tcmcobalt bond yielding a reduced form of
IB
oymocobalamln*. With the addition of air oxidation to 
hydroxooobalamin ooouro (Brady and Barker Igêl). The 
addition of acid aplite not only the oarbOB**to**oobalt bond 
of ooem^yme B12, but also the nucleotide bond, roloneinif 
free adenine and a sugar derivative (Brady and Barker 
1961)* Cyanide has aomeifhat similar of foots foming not 
only oyonoeobalamin, but also free adenJrte m û  a 
oyanohydrin* .
Byateme that can oonvart oyanooobala^ iin or 
hydroxooobalamin to deoxyadenoeyX BI2 have been deaoribed 
In baotoria (Weieobaoh et al 1962)# The reaction requires 
â#T*f* whioli aervoa to transfer the 9#&eoxyadenoeyl moiety#, 
reduced flavin and a eulphydryl compound; inorgenio phosphate 
being released an a by*^produat*
A oobmine eompoimd has been shown to be eaaontiaX 
in name enaymatlo reaetione; # w  common active form being 
teoxyadenoeyl B12*
(1) Icomeri»atien of glutamate to ^ metl^laspartate 
by the glutamate ieomeraee# (Barker et al 19#)#
(2) In reactions Involving hydrogen transfer under 
the Influence of the enzyme glycol deliydraee* During this
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r m o t l m  there is deactivation of the deoxyadmoeyl B12#
It hm  been suggested that this en%yme is deoompoaed to 
hydroxooobalamin, whioli in turn deactivate# the glyeol 
delsydraee# thus bringing about the observed slowing of the 
réaction# (Me and Ahelee 1963)#
(3) Methane fomatim from Co2 ^  Carbon Dioxide,
formate, methanol# éerine eto_# by maoroblo bacteria# 
utilises methyloobelamin m  a oofaotor mâ  intermediate 
metabolite*
(4) Diosyntheeie of acetate from 0o2 # Carbon
Dioxide#
(3) Isomerization of metbylmalonyl OoA to 
euaoinyl CoA by Methylmalonyl 0oA ieomeraee la m  important 
raaotion in the metabolism of propionate* #%ie reaction 
involves m  intrmoleoular group transfer (Stadtmm et al 
1960)*
(6) In Methionine eyntheeis there is a transfer 
of a methyl group from |*-fethyltetrahydrofolat« to 
homocysteine yielding methlmine and tetrahydrofolata# thus 
explaining the relationship between vitamin B12, folio sold 
and oarbon#ome metabolism* The reaction takes place in 
three stages, the cobimide ooenzyme is required only for 
stage 0#
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«*<**
Borins f tetrahydrofblftte 5» 10, 
methylinetetrahydrofolate f glycine*
(b) 5» 10# meîAiylinetetrahydrofClate 9, 
mo thyl tetrahydrofolate
(c) 5, methyltetrabydrofolate « homocysteine 
tetraî^drofoiate 4 methionine#
Réactions 1 « 4 have been observed in bacteria 
only (Weiesbach ©t aX 1964)» the ieomerieatlca of metliyl 
malonyX GoA has been obeerved in mammaXe* and it is felt 
that methionine eynthesie meydlao occur in maimaXa, though 
to date this hm only been observed in photoeynthetio bacteria,
2# PhyoiologloaX OonoiderationB#
Vitamin BX2 can bo eyntheeiaed by taicro-organlsme, 
bacteria, and actinomycetee# It does not occur naturally 
in yeasts, algae, or plants (Darken 1993); any vitamin B12 
content present in th# bei% obtained from syblotie bacteria# 
Certain lower organisme require vitamin BIS as a growth 
factor (Ford and Euther 1955)# while others can do without 
the vitamin (Burton and hoohhead 1951) or replace it with 
aome other eoBentiaX metabolite# More highly orgariiseti
81
animals depend on ingested vitamin B12 for their supplies 
of the vitamin and store it in their tissues, especially 
the liver, kidney, musole, m d  In their milk and e^gs*
Man depends on dietary sources for his supplies 
of vitamin B12# The vitamin is nbJmially synthesised in 
large amounts by the intestinal flora, hut apart from 
coprophagy this source is not utilised* The minimal 
daily requirements are not known with certainty# Although 
Ganong (l$65) claims a minimal daily requirement of 2.8 ,
1 ug. per 24 hours has been shown to he sufficient to prevent 
pernicious anaemia (Eeisner and West 1949)* Dietary vitamin 
B12 is absorbed in the terminal ileum after conjugation with 
the intrinsic factor mucoprotein secreted by the gastric 
mucosa. In man vitamin B12 is mainly stored in the liver, 
but large quantities are also found in the kidneys, the 
Central nervous system and the myocardium# Vitamin B12 is 
present in serum either "free'* or "bound"* A small amount 
of vitamin B12 is normally present in serum as the "free" 
vitamin when it can be utilised by the tissues# The 
larger portion of the vitamin present in serum is "bound" 
to plasma protein {Pitney #t al 1954); principally to 
alpha*globulin (?35^ )t albumen (l^), beta*»globulin (7^) and
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ganima^^globulin (4^) (Heinrich ot nl 1956) # formally the 
protoine ere not fully aaturated and oan take up additional 
vitamin B12.#
Hydroxooobalamin la firmly bound to the proteins 
genorally, whereae oyanooobalamln is bound to apeoiflo 
globulins only (Miller and Sullivan 1958)*
Bogore et al (1955) otudiod the oerum vitamin B12 
aoncon-tration in a large group of normal healtliy eubjeota* 
They, used a biological method of assay utilising hw 
Ifqiphmamli as tho test orgw%iem. They discovered a 
negative correlation betweon aomi vitamin B12 concentration 
and age# . Analysis of plasma by chromatograpliiy hue em^bled 
the isolation of four vitamin B12 fractions in tho blood, 
namely cyanooobalamin, hydroxooobalamin, dooxyadenosyl Big, 
and îîietîiylcobalafâin (Bindstrend and Btahlberg 1963, 
Bindotmnd 1964)* Of these me#:tylGObalamln m n  present in 
the largest proportion and Smith (196S) believes that this 
is the form in which vitamin B12 usually is transported 
within the body fluids*
3# Pa tho Physiological. Qoneiderations*
B3
Bifiistraiiâ ©t al (1966) examined the plasma of 
a group of healtî^ emoklng euhjeota* fhey did not find 
a algaifioant ri.ee in the level of the oyanooohalarsin 
fraction, and felt that their résulta did not support the 
liyfotheoie proposed by Smith# Smith (I96I) had found that 
the difference In eaeay levels, by h# Miehmanil# of serum 
vitamin Bia oonoentratioh with ant without added oranlde, 
was lees in smokers than non^-amokers# He proposed that 
thin was brought about by the presence of a higher 
concentration of oyanooobalamin In the plasma of smokers# 
This he claimed was part of the derangement in cyanide 
metabolism underlying tobacco amblyopia and related 
conditions, Bimell et al (196b) found that the urinary 
excretion of vitamin B12 and thlocyanate was raised In 
smokers and that the concentrations of these substances 
bore a positive relationship to eaoh other, and further, 
the urinary thloeyanato concentration bora a negative 
relationship to serma vitamin B12 oonoentratlon* a
very high thiocyanatc excretion may be associated with 
subnormal semm vitamin BI2 concentration*
In hepatic cirrhosis Bwemdseid et al (1957) 
found that there was a greatly reduced concentration of
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OF V ITAM IN  B12 W IO im O Y  BTATO -
S U M M A R Y  of  D E F I C I E N C Y  S T A T E S  i n  M A N
Causes of nutritional 
deficiency.
Food B 12
Total gastrectomy
Gastric carcinoma
Addisonian pernicious- 
anaemia.
Fistula, resection 
Sprue
Diphyllobothrium latum
Liver Disease 
Intestinal loop
Stomach
Small
Intestine
Colon
B- „ + intrinsic  
factor
B-n + intrinsic 
factor
Bj 2 not absorved 
Bj^g synthesis
♦
B jg in faeces
"bound" to 
plasma protein
Bone
marrow
\
Bi2
plasma
"F re e "  B X12 L iver
vitamin ÎE2 in the liver, ami M m  et al (.1954) and 
llaokay at al (1957) that there waa oa laoroaao la the 
"bound" vitamin B12 and often a fall of the "free" vitamin 
B12 In plaama*
It la well reeogmiaed that the eerim vitamin B12 
ooAoeAtratione may he very low after partial or total 
gaatreotomy and in aaaoalation with the "blind" loop, 
(ladenooh et al 1955) m d  malabsorption syMromee, (O'Brien 
and %gland 1964)# divertiouXoale of the email inteetime, - 
treatment with mtioonvulemte# (Bpmy m à  Witte IggB) 
and in the preeomoe of helminthic iîifeetation» (BjorWnh.eim 
196#)# Administration'of intrineto faetor does not improve 
vitamin BIB absorption in  patients with intestinal lésions * 
However# there may bo #i improvemmt in absorption after ■ 
apeoifie treatment# suoli m  gluten free diet in adult 
ooeliao disease (Mollin ©t al W31)$ which may be o f 
dlagnoatlo value*
Beoker e t a l (1954) have Bltmm tha t diabetics 
have a tmdenoy to  vitamin 112 dofioienoy and th is  may 
explain the inoressed inoidenoe of tobaooo amblyopia in 
diabetics* low aerum vitam in BIB oonoentmtiona have bem
reported in "vegans" (Smith 1962) whose dietary intake 
is low in foods containing vitamin Bl2* A dietary 
defioienoy may fee present in some elderly men, especially 
if they live alone (Bead et al 1965) and this deficiency 
might fee expected to predispose towards the development of 
tofeaooo amblyopia in such patients#
One of the effects of vitamin B12 deficiency is 
defective synthesis of nucleo'^protsln (Oirdwood 1950)# 
desoxyrifeonucleic acid in particular (Book 1961),consequently 
many cells of thé body are unable to form new cells at the 
normal rate, large cells feeing produced at a slower rate 
(Gastie 1955)♦ This is most apparent in tissues with a
Wpid turn^over of ziew cells# such as bone marrow* In 
pernicious anaemia the marrow cells show abnormalities in 
nucleic acid content which revert to normal on therapy with 
vitamin B12 (Glaaer et al 1954)* The deficiency of 
ribonucleic acid is particularly injurious to the axon 
cylinders of the spinal neurones which show progressive 
degeneration (Gastie 195))* Mental disturbances in 
pernicious anaemia are common and vary from minor defects 
of memory to major psychoses (Smith I960, Shuliian 196?) 
and show benefit from treatment with liver or vitamin B12
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(ïJng'loy 1949); the improvement being rapid and coincident 
with belief of the anaemia (Walton et al 1954)* Smith 
(1964) reported the ooourrmoe of metabolle moephalopathy 
in a patient suffering pemioloue anaemia who whilst 
on treatment with qyanooobalamin developed a lung afeaeeea* 
Tho improvement of the encephalopathy after gOO ug of 
hydroxooobalamin was taken by Smith to indicate the toxic 
effect of cyanide aa the muee of the encephalopathy# A 
somewhat aimilar cane of tobaoco amblyopia oomplieated by 
lung abecame and ooma# was reported by Bronte«*'Stewart et 
al (1968# appendix B4)i^  which responded to oyanooobalamin 
thus indicating a deficiency of vitamin B12 rather #mn a 
toxic effect of cyanide at the dominent factor in the 
encephalopathy*^
Methods of Examination and .Eet)ult.^ A
The patients in this' analysis w#r# investigated 
for avitaminosis Bia md# when possible# theywmre admitted 
to hospital for the testa 'to be performed* Estimations of 
the total serum concentration of vitamin 112# studies of the
intestinal absorption of vitamin B12 by the Schilling tost# 
and a general test for intestinal malabsorption by the
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Xylose absorption test were carried out# In addition 
the serum concentration of folate was estimated, and the 
patients examined for evidence of coincident disease# An 
assessment of the dietary intake was carried out in some of 
the patients# In this section the results of these 
investigations are presented and their significance in 
relation to other factors is discussed# %amination of Hie 
peripheral blood and bone marrow were also carried out and 
their discussion will be found in the section on the Optic 
leuropathy of Pernicious Anaemia#
A* Serum Concentration
The serum concentration is believed to reflect 
the state of the body stores of vitamin B12# This 
concentration may be assayed by biological (Cirdwood i960), 
or radlo-isotopio means (Matthews et al 196?)* At present 
the biological assay is universally used and was the method 
used in the present group# The organisms that have been 
utilised for this type of estimation are Hia flagellate 
JSiââSa-œSSiUâJ tootobaolllua lej-ohmanll a nutant of 
Mcherichia ooli and the protozoan .OohromonaB mBlhemenalg.» 
Englena graoille posaeoses the greatest sensitivity for
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vitamin B12# Ochromonaa malhamenaia the greatest 
epeoifioitÿ'*
Ü?he estimation© of the ©eram vitamin B12 
oonoentration were carried out hy the Eju^jena gracilis 
method of assay after the method of lose (1952)» Thie 
organism was first used by Hutner et al (1949) and applied 
to body fluids by Mollin and Bose (1992)# The present 
assays were carried out by Doctor J#F. Adams, Southern 
General Hospital^ Glasgow*
Serum Vitamin B12 concentrations in Tbbacoo Amblyonia*
This was determined in 62 of the 6g patients*
The serum #12 concentrations lay within the range 15 PS 
572 pg/^1# with a mean at I96# 150*27 pg/ml* The serum 
B12 concentration was below 100 pg/ml* In 9 patient© and 
below 150 pg/ml* in 25 patients* Taking values of 150 pg/ml 
and below as abnormal ^ 26 of the amblyopes (40^) had 
reduced concentrations of vitamin B12 in the serum*
A comparison was made between the mean serum B12 
concentration of a control group of 71 non#amblyopio sub jects
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and the amblyopes* The subjacts of the control group 
were drawn from the hospital population attending with 
conditions other than amblyopia and who were over the age 
of 45 years# In age composition the groups matched 
(t « 0*07, n K» IMV P «* >0#l) but the control group 
contained smokers and non»smokers*
Numbers
Amblyopic Group 6?** 9*1 years Ibg#* 150#27 pg/ml* 65
Hon^amblyopic ' '
group 67*5* 11*0 years 2^7^ 119 pg/ml# 71
The mean serum vitamin #12 concentration in the 
amblyopic ^?oup was significantly lower than in the non# 
amblyopic group (t 2*90, n «» I54* p < O&01) thus confirming 
the findings of Heaton et al (iggS)*
In an attempt to determine whether the low 
concentration of serum vitamin #12 found in 4^0 of the 
tobacco amblyopes was the result of tobacco smoking or 
an independently determined factor, the tobacco consumption 
in these patients was plotted against the serum vitamin #12 
concentration (Fig# J., 2)* A significant but not very
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SERUM
(yva/ml)
Sérum B]2 and Tobacco Consumption 
In Tobacco Amblyopia
400
200-
2 3 5 764
TOBACCO CONSUMPTION (oz/w eek)
vitamin Bie oonaetitratlon oompared 
with totaoao oonamm^ption Im tmtreateâ tobaooo amblyopia# 
Oo^reXatioa la jaet elgalflqaat (r # •fO#3S| p<0«0l)#
9
clos© positive correlation was foimd between these factors.
(r a fO#38; n = 53; p<0*0l). fhns> tobacco amblyopia
occurred with a low consumption of tobacco in those patients 
with a low sorura vitamin BIS concentration, a much higher 
consumption of tobacco being the rule when the patient's 
serum vitamin B12 concentration was in the normal range#
Tq teot whether the relationship between tobacco 
consumption and serum vitamin BIS concentration was common 
to all smokers or only amblyopes, the following groiips were 
examined. Serum vitamin B12 assays and estimates of tobacco 
consumption were made In 26 male non**amblyopio pipe smokers | 
and 43 non*<*emoking subjects. Both groups were drawn from 
a hospital population undergoing treatment for eye conditions 
other than tobacco amblyopia (see table).
TOBACCO
AMBLYOPIA
Number 
in group
65
Age
67 ± 9.1
Tobacco Serum
Consumption Vitamin B 12 
Concentration
3 .04+  1.44 
ozs/week
196 ± 150. 27 
pg/ml.
NON-AMBLYOHC 
PIPE SMOKERS 28 64.9
years
2.74 ± 1.32 
ozs/week
269. 5 ± 101 
pg/ml.
NON-SMOKERS 43 68.8
years
228\± 116 
pg/ml.
0^;,r
(s)o]bbà0èo consumption mâ m x m  vitamin B12 eonoontratlon 
for 20 mlm ncm-amblyopio pipe omokere of elmllnr age 
composition to the amblyopic patients vas plotted# fhe 
result is shown in Fig# 3* î^ o significant statistical 
correlation was found between these two factors (r * ##0.001) 
The mean tobacco consumption of this group was not 
significantly differmt i^ ?om that of the amblyopic group 
of patients.
2.57Î 1.3 oss/wk in non^amblyopio groupi
3.04* 1.44 OKs/wk in the amblyopic group 
(t « 0.30* n # 91# p 0.1)
(b) The mean serum vitamin B12 concentration in a group 
of non##smoking subjects was compared with that of the 
pipe^smoking non#amblycpic subjects. In the former group 
the assay was 228pgî 116 pg/ml. and in the latter 269.§«
101 pg/ml# There is no significant statistical difference 
between the two groups, (t # 1*55# n * 69» p>0.1). The 
mean serum vitamin BIS concentration in the %%on*mblyopic 
smokers is significantly greater than that of the amblyopic 
group (t w 2*79# n # 91# p< 0.01).
94
SERUM B,2 LEVEL and TOBACCO CONSUMPTION  
in 20  Normal Pipe Smokers
Serum 8,2 
pjug % 
5 0 0  n
4 0 0 -
3 0 0
200 -
1 0 0 -
Or
• •
1 3 5
Tobacco Consumption (oz/week)
Figure 3* The serum vitamin B12 concentration compared 
with tobacco consumption In non#«amhlyopio smokers (r - -O.OOl)*
B* Absorption étudies»
1# fitgffiiiT BX2 Âbsôriation Teat^'.
HaXabsorption of vltaiain B12 may W  due to 
gastrio t m t o m  whloh impair the eeoretion of intrineio 
factor# or to lésions of the email inteetlne which 
interfere with the absorption of the vitamin BlS/intrinsio 
factor complex, tests of vitamin B12 absorption using 
radioactive 312 have their most useful application in the 
diagnosis of pernicious anaemia# but arc also useful for 
demonstrating intestinal malabsorption of vitamin 112# even 
when there is m  other evidence of intestinal malabsorption*
The measurement of vitamin 112 absorption is 
essentially a twc#atage procedure, the teat is first 
carried out by giving # @  patient a small oral dose of 
radioactive vitamin 112# If the patient fails to absorb 
this orally the test is repeated with the addition of 
intrinsic factor* The absorption is assessed by one of 
the following methods**
%
(#) Urinary excretion method 1955) •
(b) Faeoal excretion method (Eelnle ot el 1992)•
(e) Hepatic uptake method#.., (Glass et al 1994)*
(d) #01# body radioactivity method (Hei^eneteln 
ot al 1961).
(e) Plasma radioactivity (Booth and Mollin 1996).
In olinioal practice # e  urinary excretion method 
in the moat widely wed; however the whole body radioactivity 
method or plasma radioactivity method ia .probably the more 
accurate#
Schilling teata were performed on 46 of the 65 
tobacco amblyopia patient# a# follow# 1*
1# Patient faated overnight#
0# Bladder emptied and urine discarded 
3# Drank dose of radioactive Vitamin B10 
labelled with Cobalt SB#-
4# After Ë houre I mg# hydroxocobalorain waa 
given imtramuBcularly#
5# All urine was collected for 24 hours mâ the 
radioactivity present measured#
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TaXues of less than recovery were found in 
21 taeta (45*7^) and of Xoas than 9^ in 6 teata (ij^)*
The Schilling teat results were plotted against tobacco 
consumption.. à similar trend to that found on comparing 
serum vitamin B12 concentration and tobacco consumption 
was revealed though the relationship was not so statistically 
significant (r *» n» 40$ P< O.O5)* The Schilling
test results showed that in tobaooo mablyopla, -poor 
absorption of vitamin 1X2 tended to be associated with low 
levels of tobacco consumption and with test results within 
the normal range, tobacco consumption was high (Fig. 4)>
2* . Xylose Absorption Test of Helmer and Fo^ts (1937). -
This test was used as a general indicator of 
intestinal malabsorption* Xylose is a metabolioally 
inert sugar and its rate of appearance in the urine is an 
indicator of its rate of absorption*
This test was carried out on 53 of the tobacco 
æiblyopia patients as followsi*
1. Patient fasted overnight.
2* Bladder emptied and urine discarded*
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SCHILLING TEST 
60Co^Biï 
Recovery (% )  
40 - 1
3 0 -
20
10
B,2 Absorption ond Tobacco Consumption 
in Tobacco Amblyopia
A
#
4
TOBACCO CONSUMPTION (oz/week)
^9 4* OomparlBOR tôbacao oonaumption ma#
SolîiXIlng test mmxlt in untreated tobacco cmiblyopia 
(æ » +0.53* »<0.0§).
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Intestinal Absorption & Tobacco Consumption in Tobacco Amblyopia
Xykwe absorption 
Test 
Urine Xylose
6 -
4 -
3 -
1 2 3 4 95 6 7 8
TOBACCO CONSUMPTION (oz/week)
1‘lgure il 5* Gomparlaom betweem tobaooo consmptlo» aad 
8ylo$e a’baojyption teat m m l %  tn mtreated tobaeoo amblyopia, 
(3? 4-0» 254® P ^ 0*1) e
100
3» 3 ### Xyloee taken omily in BgO mla* of 
water* Thla m e  then followed by a oooond 250 mln# of 
water*
4* Patient waa kept at roat and had nothing to 
eat or drink till emi of teat#
9» Blood aample was t^mn at t h m m  after oral
Xylose,
6# Bladder emptied at 5 hoars after oral 3*ylos@*
When the Xylose absorption test reault was plotted 
against tobacao oonaitmption a eimilm? trend to that found 
on oomparing tobaooo ooneumption with serum vitamin M2 
Gonoentmtion# or the Schilling teat was obtained# The 
statistical correlation however, fails to bo si#iifioant,
{%f ^  f0,234$ n «» 29f #0*1)# (Pigure g)*
The Xylose absorption test probably gives a measure 
of intestinal absorption, partioulairly in these patienta 
whose faulty vitamin B12 absorption is not due to a specific 
defeat euoh as Addisonian Pemiciou.a Anaemia#-
Û#, Serum Folate Ocaucentmtion*
In contrast to the well recognised neurological 
abnormalities produced by a low oonoentration of vitamin 
B18 In the serum the effects of a lack of folio acid on 
the nervous system are relatively unknown* Reynolds (196B) 
suggested that folate deficiency was the cause of some of 
the mental changes seen in old age and that apathy led to 
a deficient intake of dietary folate. Girdwood et al (1967) 
were unable to confirm low folate concentrations in an 
elderly Scottish population,
Though dietary deficiency alone can produce 
megaloblastic anaemia (Jackson 1965), in Great Britain this 
type of anaemia is often associated with conditions which 
increase the requirement for folate, such as pregnancy 
(Gough et al 1965), psychiatric problems (Oaimoy I967), 
Ingestion of drugs (îîalpas et al I966), alcoholism and 
alcoholic cirrhosis, (McGurdy et al I962, and Waters et 
al 1966), chronic renal disease (Sevitt and loffbrand 19&9), 
Orohn*8 disease (Hoffbrand et al 1968), and rheumatoid 
arthritis (Gough et al 1964)* The serum folate concentration 
is the earliest and most sensitive index of folate deficiency 
(^rit. Med. J*, (i960), 2,570^ , and on this basis Head et
al (1965) and Bundle and Piéton Williams (19É6) found 
defioieaey common in elderly patlarite in imetitntions#
.Serum Folate Cloneefitrations in Untreated ToWeeo Amblyopia.
fhe serum folate ooneantrations were eetimated 
by a bioiogieal method of aessy after Maters and Mollin 
C196I) utilising laotobaoillna easel. One patient in 
this series was receiving thorapeutlo folate for a macros 
soy tie anaemia due to alcoholic airrhoeis, m û  le excluded 
from the analysis, Serum folate oonoentratlons were
obtained in @1 patientsi**
Of 9 patients with pemioiom 
anaemia the moan folate was S.28 ng/ml Î 2*89 ng/ml.
Of 42 patients without anaemia
the mean folate was 6*17 ng/ml t 5.06 ng/ml
Of all patient# the mean folate 
was 6*43 ng/ml t ng/ml*
1 0?
Pathologically low folate omomtmtlon#
( 4 ng/mX*) wsro found in 10 patianto (l0fS) of whom 1 hed 
pamioioiia aaeomia and g did mot* A comporiaom between 
# e  moan folate ooBoomtratidmo im tobaooo amblyopia 
complicated by pemiolow anaemia and mot complicated by 
permlelomn anaemia ahmed little etatietieai difference#
(t *»f i.757, n m 49, O.05<9<O*l)-#
Although a comparison he Worn, age m â  aemm folate 
oonoentration yielded a positive oorralatlom %#ich proved not 
to be eignifiaamt (r # 0#?f n # ## p>0,l), a significant 
mnmber of patiente m m -  the age of 6g yeam had emmm folate 
ommntmtiom in the subnormal range (Wlo%f 6 tkl/ml)#
(% *  4,774# m *  49* 0»&%<p<0t05)t
In untreated tobaooo amblyopia the mm\m folate 
concentration was compared with tobacco eonawmptien in 51 
patiente, a positive correlation was obtained but thin 
proved mot to be (r ## 0,074# n 49i
p>0*l)# Vlhmi the pernloimne anaemia patiente m m  excluded 
the correlation became more positive* (r # 0##6# n ## 
p * 0.1) Ficpre 6*
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SERUM FOLATE AND TOBACCO CONSUMPTION IN TOBACCO AMBLYOPIA
SERUM FOLATE 
(mpg/m l )
20
15
10 .
5 .
4-
• •
• #
: i 
#
 f- 4- 4-
1 2 3 4 5
TOBACCO CONSUMPTION (oz.,w eek )
Figure 2* 6# Oemparison between serum folate oonoentration
mil tobaooo ooneumption in untreated tobaooo amblyopia (r » 0*256) •
Patiente with pernioioue anaemia were excluded#
105
B12.
Ganong (1965) claim# that the minimum daily dietary 
requirement of vitamin B12 is 2»B Heinrich (I968) has 
shown that the tmmover rate of vitamin B12 in the body 
metabolic pool is O.Og^ (approximately 2*55 U® per day).
This daily faecal and urinary excretion represents the 
optimal nutritional requirements. The minimum vitamin B12 
requirement of 0*5 •“ 1#0 pB P®^ day is just sufficient to 
satisfy the needs for normal erythrooytopoiesis end central 
nervous system function, but does not normalise vitamin B12 
levels in the serum and tissues* If the daily metabolic 
turnover is not compensated for only the vitamin B12 pools in 
the storage organs and tissues can bo used as a source for 
the metabolic vitamin B12 requirement* Thus, in face of 
reduced intestinal absorption of v it#ln B12, there is 
progressive depletion of ooenzym© 312 stores and a reduction 
in the senm concentration of vitamin B12*
With the aid of the hospital dietician the diets 
of 13 patients ware analysed for vitamin B12 content* W i m  
the vitamin B12 content of uncooked food was estimated, the 
mean daily intake was 4*04 ug per day; 7 patients having
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intake of 2*5 ug per day or Imm* Aosmin# a g #  loan 
through cooking, the mmher of pationta whoa© diet oontained 
2*5 u|| per day vitamin B12 or lose, roaa to $ (6%'G), Of 
thoae patients 5* (30,5#) were helo# the minimal dally 
requirment of 1,0 %-# outlined by IMnrioh (1960), Tlieaa 
figures oonfim that the majority of tobaooo amblyopes diet 
in low in foods containing vitamin B12,
m,
do prediapooin® to tobaooo amblyopia the ioltmims 
diaeaaea have been olted ##- digestive cliaorâera (de Boîiweinitss 
aad Msall IgOg), diahateo (llattiaehip and iWmonda 1883* 
OazToIl 19561 Mggmt 1959)# syphilis (B'ttaay 1926), and 
m alm tritim  (Barry 1804* ialati 1687# %1$ 190$, îta te a iii 
and Sohepcme Ig#, #roa% 1949? Boggart 1959), Wiahmm 
(15)51) found that tobaeao mblyopia and the opt'Ie nmropathy 
of pemioioue anaemia could eo^ exiot,
Examination of the patients investigated revealed 
the following eyatemio dleeaee##*
(a) àMimnisu Pemioiow Anaemia 11 (16*94#)
(b) Fra Pmmlolouu Amamla 11 (16,94#)
(c) Dlmbetos 6 (9.24#)
(&) Hepatlo d&ea&s# 2 (5,08#)
(#) Skeletal system âisoase
Badge0 flisaaaa of home 1 (1.54#)
Hhemimtolé arteiti# I (1,54#)
Ûhroïii a omteomyoll ti o I (1.54#)
(f) 8quamow& oaroi&om& of skin % (1.54#)
Bo e^Menco of other oofijplioatiue fliseasa isi 3S1 (47«?4f0*
lOf
m m  TOKia i m m n  m  Tomooo
All olaseio writers attributed to tobaooo its 
full share of causation as a source of amblyopia 
(Wordsworth 1065)* fho opinions of later writers 
(Mottleshlp ISBTt bautenbaoh 1890$ Gottlieb 1941$ and 
Boggart 1959) that tobaooo as a cause of toxic amblyopia 
(but not necessarily the only agent capgible of producing 
this condition) were not synonymous with proof* The 
observation that recovery from tobacco amblyopia could 
lie in abstinence from tobacco would seem to implicate 
tobacco in some way (HoKenssie 1854) * heishman (l95l) was 
of the opinion that some noxious agent associated with 
tobacco, other than nicotine, would appear to be the 
ultimate source of tobacco amblyopia, and Hambresin and 
Bohepens (1946) considered that tobacco amblyopia was only 
one symptom of chronic tobacooism* bautenbaeh (189S) 
comsidered tobacco amblyopia occurring in smokers to be 
induced not by the direct absorption of nicotine, but by 
the volatile products of combusion; but this could not 
explain tobacco amblyopia observed in tobacco ohewers and
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muff tekera* f m p a l r  (I930) olaimed that # #  excltl% 
m m m  of tobaooo amblyopia woo tobaooo# but the dlaeago 
was determined by a in the patient* 0 health# or
a nmtritionel defieienoy oepeoielly of vltmmim## Thus# 
in peraono with worn mild vitamin B12 âofioimoy the retina 
or optio nerve Mmtû hmorm unduly eemeitlvo to the offoots 
of tobaooo (Heaton #t al 1958) • liana (1908) after 
e^iMorating various aubetanoea found in tobaooo smoke, 
stated that mm&t  Investigation# pointed to nicotine m  
the sole effective p M m m m  conetituent and referred to 
Habemann and Eheenf&eld who had statecl that in tobacco 
moke nicotine mm  by far the mo*t important component, 
the others Including i>yrMine m m  of no importance*
%hor (1927a) examined mrlome tobaccos %  estimating the 
nicotine content; of the brand of tobacco smoked by 92*9|S 
of hie amblyopia oa*e# the nicotine content mu 3 ^  3*07##
Bontly and Bomy (1959) in their review atate 
that early reecarchee on cigar moke reported the Isolation 
of pyridine (05II9i) end its analogue#* Arsenic appear# 
to have engaged the ettentioa of many early worker# but
and (hmdemaon (I9I2) were firat to diacua# cysnMo* 
They found hydi^ ogcn cyanide and hydrogen thiocyanido in both
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the gaseous amé partlqulete phase of tobaooo make from 
acid mid alkallae tabaooosf oigsr mok# coiitaining more 
apmide tMm cigarette moke (Boholler 1935)» Oebome et 
al (1956) mail Jotoatoue mû flismaer (&9S@) examined the 
ganmm phase of cigarette amok# by infra-red methods# and 
fomd oyanide present in the oondenoable fraction to the 
amount % 3  ^ 31 #0x1#''2 mole## ' the h#B# Bmrgeon General 
(1964) reported a tobaooo moke oyimlde ooutmt of up to 
1*600 p#p.m# These are high values Indeed in the light of 
aialeter* e (1953) etatmmt that- 011 etmoephero' containing 
3*000 p,p#m# of oymide mn letlml to homo aaplem# à 
reofiat report (Darby ami Wileon 107) indioat-ed that them 
m m  little variation in the smoke cyanide content of various 
temde of pipe tobaooo# fhesa author# further eonolude 
that the meooiatlon between certain brand #■ of tobaooo and 
tobaooo amblyopia was dependent m t  on differenoe in 
meumto%iol%^ but mi popularity and eheapnem#
llohor (1927a) from hie analyeia of 1100 oaeoa of
tobaooo amblyopia eolleoted in Aberdeen* oonoluded that the 
majority of tobaooo amblyopes moke rather lean tobaooo then
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mokers# III#  figures m m  8+8$ om§
per m m k  for the amblyopes me against 2*72 oza# per week 
for the mom#amblyoplo mokers ^d\m the total mmlmra 
were ooîîeidereâf W t  when only subjects over the age of 
50 year# were oonoidtred.| the average- oomemptio# for 
the amblyopia group fell to 2*56 mu* p m  weak, and the 
mouwamhlyoplo group to 2#6o 0%## per week*
The mean tobaooo oonemptlom of the present 
group of patients suffering from tobaooo amblyopia is 
3*04^  1*44 o^s* per week with a range o f 0*5 oaa* to 
7 08S* per week# th is  -group comprises both pipe miâ 
olgarette smokers, 57 pipe only, 3 cigarettes only and 
5 hath. The tobaooo omeumptlm In the amblyopic group 
is  s is n ifio im tly  higher them tha t of a comparable grouf 
o f 37 uoE**anMyopio smoking subjects dram from a 
hospital population, in  which I t  ie  l#0ÿ£ 1.19 oas* per 
week f t  # 14*39$ u # 75$ p 4 0*001)#
The following schem# was used to convert 
cigarettes smoked per day Into m m m $  of tobacco per
week# The average weight of tobacco contained in 28- 
tlifforant brands o f c igare ttes, plain o r tipped, was
1 12
fom d to bo 0*7665 gm# (im idoy Times# 8th June# 1969)#
5 Qigamttm per day # 1 o%# tobaooo per week 
10 *' " (* o&* " " w
15 " # 3 0%.
80 " " % * 4 08* " " "
25 '* " " * 5 00* » '* ''
Beoeuee o f its  reactive  nature# and
difficulty in its detection in body fluide# 'Vlileon 
(1965a) concluded #at m  investigation of cyanide 
metabolism must ooneentrate on the products of that 
metabolism# Although cyanide ia mainly converted to 
thiooyanate#. the estimation of thiocyanate in body fluids 
is not an accurate index of cyanide exposure# because of 
alimentary absorption of dietary thiooyanato and variable 
concentration in body fluids* lïmoxi^ ut the factors which 
effect the concentration of thiooyanate the following 
ate recognised#*
(1) Dietary intake of preformed thiooyaimte 
contained in green vagctablee and milk# is aubjootcd to
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seasonal variations (Stoa 1957)•
(2) Deficient intake, as in anorexia nervosa 
and prolonged vomiting, I0 associated with low 
concentrations of thiooyanate in plasma (stoa 195?)•
(3) Defective absorption of oral thiocyanate has 
been observed in patients suffering from gastric carcinoma 
(ïiaïigman et al 1966),
(4) The ïïrinary excretion of thlocyanate tends to 
vary directly with urine volume and with chloride excretion 
(Btoa 1957).
(5) Cyclical changes in thiooyanate concentration 
of plasma have been found to coincide with the menstrual 
cycle (stoa 1957)* These alterations are probably related 
to the state of hydration*
Naturally oocUrrlng cyanide and thiooyanate are 
found in foodstuffs such as cabbage and spinach (Btoa 1957)$ . 
in dairy produce and milk (Wokes et al 1952), in alcoholic 
beverages such as beer and stout (Stoa 1957), and in tobacco 
leaf and smoke (Lehmann and Gundormann 1912)* Cyanide is 
produced endogenously from thiooyanate by enaymio action 
end is a by-product of bacterial growth in closed cavities*
1 1 4
that the major portion of mcogenone or 
©Mogenoue oyanid# is eæoreteâ in the wine ae thiooyanate 
was first deeorifeed %  lang, S# (2.S94) and later by Smith 
ant Maleolm (l93û)«- The idontifloation of the meyme 
ays tom was eetabliaiied by lang» E* (1935.)* The enoyme 
was sailed Ihiodfinee© and it has been fonnd to be speoifio 
i m  free cyanide withont action on organically bound cyanc^ 
groupe* In tlds context it competes with hydroxoooljalamin 
which takes up cyanide avidly to form the harmless 
cyanooobalamin {Smith 19#)* Eecent studies on the 
distribution of rhodanese in the tissues* show it to be 
widely distributed in the body* activity being greatest in 
the liver (Himwioh and Saunders Ig# mid Eaunders mid 
llimwioh 1950)*
As well as a mechanism for converting cyanide to 
thiocyamte* there exists a reverse pathway which mediated 
through fhiocyanate Oxidase (Goldstein and Hiedera 1953)-* 
This en%me is found in red blood corpuscles. The presence 
of thiooyamte osdldaso* which ensuroa a persistent trace of 
cyanide in the blood* is confirmatory evidence that the 
latter in minute amounts is an essential metabolite (Smith
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et al 1963)1 1$ reeponsibl© for the positive
relationship between plasma cyanide and thiocyanate 
concentrations found in non#9mokers and healthy smokers 
by Wilson and Matthews (1966)*
Patty (1921) observed that organisms grown on 
stagnant protein produced cyanide in quantity. %is was 
especially true of the pyocyaneus and coliform organismsi 
‘l?hus oyanide may be produced as a by-product in abscess 
formation» in urinary diverticula» or in the blind**loop
intestinal syndrome (üngley 19551 Smith et al I963)*
'
Boxer and Pickards (1952) concluded from their 
studies On the metabolism of the carbon of oyanide and 
thiocyanate that cyanide carbon enters the carbon-one 
metabolic pool# Their studies made use of radio-active 
carbon as a tracer* Cyanide injected into the experimental 
animal appeared in the urine as free cyanide» thiocyanate» 
and vitamin B12 bound cyanide (oyanooobalamin). Cyanide 
and thiocyanate were found to be in dynamic equilibrium as 
demonstrated by the activity of hydrogen oyanide in expired 
air following the administration of labelled cyanide and 
thiocyanate* Activity was also demonstrated in choline
and methionine» and In the intermediate formatej 
aotivity waa also observed in liver proteins* These 
authors further state that the oxidation of cyanide to 
carbon dioxide occurs to a large extent*
Baumann and associates (1933) concluded that 
the thyroid gland had no part to play in the conversion 
of cyanide to thiocyanate but it had in the de-methylation 
of aoetonitrils, thus accounting for the increased excretion 
of thiocyanate on its administration# The tliyroid gland 
along with the salivary glands form part of a concentrating 
mechanism for thiooyshate* Olemedson et al (i960) 
demonstrated active secretion of thiocyanate into the 
gastric juice# and deposits of thiocyanate in the walls of 
the major blood vessels by means of auto-radiographio studies#
Oyanide Semyellnation*
Wilson and Matthews (I966) thought it possible 
that relatively low (though physiological) vitamin B12 
conoentrations may reduce the body*s ability to detoxicate 
oyanide and result in relatively high blood concentration
118
QÎ this radicle* Suoh ooncontratioB© may contribute 
to the potbogeneaie of the neurological oomplioatioua of 
vltemlu B12 deficsienoy aa well m  reported ahnormalitiee 
of pyruvate tolerance (Homabrook and larke 1#60)# Over 
the past 80 years much research effort Ime been put into 
solving the mechanism of oyanide dei;^ellmtlon without ‘ 
concrete auooeea* . The earlier workera used relatively 
large û m m  of oymlde and the neurological leaiona were 
diverse and inoonatant» m d  could not be separated from 
the effect of anoxia# . (Golllma end Itetland 19OB» Buret 
1942# moke 1950, humaden 1950» Boee et al 1954» and 
Bovine and Biypulkowaki 1959)* That cyanide in small 
'dcmea was capable of producing fool of -dcmyelination in a 
conatant and reproduceable manner was shown by Smith et 
al (1963) and Smith and Duckett (1965). . It has further 
been demonatrated that the liver atorea of vitamin B12 in ' 
the experimental animal were depleted on chronic oyanide 
administration (Braokkan et al 195?)» and that over a long 
period the ability to excrete the bulk of the administered 
oyanide se- thiocyanate was lost (Smith mid Duckett 1965)* 
Huohett et al (1952) have shown that hydroKOOObalamin 
protects the laboratory animal against lethal doses of
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oyanide» a property confirmed by the studies of Smith 
et al (1963) and found not to be shared by oyanooobalamin 
(Smith and Duckett I965)# The latter researchers felt 
that hydroxocobalamin in some way preserved the integrity 
of myelin# as there was no evidence of demyelination in a 
group of animals subjected to chronic oyanide administration 
covered by hydroxocobalamin such as there was in a comparable 
group of rats in whom the oyanide was covered with 
oyanooobalamin*
Gystine# a highly insoluble amino acid# is 
capable of passing freely through the blood-brain barrier 
and becomes incorporated into the neural proteins (Ford 
et al 1961)* Oyanide combines with cystine to yield 
2-imino#'4*‘thia^olidineoarboxylic acid both invivo and in 
vitroo(wood and Cooley 1956)# These authors further found 
that the expected reaction on combining cyanide with 
cystine to yield cysteine (Toegtlin et al 1926), and 
B-thiocyanoalanine did not occur under normal physiological 
conditions in the experimental animal* The thlooyano- 
alanine would yield thiocyanate after deamination to 
thiocyanopyruvio acid and subsequent decomposition. This
1 2 0
aomvoreion may Indicate m  alterna tlv# pathway of 
cyanide dotoxication* The imiwrtance of 
thiaaolidlnaoax/boxyllo acid in relation to denyelinaticin 
is as yet mtoown*
Methods. Itsed in the api^lysls of pvanlde end thiocyanate
In a critique of the methods for thiocyanate 
determination Stoa (195?) observed that the Pyridine- 
Benzidine reaction was the method meet m l  table for the 
determination of thiocyanate in blood aerum# Aa a routine 
method of aorum analyais tlio pyridine^bonaiidine method 
cannot be rivalled# as the reaulta obtained at low 
conoentrationo of thiocyanate were as reliable as those at 
high oonoentratiens. This property was not shared by the
Ferric nitrate method which is not accurate at low 
Gonoentrations $
In the earlier part of this analysis the Ferric 
nitrate method of Bowler (1944) was used as this was the 
only method available* later when in reoept of a Medical
1 2 1
Researoh Gommll grant# determlaatloma were carried out 
after pyrldi%ie#*ben%ldine meMiad of Aldridge (1945)* iu 
thie subsequent portion of the oaalyaio# the amendment® 
of Wilson (1963*65) to the Aldridge method# and the 
aeration technique of Boxer and Biokarda (1952)# were 
followed*
(a) 0plp3t?ifflptria yalyale of ^ Ferric fhioovanate (Bowler 1944)
To 1ml* of serum in a test tube# 6*5 ml* of 
water and 2*5 ml* 2(# friohloraoetio Aoid are added* Mix 
and stand for 10*15 minutes* filter* To 5 ml# filtrate 
add 5 ml# ferric nitrate aoid reagent* Bead in photo-, 
electric colorimeter using transmission of wavelength 
470 m u* from a standard curve the optical density 
readings are converted to milligrams thlooymate*
ferrie Hitrato - litrio acid reagent is prepared 
by dissolving B'errle Witrata in 2 I nitric acid* Standard 
curve is prepared by measuring the optical density of 
known concentration of potassium thiocyanate solutions*
(b) qp^oyimetgie amlyBis of 194S>
12s
I# X ml* sample (depreteimieed plasma,# or urine).
II
fO#5 ml. Ÿ  Hydroehloric Acid*
2. 0*1 ml* (â drops) solution of Bromine water# This
couverte oyanide and thiocyanate to cyanogen bromide* 
3# 0*1 ml* ^  araonious aoid - removea exoeee Bromine* 
Shake well*
4* Draw air off surface of liquid with water pump to 
remove any %»omlne vapour preemt#
5* Add 1*8 ml* of fro# Beuisidiiie-pyrldine mixture*
6* heave lg*20 minutes.
7# Head in epeotro-photometer at a transmiesion wavelength 
of 532 m^ yU, The optical density reading is oonverted 
to micro moles (xm) per 100 ml#.' from a standard 
curve prepared from known ooncentratione of potassium 
thiooyanato.
2^ araeniôus aoid ia prepared by dissolving sraoirioue 
oxide in sodium %<£lroxid#' solution* The solution is then 
rendered aoidio by back titrating with aoid using 
phenophthalein as indicator till jh ? Is reached#
The Beai^ldim-pyridine solution is freshly 
prepared by mixing a solution of pyridine with a benzidine
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©olution in proportions 5 * 1*
(a) pyridine solution in Hydroohlorio aoid is prepared
in the following proportione - Pyridine s Gone* 
llydroohlorio aoid * water - 6 « 1 s 4»
(b) Bensidine solution is prepared m  a 8^ 5 w/v oolii* in 
Sydroohlorio aoid*
Analysis of urine for thiocyanate ia carried out 
S0 followas- .
t* A 20 ml* aliquot of.urine is diluted in 200 ml* with 
distilled water* 1 ml* aamples arc taken for 
thiocyanate estimations after the method of Aldridge* 
2« lo farther preparation of the urine is required unless
protein is present• The protein must he removed by
precipitation, with friehloroaoetlc acid before 
dilution la carried out*
(o) Sanroteiniaatipn o^.olaamai
1* 10 ml* blood placed in a heparinlsed tube*
2m Centrifuge at 3,000 r#p*m* for gO minutes*
3* 5 ml* of supernatant plasma are then mixed thoroughly
with 10 mis, 10^ Trichloracetic acid# allowed to stand
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for 10 minutes emd then centrifuged for 30 minutes*
4* Supernatant is then decanted into a $0 ml# volumetric 
flack, or an aeratiom-tube*
5* 5 ml* lO^ o frioliloracotic acid arc then mixed with the 
residual protein coagulation and c0nt3Èi.fùged for a 
further 10-15 minutes*
6* fhe empematant is decanted m  before*
7» Steps 5 and 6 are now repeated two farther times.
8* the volume of eupejmatant fluid la now 30 mis# This 
. ia either diluted in'the voitusetric flask to 50 mla. 
by the addition of diatilled water, 1 ml, aample# being 
used for thiocyanate estimations after the method of ■- 
Aldridge, or the 30 mla# are used for the estimation 
of plasma cyanide* ^
The method of Aldridge makes no distinction ‘ 
between thiocyanate and cyanide* The cyanide being 
volatile ia removed by the aeration technique of Boxer and 
Rickard© (1952), as ■follov>/et-■
1, The ample before dilution, 30 mla* of deprotelïâaeâ 
plasma, is placed in an aeration tube*
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Oxygen Free Nitrogen
W
4 3 12
Figure 4?1« Illustrating the aeration train required 
to separate Cyanide from sample after Boxer and Rickards 
(1952).
2#' fnia tube le p M m à  in àm aemtlon train ae f#Iawe# 
lie* I 20 ml &  mvi0 Bulphate in ^  sulphuric aoM*
Be. 2 20 ml 20# w/v Silver sulphate in y  sulphuric aoid.
He» 5 20 ml$^ Sodium iydroxid© oolutlon*.
No* 4 Sample#
lo* 5 1 ml* §  #diu# hydroxide aolutlon#
No* 6 1 ml* V  sodiua, hydroxide eolution*
3* Oxygen free nitrogen is bubbled tîirough the train .at 
a flow of 790 mle/mirnte for one hour*
' ■. ^ ■'■ -
4# êfter this'time the sample ia diluted to gO mle*
before and 1 ml* aamplea used to measure the thiooyabate 
concentration*
5* # 0  & ml* eamplcs of sodium hydroxide not as an alkali 
trap for oyanide and the measurement» are carried out 
on them directly by the method of Aldridge* fhe mm 
of their omcentmtlome gives the cyanide ooncentration
) i I
in the original sample of plasma^ l*e* in 5 mis* plasma#
The cyanide estlmatioii in urine requires a alight 
modification of the aeration technique, as follows**#
Tube Bos* l-»3 as before*
Bo* 4 20 ml* aliquot with addition of 4 ml*
4H sulphuric acid*
Bo*. 5 repeat of eerie sulphate solution*
1:6
Ifo# 6 repeat of silver sulphate solution <
M
lo* 7 80 mlsgwx sulpWrio aoid#
Bos# 8 end 9 alkali trap®
The aeration time ia  B homm# The a lk a li trap 
is ©hanged after 1 hour, m d  the oyanide oontent in êietriWteâ 
in 4 eampl## ef I ml# sodium liyaroxido#
After aeration dilution of the 80 ml# aliquot to 
BOO m%B$ ie carried out as before and 1 ml# eemplea are 
taken for thiooyanute amlyeim,
,ln. .Tqîmooo âfjiblyopia#
8emm thiocyanate determinatione by Bowler’s
method (1944) were made m  three |p;mipa of mbjeete# Group
I eoneinted of 40 patiwte suffering from tohacoo amblyopie, 
dia^oeod aoooz'ding to t*)© criteria of B m t m  et al (iggO)#
In group %I were 37 non#mblyopio emoking auhjeeta dmum 
from a hoBpita& population# Group III contained #  non- 
smoking Wepital patients# Thoee In group II and III were 
elderly patiente attending lioepital with ooMitlme imrelated
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to tobaaoo miblyopia# oomposltioxi of all three
groupa was olmllm?* Patimte i*i the three groups were 
olaeelfled at eaoh of three levels of aemm thloaymata
o<moentratlo%% as show In the figure# Sixty one per omt of 
the non^ omokere had a thlooyanato eomentratlon of 0*5 mg*
per eemt m  leoe# only 6*5 per cent having a aonoantration 
of 1*5 % *  per omt or more* In oontmot, a oezm* thioqyaaate 
ooaoôtt'teitioa o f 0*5 mg# per cent o r less mm foiraû Im gO 
per Qm0 of aoa#emblyopio mokera, whereas g: per cent 
had oomoehtmtlome of 1*5 mg* par omt or more* the 
cliateihiitioa o f aomm thloa^ a^nate oonoentratlohe ia these 
two groups ta el#lfioamtly different* ^ 11*76, ri 2$ 
p 0*01) eomfimih# the findings o f Btoa (1957) that aerm 
thlooygmate oonoantrationa are higher in amoking tlian in 
mon^emokim# euhjaota (figiire 4,t)#
Â0 outlined, the mean tohaoeo acmaimption of the 
grmp of patieiite suffering from tohaooo amblyopia warn 
hi#ier thm that of the no%i#amhlyopio mokere* In spite 
of tills, the group of amblyoplo patients in gmeral showed 
mmoh lower &mmm thiooyaaato than tlM the group of non# 
emblyoplo mokere, the âietrihàtion of thiooyanate
No. of cases % 
lOOn
50-
37
14
I
i m  Tob. amblyopia 
Non smokers 
Norm al smokers
12
I
0  5 or less 1 0  1 5  or more
SERUM THIOCYANATE (mg %)
SUgiir® 8» t’ot' Btmm thiocyanate oOHoanteationo
ecmparlng snh.iooto with toMoco atamyopla, non-aablyopio 
smok®3.’0 and non-smokosa.
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concentrations being significantly différent In the tv^o
9
:;*oups (%*' Î* 10*47$ ^ 2» f 4 0*01)*
Somewhat fôtirprieingly, in apit© of thoir heav;^  ^
ooîieuî^ iption of tobacco, the distribution of thlo%mnato 
concontratlono In thio group of mmhlyopic patient© rGoemhlod 
that of the noii^ amokora end in fact the distribution of 
th.ioQyanato concentrations in thooe two groups waa not 
oigrjlfioautly different «» 3,9% n # 1, p> 0*05)•
(Soo appendix B0)*
These relatively reduced oonoentratiouB of serum 
thiooyaiiato in tobacco amblyopae m  compared with healthy 
cmokora, cuggost that if cyanide derived from toWcoo smoke 
is indeed a factor of aotlological importance in the 
development of tobaooo amblyopia, the biochemical defect in 
theao oaeoa may be a failure of conversion of oyanide to 
thiocyanate, its main detoxification product, as cuggoatod 
by Smith and Duckett (1965)#
B* During frea’tnemt wit!
Sorum thlocyanato eist.imatlona we»o sopoatotil aftor
1 3 0
No. of cases % 
100
5 0
Tob. amblyopia prior to treatment 
Tob. amblyopia after 6 mths. treatment
20
13
I
10
0*5 or less 1-0 1*5 or more
SERUM THIOCYANATE (mg%)
3* nistogram showing serum tMooymate 
oonoentratlone oomparlng patients Buffering from totaooo 
amblyopia prior to and after 6 months treatmmt with 
hydrozooohalamln*
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aix month© treatment with hydroxocohalamin in the group 
of patients with tobaoco amblyopia* Of the 40 patient» 
with tobacco amblyopia who had serum thiocyanate estimatione 
carried out by Bowler*» method described above, only J1 were 
availsble for repeat analyaie after 6 monthe* The reasone 
for tbia included replacement by Aldridge’s method for 
Bowler’s method, default, and death of a patient* Details
of the treatment are given in the appropriate section*
Mhcreas 11 of the amblyope» had a serum thiocyanate
level of 0*5 or less, 20 had a level of 1*0 and
none a level of 1*5 or greater^ after 6 months 
treatment 8 aubjeots had a level of 0*5 or less, IJ a
level of 1,0 mgm^ and 10 a level of 1*5 mgn^ or greater^
There Is a significant alteration in the distribution of
p
thiocyanate levels in the treated group (% - 10,02, n ^ 2, 
p 0.01), 80 significant difference in distribution ia
detected when the treated group Is compared with the non- 
amblyopic smoking group of the previous section {x^ ^ 1*57# 
n w 2, p S3 0*5)*
Plasma Oyanide and ThlcoyaBOte Gonoentrations in
Wilson and l^ latthowa (l$ô6) showed that a 
negative relationship existed between the plasma oyanide 
and aerum vitamin, B12 oonoontratione in healthy ©mokere 
and non-smokera* Plasma cymid© ooncentrationa were 
estimated in il patients suffering from tobaooo amblyopia 
by the method described above and the serum vitamin B12 
concentration was estimated after the method of Boss 
(1952)* Bee Table 4# 1 for results*
Of these patients the mean cyanide concentration 
was 0*065 Ï 0$0:4 mioro moles/lOO mis* This value is 
considerably higher than the value of 0*022 micro moles/
100 mis# found by Wilson and Matthews (1966) in non- 
amblyopic smokers by a similar method of analysis* When 
the plasma cyanide and serum vitamin B12 were compared a 
negative correlation was obtained, and this proved to fall 
just within the significant level (r « #0*555» n « 9»
0*05 <p <0»l)# Although not a very significant correlation, 
possibly due to the small number in the sample, the general
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trend does support the view that high plasma oymlde 
oonomtratlom In # 0  preoenee of redueed serum vltmln
II a eonoaatratione ooald Ise ussooiateci with neurological 
lO0lOA8,
On comparing the plasma oyanide ooaoontmtlon 
with the omonmptlon of tobaooo (tho prommed eouroo of 
©yaaidt) ii% these patlonto a poaitivo correlation waa 
obtained which failed to be olgnlfloant (r # 0*344$ 
n M* 7# p>0#l)#
flia mean plaasa thiooyanato oonoentratiom of 
Ig imtrmted tobaooo mblyopoa was found to bo g#8lt 3# 386 
mloro molea/lOO mie* This value le lower than #iat 
Qbtalnod, by a olmllar method of amlyalo# by Wilson m d  
Matthews (1966) who found a mean oonoontmtlon of 11*5 
mloro molee/lOG mle# In 18 non-eWblyoplo emokere* Them 
autWra fhrtWr deaorlhod a 8l#lflomt poeltlvo eormlatlm 
hetwemx the plama oyanide end plaama thiocyanate 
oonomtmtlono# On oomporlng thoee two faotoro In the 
present group# the oorrolatlon obtained# although positive 
was m t  eignlflemt (r $0#351$ n 7; p>0*l)#
Ae desorlbeâ above# a rise ia the aorum 
thiocyaiiate concentration oocura on trea#mmt with 
l^âroxooohalamiïi for tobaooo amblybpia# If # m  renal 
olomranoe of thiooyaaate rmtilmd at the value of 1*33 ^l* 
per ailmte# found by Btoa (1957)# t h m  the rioe in blood 
tnioofBnato may bo mfimtml by a rime in iirinaiy 
exoretion# Thmoon (igO:) foimd #at the toxicity of 
the wine in tobaooo mblyopea# treated by abatimenoo 
from tobaooo# readied a podc 7#14 df^ yo after # o  
oommenoement of troatmmt and was aooompaniml by a diwoala, 
This Inomaoo in toxicity wao taken by him to indicate 
the body getting rid of poieonoaa aubatmoes# The renal 
clearance of thiooymate wae foimd by Thomas (1949) and 
$toa (1997) to depend on wine volume m d  renal 
excretion of chloride# as the thiocyanate ion Wiavee ne 
a pemdo halogm# Wokoe m d  Bllia (1966) found that 
the diwnal rhy#m of reml thiocyanate olearanco 
paralleled that of the total nitrogen clearance#
(a) The relatioBahip between the urinary 
thiooyanate excretion over 24 hours and the serum vitamin 
B12 oonoentration was shown hy Mnnell et al (1968) ta he 
negative in non**amblyofio smoking anhjeots* The values 
for urinary thiooyanate estimated as outlined above and 
the serum vitamin B12 oonoentration after the method of 
Robs (1952) were ooapared* They yielded a negative 
oorrelation which showed a significant trend (r « #0*479$ 
n ^ 2i  0#05<p<0*l)$
(b) The renal excretion of thiocyanate was 
followed over a period of 6 weeks in 14 patients whilst on 
iiydroxooobalamln therapy* The results are expressed 
graphically in figure 4* On the same graph is sWwn 
the mean alteration in urine volume for the same patients*
TIME 
IN WEEKS
MEAN URINARY 
THIOCYANATE IN
MICRO MOLES /  24 HOURS 27.3 (100%) 30.44 (111.5%) 37.6 (137.7%) 33.29 (121.9%) 29.92 (109.5%)
MEAN URINE 
VOLUME IN MLS. 1464 (100%) 1850(126.3%) 1778 (121.4%) 1536 (104.9%) 1301 (88.8%)
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Percentage 
change
X  Urinary thiocyanate concentration 
'# Urine volume
150-1
100
50
WEEKS
4f 4o Altération in urinary tlnloc^anate conacmtratlori 
ailé urine volume 1% toîmcoo cm treatment with
1 m
There van a r tm  in  the u riîia ry  exeretlon o f 
tMooyaaat© on treatment w ith liydroxoeobalamin* which 
reached a peak a t 2 weekc* ehowliMI a inoreaee* before 
alowly declin ing* â s im ila r ric e  was noted in  the nrinary 
volume*
(c) Stoa (1957) examined the renal thioeyanate 
clearance in healthy amokera and non#*am.Dkera* He foundJ' : 
an average clearance of .1*33 ml* per minute, with a rahge'v> 
of 0*14 - 3.* 53 ml#* per minute* There wa# no correlation 
hetween the thiocyanate concentration in the blood and the 
renal clearance for thiocyanate* In the preeent group %, 
of patients a significant negative correlation was found 
between those two factors (r « n # 0#001<pc0*0l)
(B’igura 4»5)* After six weeks therapy with hydrozocobalamin
the correlation showed a trend to becoming positive 
(r w f0*770; n m 3§ p> 0*1)# The average clearance of 
thiocyahste rose from 0*601 to 1*1 mis# pei* minute on this 
therapy after six weeks*
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RENAL CLEARANCE of THIOCYANATE & PLASMA THIOCYANATE CONCENTRATION
Clearance 
in m is./m in.
in UNTREATED TOBACCO AMBLYOPIA
1*5
Plasma Thiocyanate Micro moies^lOOmls.
Fipœe %  Eolation^hip renal olearanoe of
tbiooyanate and pl&ama thiocyanate ooneentration in untreated 
tohaooD amblyopiaf
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ThUG the renal olearanoo of thiocyanate 
varies inversely with the plasma thiooyanate coïioen trail on ^ 
low thicoyaiiat© clearance mtea being associated with high 
plasma thiocyanate concentrations * A comparison wae made
between renal thiocyanate clearance and toWcco ccnsmaption# 
The date for 9 patients was available; a negative 
correlation was obtained %Aioh was Just significant 
(r -0*681f u » 7# 0,02<p<0#05)#
% n s  low renal clearances of thiocyanate are 
associated with high tobacco coneimptlons and high plasma 
thiocyanate concentrations and high renal clearances of 
thiocyanate are associated with low tobacco consumptions 
and low plasma thiocyanate concentrations.
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âlistlnenofâ from tobacco has boon considered 
neoeeeary# important> or desirable in the eiiccessfal 
treatment of tobacco amblyopia (Hutehlnson 187)# Webster 
1880* Hartriilgo 1886* Ohieholm 1890# Fairley 1901, Dyle 
1905, Oarroll 1935» ^ambrasin and Bohepene I946, Hedges 
1957, Boggart 1959)# For many years this belief was the
keystone of treatment, till Oarroll (193?) showed that_
abstinenoe was not necessary# 9?he effect of pharmacological 
preparations has been investigated by authors to ascertain 
which, if any, accelerated return.of visual finiotion*
The earliest and most popular drug used was 
strychnine# Injections of this drag were considered to 
hasten recovery by Chisholm (1878); combined therapy with 
strychnine end potassium iodide was used by hautenbaoh 
(1898) and Findlay (igOl), Hartridge (1886) in a 
controlled series, discontinued smoÿlng in all patients, 
administered strychnine to half, and a placebo to the other
14^^
(3d* agsxpgip iwN&#
agi%Gdl3.;y igSKKl,
Tüdltdb 
llim
m
I nitrites were used by Powers (1886] 
g%%k) (wuGoewse t&iibh t#t& tiee <)f
m d  lfa»ington (19)5) was
that vleml
I m p m v m m t  was hastened by 
m d  that tMe d m #  was superior to nmâ%m
*1
diet# I te
;e (m (a&OQuadx)
> a partial or complete reoovery# in ei 
twae of tw)%H&oeo üwloo&woüL* Ils* (%&$
il/tBi tfGwe aw) 4gcM&d ate awa&r %%&(&vdLowei (sawejLee* jku wiiidsti idbe 
rhBimû. from tobaooo. Oarroll further eWwed 
i#w&t lcw%#e dooGB of TfitaBdhi B c%mg&le% &%%& 8 iwall 
diet were eeaentiml for m rapid return of vision# Gome
ewKwxaoiBe iweae <)%ytw%&JOWSGl Tbgr tfsüüasaHoat (31S>30) Tbar &&&G) atd%BjU&:ltrtKK%&tdl(%KL 
of vitamin B1 fThta^s
leatou et #% finding reduced
concentrations of vitamin B12 in the blood pi patients 
suffering from tobacco amblyopia, treated their patients 
successfully with parenteral oyanocobalamin whilst allowing 
continued smoking# Their patiente recovered vision more 
quickly than would have been expected on treatment with 
vitamin B complex* the dose schedule was lOGpg twice 
weekly, where amemia was absent, 1 0 0 daily for fourteen 
days followed by 100 twice weekly, where anaemia was 
present • Treatment was discontinued after six months if 
there was ■ no evidence of pernicious anaemia* Quatermas» 
(1950) achieved some success with parenteral oyanooobalasdn 
in the amblyopia found in a smoking alcoholic#
It had been shown that commercial preparations 
of oyanpcobalamin contained traces of other vitamin B12 
analogues (Baxter et al 1955)» notably of hydroxooobalemln* 
This, reasoned Smith (196I) had brought about the cure in 
the patients reported by Heaton et al (1958)# As the 
result of a personal comnmnication this author is assured 
that the commercial preparations of cyanocobalamin and 
liydroxocobalamin available in Great Britain today do not 
now contain other vitamin Big analogues as impurities* 
(Snell 1967).
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T re a tm e n t o f  Tobaooa
The patiente la the proaeat study woro treated 
prenarationo of vitamin Dig maimfaotwod by Glaxoim VÆ V.L xA*
Itsboratorioo Btd* They were roquoatod not to el tor their 
oBXoMng habit# la gmoral» the patimte moolvod their 
first fourteen d%o troa#mt as in-patients in hoopltal# 
They worn reviewed, ae mar am poooihle# at monthly 
intervale# Adjuetmonto to Mxorapy wore made from time
%
follow up period varied five months to thirty five 
monthe %^ ith a mean at ninetom month#*
The progroso of each patient at the end of tho 
follow up period was amoemood visually end graded by a 
oorloo of oymhale*#*
0 $» no ohango
- % Woreonim
H Improvement in  visual acuity to
0)7 35^ on the perotmtago acuity eoale#
4^ A» Improvement In vlou#l amity to 6^  
on the poroenta# wulty eealo#
miell
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m  or on
y to
faking # visual reault o f 6/12 or Wttor at #e 
smci of #e follow' up period, m  a good result and 6/lê 
or wome #a a poor roault# there were #  witli a good 
and 19 with a poor result# The remaining patient#
In n £S M
Of the 15 patlaite In t%)0 
a roomTenoe of # 0
a p%*eviouo attack of #0
roup, 4 w#m undergoing
i t  may be poaslMe tha t 
recovered fmm th e ir pi 
6 patient# wlio had expo 
, had been treated by 
&88B than 7 yearn before, am 
after a variable Interval on
OUTCOME
NUMBER 
IN GROUP
MEAN DURATION 
OF SYMPTOMS
+ + + + +
30
4.9
months
10
8.6
months
8
9.3 3 11.4
months months months
Thus 40 patients (72.^) whose mean testation 
of symptoms, before seeking adTice, was 3*45 months, had 
their vision restored to 6/12 (Snellen) or better during 
the mean follow up period of 19 months and the. remaining 
15 (27*8?l) (mean duration of symptoms 9.6 months) showed 
little or no Improvement, There is a significant 
difference between these ^oups (t *« 2*07; u 53? 
p<0*05)# Thus it would appear that the duration of 
symptoms influenced the outcome*
The 30 patients who had a visual improvement to 
6/9 (Snellen) or better were examined for the rate of 
visual improvement* This group consisted of 26 patients 
who received hydroxocobalamin while contiîiuing to smoke,
3 patients who were treated by abstinence from tobacco, 
and one patient who failed to respond to hydroxooobalamin 
and in whom visual improvement only occurred when smoking 
was stopped in addition to receiving hydroxooobalamin 
(Patient Ho* 52)* This patient is excluded from this 
analysis*
Of the 26 patients treated with liydroxocohalamiii 
only, the mean period of treatment over which the visual 
improvement oociirred was 6,82 i 4*49 months, The 
improvement in vision waa calculated from the ratio
initial visual aouityÿü 
The mean improvement in visual acuity per month of the 
right eye of the 26 patients was 1*75 ^ 2*)8 units.
Of the 3 patients treated by abstinence from 
smoking the mean period required to produce a visual 
improvement to the same standard was 3*0 months, and the 
mean improvement in visual acuity per month of the right 
eye was 1,58 t 0,54 units, The rate of visual improvement 
was thus equally good by either method of treatment 
(t c 0,264; u « 27; p>0,l).
Initially patients were placed on therapy 
alternately with cymocobalamin and hydroxocobalamin, 
By analysing the first thirteen patients M  whom seven
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were receiving cyanocebalamin, and six, hydroxooobalamin.
It was clear that hyclroxocohalamin was the superior treatment* 
The dosage used was usually 1000 daily for two weeks 
followed by 1000 jug twice weekly for four weeks, and 
thereafter 1000 at monthly Intervals* One patient 
however, (lo*?) received 1000 ^ ag* of oyanocobalamin once 
weekly for one month followed by 1000 fortnightly while 
another patient (Ho. 1) received 1000 )%* of oyaaooobalamin 
daily for one week followed by gOO 3%* fortnightly.
G R O U P  1 (Treated with Cyanocobalamin)
Patient
Number
Tobacco
intake
(ozs/week)
Duration of 
Visual Symptoms 
(months)
Initial
Visual
Acuity
Initial 
100 Hue 
Score
Visual 
Acuity at 
5 months
100 Hue Score 
at 5 months
1 1.0 9 2/60 - 2 /60
7 2.0 2 2/36 - 6/60 758
18 2.5 24 1/60 904 2/60 944
38 3.0 12 6 /18 1068 6/12 1057
41 2.0 2 6/36 - 6 /6 -
48 3,0 2 1/60 1120 3/60 1221
59 5.5 2 6 /60 623 2/60 531
G R O U P  2 (Treated with Hydroxocobalamin)
3 4.5 4 6/18 339 ■ 6 /6 177
11 7.0 5 6/60 996 6/2.4 630
12 4.0 12 3/60 600 6 /9 327
22 3.0 4 6/24 824 6/12 505
54 1.5 3 6/60 676 6 /9 256
58 3.0 9 6/36 625 6/18 536
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Details of the patients treated are met out In Table ^  1# 
All hut o w  were pipe smoking elderly males* the exoeption 
was one who smoked only eigarettoe* All had impairiaent 
of oentral vision and of oolomz vision at the etart of the 
trial# The memi ago of the patients in eaoh group wae 
oimilar (Group 1 69#? years; group 61*5 years) alüiou^i 
group 1 ooatalwd eome patiente who were older than any 
in group 8# m e m  tolmooo oononmption in group 2 woe
higher than in group 1 (5*0 osa* per week ae compared with 
2*7 0S8# per week)# The mean length of visual history 
was 0imilf3a7 In each group (group 1$ 7*6 months; grou%? 2
6*2 mmthe)* The slightly hi^ier figure for group 1 was 
W  proaenee in this group of one patimit with a 
history of vlmml failure (two yearn) *
To esBoae the reeulte of treatf^ent* the vieiml 
acuity on the Baollen teat type at 6 metres wder standard 
Qonditione of Illumination was expraeeed as a peromtage
takiïig ê/ê tm 100^ (Blclloy 1959)* %o improvement in  
per month wa@ oaleulated as eliown on page
mean 3j%provement vieua
of the poorer eye of each caee Im the two groups Is 
shorn in figure 1, xAera it can he seen that both the 
rate and magnitude of the improvemait in vision of those 
08888 treated with hydroxooohaXamin is greater than of 
those treated with oyanooohale^in, The recovery of 
vision in the two groups is equivalent to an improvement 
from 6/60 to 6/9 in the case of those treated with 
hydrOKOOOfoaiumin and from 6/60 to 6/36 partly in those 
treated with cyanocobalamin#
There is a ai^^iifioant statistical difference 
between the two therapies# (The mean improvement in vision 
over five months for those oases treated with hydroxoooi 
tbalamin è» 5*54 ^  4*4 %%nits# Mean improvement in vision 
over five months for the oases treated with cyanocobalamin
« 1.91 * 1.64 HMi-iiS. (t » 0*39? a = 2; p » <0.05)]
Measurements of colour discrimination were also 
used to assess the progress of the condition in the 
.patients described above# The initial and final error 
scores with this test for each patient are shown in fable 
5,1 where it can be seen that prior to the start of 
treatment, the error score was g#ossly abnomal in all
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Mean Improvement in Vision
/ Visual Acuity % \
\ Initial Visual Acuity % /
601
/ X  6 PATIENTS
X /
50-
3*0"
7 PATIENTS
2 3 4 5 6
Duration of Treatment (months)
Figure 1# Oomparlùom betimm the rate of vlaual 
ImpTOveamt per moath la patlmte i&th tobaoae amblyopia 
%flth pareateral hylroxooobalomla mti
oyaaooobalamla 9)he ra te  o f viaim l Improvemmt oaâ
tim maximum improvemmt ooomzizlag le elgalflomtly better 
In tïïooe patiente treataû with liyârexeoebala^lm#
ig e
toot®A# la flgum the memi error ecore
for thoee patim^ta on treatment iflth l%yt%raKooobalmln 
hem been oompamâ at monthly Intervale with thème troatoâ 
with oyanooohalomln* In oaoh oaoo the figure for one 
eye only W e  been taimn# the eye oelooteâ being that with 
the poorer oolow diaorimination at the etwt of the trial* 
Again# it earn be m m  that there ie a greater improvement 
in oolow dieoriminatlon in reeponeo to treatment with 
ïiydroxooobalamin than to oymooobalamin#
mam' in the reeponee Of tobaooo
amblyopia to hydroxoeobalamin e# ooisiparoi wi*» 
is borne out by oonei&eration of the ehbecqnent bmhaviow 
of t W m  oaeoe initially treated with oyanoeobalamin who 
are mow moelving hydroxooobalmin* In f e w  oaeee 
(patiente Moo# 1# 7# 50 m i  41) tlw vional aonity improved
W ft* of treatment wit
(A published aoeonnt of the findlnge of thie
Bi)#
Dameon 3
Mean 100-hue 
Error Score
1200-1
8 0 0 -
4 0 0 -
53 42Start
Duration of Treatment (months)
2# Heea Iti oolom? (tleorimlnatlon
Im with tobaoGO amblyopia tyaatedk t^ lth
liydmxoooWlamln aa oomparoâ with oymooobalmln
(0«"#0). Improvement 1% oolour vieion (a reâaotlon in 100
line error score) oooiira mtmig patlmto treatei with
l)ydro3cooobalamln W t  not maong those treated with oymo# 
(oobalamln, Vbrtloal bare indicate the range of eoores,*
Following on oomparloon of rato of 
Improvement following thempy with oyanooobalmiln and
%'êr03iowbmlamlm$ anû # #  fovowmble outcome for 
hyêromaobalmm#)^ # a ll patiente have boon plaoed
OB. therapy with h^^oxooobalamln#
rate o:^ , ylffital xv^ ODVai^ y, a M  oolour
Fig* 5# g lo a gmphlo representation of the 
Imprevemmt In vlmal aonlty anti Farnsworth 100 Hue error 
aeoro on treatment with hy^ roxoeohalamlni* fli© patimt is 
a pipe*emoId.ng male ageâ 6g yoaro who haa been amoking 
4"*5 of pipe tobaeoo weekly miâ haâ a daily intake of 
alcohol* Hie vlenal aym%)tome tfore for five mwithe only* 
Gorreoted vlonel aonity In the right eye was 6/18 and in 
the loft eye 6/1:^ # Oontm#*oaeoBl defeote to oolonr woro 
found both vimal fielde end tho Pomeworth Mmieell 100 
Hue toot error wore in the right eye wae 5)9 and In the 
left 4)4$ eemm vitamin Bia woe 110 pg/ml# He %me placed 
on treatment with IiydroxoaoMlamln and oontlimed to emoke* 
After few monthe treatment the vieiml aonity had Moon
RESPONSE of V ISU A L A C U IT Y  and COLOUR D I S C R IM IN A T IO N  
to I.M. H Y DRO XOC O BALAIV IIN  in a case of Tobacco Amblyopia.
100 Hue VISUAL 
error ACUITY  
score 
400-1
300-
200-
100-
0-J
100 Hue error score R E. 
Visual A cuity R E.
% Holidays
%
AVERAGE
NORMAL
-  1000 jug 
doily
1000 jug 
2xwk.
1000 ug 1X month
H Y D R O X O C O B A L A M I N
WEEKS of THERAPY
Figure Oomparison of visual and colour
discrimination improvement with time» on hydroxocobalamin» 
Patient Ho*3* It can he seen that improvement in colour 
vision lags behind improvement in visual acuity# ■
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to 6/9 in the right eye and 6/6 ia the left. He has 
now heen on treatment for 22 monthsi ÏI® ia oncrently 
reoeiving 1*000 p.g of hydroxoaohalamin th»ee monthly and 
hia visual acuity is 6/6 right and left* Paimsworth Mtmaell 
error soore right eye 104* left eye 134*
It ie apparent from figure 5* 3 that the improvement 
in colour disorimination Inga behind the improvement in 
visual acuity* confirming the earlier finding of Riddell 
(1956)*
Rate of Reooverv of the Oolour 8en$e,
As there is abundant evidence that eetimateeof 
the oolour sense provides as sensitive an index of retinal 
function as does visual acuity* estimations of patients 
visual improvement were also based on the Ramsworth 
Huneell 100 Hue test of oolour disorimination result.
This can be observed by examining the changing profile, 
or comparing the numerical error score against time on 
treatment*
157
(a) îm example of change in Fameworth^îtoeell 
100 Hu© profile ie given by following the progreae of a 
50 year© old male who amoked ozb of pipe tobacco a week 
and gave a 6 moniîha hie tory of vlaual fallwe and trouble 
with identity of oolour©# (Patient Bo#54)* ^ha corraoted 
vieual acuity of the right eye was 6/6O and of the lefjfc ©ye 
6/24# Who Famsworth'*îtosell 100 Hue error score for the 
right eye was 676 and for the left ©ye 4B0# Bxamination 
of the optic discs showed temporal pallor and there was 
a o@ntro*»oaecal field defect in the visual field for each 
eye# On treatmexit with 'hydroxocobalamin the changing 
profile of the right eye can he followed from Figs.
4,5i6 and 7* With treatment there is shrinkage of the 
area containing the error*
(h) When the nwflerical error score ie compared 
with time on treatment a curve is produced* The figures 
fit an O3cponeritiai curve of the equation*
y « A wkt + c
(y*#o) es à *.kt
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log: (y-c) « log A ~kt*Ç3 w
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Figiiue 4« PanwTiorth Kmsell Hundred Hue test 
profile in untreated tobacco amblyopia. Patient Ho. 54.
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Plgur* i  5. 7#xnaworth Munamll 100 Hua teat profile 
aftar 1 month'# treatment with hydroxocobalamin for 
tobaooo amblyopia. Patient Ho. 54.
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Pigur# ^  6# Pam#vorihmMun8ell 100 Hu« t«at profile 
after 3 eon the treatMnt with t^roxooobalaoin for 
tohaoeo amblyopia. Patient Ho. 34#
161
-A|«. Do M  /  ......./
If I 1 I 4 S é 7 • t 10 n II II M IS 14 17 II If 10 II
M II II II 14 IS 14 17 14 If
44 41 44
40 41 41 41
77 74 7f M  tl 41 41
s
S
200
Figure ^ 7 *  Farnsworth Nonaell 100 Hue test profile 
after 6 months treatment with hydroxooobalaoiin for 
tobacco amblyopia* Patient Be# 54#
1 6 2
y ** Î W  100 Bue eoore
o # Oometmt #ilob la ea individual
d h a m o t e ^ e t l o  o f  o a o h  p a t l m t *  I t . i o  t h o  0 3 ? r o : ?  
o o o r a  a t  w M o h  t h e  e x p m o a t l a l  o u r v a  w o t % l d  b e o o m o  
h e a ? i m o a t a l *  ' I h i o  v a l u e  le d e p o M e a t  o a  p a t i e n t  
o e u l a r  d l e e m e e  m â  e o m e  e y o t m l o  d l e e a e e e  
which # œ  toown to mmB m  upect tu the oolom? 
emee» : | [ ( # % m e a r  1066) » Pemlolow 
m a m l a  ( A d m e  e t  e l  1 9 6 ? )  { 
k  #  B l q p e  o f  ( y « " o )  O j ^ l a e t  t i m e #  m % d  l e  m  l M e %  
of the mte of Improvommt Im colow dleozdmiaatlm, 
t # fImst
#elmg the fomule the ouwe um tmnmm linear -*
1lo0 of the MW9 computer at Olaogow IMlverelty wao made to 
fini the moat suitable v#Im# for CJ which #vo the ^*bmt 
fit** to the reeulte over the flrat 18 mouthe of tmatment#
An llluetmtlve oxaaple la that of a 68 yeore old 
male (patient Wo#ÿ?) oolour niatoher of a cotton xxdll# who 
smoked 2^000* of pipe tobacco weekly and a vlwal
dletm?hanoe mtoMlng over two mmthe# left eye wae
Imom to have poorer violon #@â the % o  oorreoted
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of left
|%&nH&ï3L(W&)# l8%N&1k%K>*f38W&CN&3L a%(N)tH3K&GW& lWe%%& %f%NS2w3%
(&f 488H0&& (%yx&* g!]ba !&BKR%w&%f03;t%& &%%&%& 
&0# IÎW8 tioat» a&8Mf(% i&Bk <3G2KM3W iDdT ,$08 tfl't&i t&%0 ar3.0$*1) (sgfe %w&&
{ïoveâ
03? with the left» After 10 mmÆm of treatment with 
h^armsoùolmiamiü the viemal aoititf of moh 
to Û/9 pt# (Bmellen) a M  the Fameworth Hmi 
error hoâ falim to 180 with the ri^t oaro ana 860 with the
h Z&mw*.
error e m m  with time la ohown In fig*. 5, 8,
With a o valno of iO and plott:
n » %. p<0.00l)., ®te $)lon
Ilm le mi* a
la ehow on 9*.
%  msaiie of *IMo teoMiqne, It le poaeihl# to 
oomparo the ratw of Improvement In oolow Oloorlmlnatlon
with Weatmmt In m m y  patienta» % e  following gronpe of 
oatiaiite were aval labia for oomparieon##
Raw 100 Hue 
Score
400  ”
3 0 0 -
200-
100-
MONTHS
with tiîiie Oïl h^é^B%owhaIamim# Pa tie# Mo<
Loge(y-c)
2 7-1
2 6 -
2-5-
2*4 -
2-3-
2 2 -
2-0
MONTHS
Wigiivù 9* Improvement in colour ctisorimination with 
time on hyaroxooolsalamin. log (y»o) against time, 
o ■=> 20 (r = G.990). Patient Mo. JT.
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(a ) Tobaooo amblyopia oompIloateA by fon iio icae
(o) foteooo amblyopia ooapliüsteâ by âiabotos#
(<l) fobacoo amblyopia treated witli hydmxooobalamln#
(e) % W o o o  omblyopla treated by aWti$ionoe from tob&Qoo^ 
mean valum for k (rate of lmprovemmt)wer0
for all #ea$ groi%p$ m d  are contained 
of k do the tangent of the elope
Tobaooo omblyopla In proeenoe of 
pro pomloloim anaemia 
fobaooo amblyopia in preaenoe of 
dlabetea
r w  value
0,195 2*^1'
0.?
o.s
S0®42‘
IB*
Theae three 0 ^ p B  all reeelvod the eame therapy 
)ln 1000 dally for 14 doya followed 
by 1000 jag thrlee weekly, % m  the rate of Improvement 
In eolow emae %me pooreet In the group oomplleated by 
pernloloue anaemia# %ere la Inenfflelent data to observe 
whether thle could be Improved on; by giving a larger doae
Oyt rt f
of hydroxooobslamin, g. An^ l^©
ïïïioomplioatecl tobacco amblyopia 
treated with hydroxooohalamin 0*284 15
ÏÏncomplioated tohacoo amblyopia 
treated by abstinence from tob£?.oqo 0*302 15^ 43*
%here is little difference in theeo two groups| 
the rate of improvement in the colour sense being equally 
good by either method of therapy*
1 6 8
OMFi'SÏI VI.
l*0bor*s hereditary optio atrophy la a relatlvoly 
rare condition obaroetorisod hy ooute or euhaoute failure 
of oentml vieion preomting a» a rotroWlWr nowltie or 
optlo atrophy, typically in yomng males in their late teono, 
or early twantiea* It ie moommon for mly cmo eye to he 
affeoted and equally imoomon for the condition to resolve 
completely, thou# <imamplee of complete or marly omplete 
recovery have hem dooorihed, Many patiente with Wher*8 
hereditary optlo atrophy ore registered ae hllnd pereom ae 
the central aootoma is large and demae in eaoh eye and 
aoQonnt for 0*g^ of blind regietrationa (î&reholl and 
Beilw 194:^ )$
labor (1071) ommidered that the ago of meet 
%me moot common between 13 and Ê6 years# àmeman (1936) 
found that the dieeaoe hegm hetwem 20 mi 30 yearn in 
47#0^  ^of hie eeriee# Boveml antliom have stated that the 
age of onaet in mmoeedlng generations beemeo progreealvely
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younger ao called mtlolpatlon 1909$
MaaMenfeurg I9B3)#
Aoeman (1950) fomd that the dlemee invariably 
begm %flth m  acute reduotlm of violon, i^ hloh was followed 
by a period of alow progreoolon which oould last for 
several menthe# % e  dloeaee nearly alwaye attacked both 
eyoa$ eoDaotlmee elmultmeomly# eometlmae with an lnte%*val 
which varied from weeke to mmtho before the second eye 
was ai^ ffeoted# The acute diminution of vision may lead to 
oomplete bllndneee or aufflelent Impalmmt to warrant 
blind oertifloatlon# In a minority# the oonditlen Impmvee 
apontanoouely after a variable Interval, with clearing of 
the centre of the eootoma leaving a ring sootoma.
Generally# ho%mver$ the patlmt la loft with a deizee 
permanent aootoma affootlng tho fimtlm point in oaoh eye# 
In a study of #o dyaohmmatopaia which aooompanloe this 
mnditlon# Pranooio at el (I96I) oonolWed that the oolom? 
defeot was ohamotèristioally to be found in the red^ 'g^ o^en 
arm# of the opeotrm %Aloh served to differentiate 
hober*0 hereditary optio atrophy from the dominantly
1?0
inherited optlo atrophy in which 
wore affected#
*hlim 3?qgifMs
OphthalmooQOpy in the amte phsae may mve&l 
a normal optio disc or a disc ehot^ ing the oedema gmd 
hyperamla of papillitis# Amduo plotwo es deeorihed
by leher (1871) %me of a pE%plllitis# %her (1927h)
oommmtad on the preemoe of haemorrhagoa at the diao in 
the amte phase# àtrophy of the optic dieo met in after 
an interval of 2 montW or no, hut the dogroo of atro#iy 
gave no indication of the final vional aouii!^  (Battm 
1909# tieher 1927h, IWiAsgaoi# 1944)» Bmigioal exploration 
of the ohiaemal area revoalad araohnoidltio and a oeroue 
moningitia in a nnmhor of
Autopay reports have been publlehed on 
imquwtioned oamea# In Rehetoinor*e (1930) 
the eyes and the optio nervoe were e$samined; IWittken m d  
Bareat (I93h) claim to have carried out t W  first oomplete 
exaisination# Further oo^o^lete pathologiesl e^Eomi^mtiono 
Imvo h e m  reported by %;ilaon (1963)# and Adame ot al (1966] 
In all reports there were atrophic oMngee in the retina
miâ the optlo nerves were exteaoivoly dcFKyelinatsd, the 
papillo#maoular bundles being completely atrophied*
IWlttkon and Barest (1930) noted that there appeared to 
W  a primary trmtomwoml degmiomtlm la # o  whole optle 
traot exoept for the oalornrlm cortex# These authora 
f\%r#er deaorlbed aplml oord eymptoms and for w%üoh
oorreopmdlag newo»patholo#loal changes couM he 
demoaetrated, %eee oha%aa In tha spinal cord thoee 
authore attributed to malnutrltlcm# Rehotoluor (1930) 
oonolWod that the pathological evldawo w m  iâoutloal 
with that found following the toxlo etrophy of the optlo 
norvo in diahotoa or tohaooo gai#lyopla, and did not roaemblo 
the atrophy resulting from retrobulbar wurltlo* The 
majority of # o  oaaee dooorlbod hy.Wllam (I963) showed 
manlfeatatlone of a diffuse nourologlool disorder, Long 
tract el^o were preomt In moot m d  luoluded lower or 
upper llm%) paraootheelao, defective vibration seme, 
œteneor planter reepowaa, epaetlolty and hyperreflexla#
An eighth nerve dyeibnotlon of varying degree was 
demonetrable In half the eaees, There %me no oonvinolng 
huematologloal abnormality; but all the oaeea for whom 
relevant Information was available wore amokere#
17g
Additional infozimation of a like nature was presented by 
Adams et al (1966)*
Leber (1871) himself wrote that even unaffected 
members of a family may suffer from px^ otean neurological 
disordera such as migraine# giddiness# wealmess, or were 
easily fatigued* This has been amplified by the frUiding 
of associated neurological conditions# such as epilepsy# 
mental retardation# spastic quadrlpesis# ataxia of 
cerebellar origin, posterior colmm loss# various aches 
and pains, and paranoid schizophrenia. (Taylor 1892, 
Ne#tleship 1909t Taylor and Holmes 1913# Ferguson and 
Oritohlay 1926, Golenbrander 1962, Walsh 1957, Kwittken 
and Barest 1998). In moat of the reported cases the 
neurological disorders have developed in the presence of 
advanced optic atropliy or severe retrobulbar neuritis and 
usually some time after the initial visual disturbance# 
however, this was not so in oases described by Bruyn and 
Went (1964) and Adams et al (1966)*
Manifestations of the malady are not confined 
to the central nervous system  ^diverse skeletal
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abnormalities, a tendency to fracture, arachnodactyly and 
atypical ankylosing spondylitis have been described 
(wilaon 1965b)♦
I'he pattewx of inheritanoe is p^ wssling. She
reported pedigrees variously show features suggestive of 
a S0X#linked Inheritance, autosomal inheritance, or 
oytoplasmio trmsmission* Oolenbrander (I962) postulated 
the presence of a ^%ebervirus^* in the cytoplasm whioh 
produced a cellular mutation* Van Benue {1963) felt 
that an autosomal modifier gene was required for the full 
expression of a sex linked inheritance# Wilson (1963, 
1965a) and Adams et al (1966) feel that the basic condition 
is an inborn metabolic error, for whose oxpression 
exogenous factors are pre*#eminent, and that there are 
relatives of affected persons at risk who are predisposed . 
to the malady but have not encountered the exogenous factor, 
These authors further postulate cyanide to be the toxic 
factor#
Wilson (1965a) examined patients suffering from 
Lobar* s hereditary optic atropîiy for products of cyanide
metabolism, and found aignifiosntly reduced 
oonoentratlons of thiooyanate in the plasma and in the 
urine, the dlfforenoea being more marked in those patiente 
who smoked* In this respect the disease resmahles tobacco 
amblyopia* Because of the reported success in treating 
tobacco amblyopia with hydroxocobalamin (Ohisholm, Foulds 
and Bronte^Btewart, I967), the following patient suffering 
from Leber*a hereditary optic atrophy was given similar 
treatment*
This man, aged was aeon with a year* s history 
of numbness and paraasthesiae affecting the right side of 
the body and coincident blurring of vision of the right eye* 
Similar bltuxring of vision of the left eye had been present 
for one month* He sriioked #  cigarettes daily and drank 
several pints of stout per day* On examination the visual 
acuity of the right eye was 2/60 ( Snellen) and that of the 
left eye 6/12 (Snellen) with a dense central scotoma in the 
right field of vision and a smaller oentro«*oaeoal scotoma, 
more striking to a red target, in the left* The right 
optic disc was pale and the left oedema tous* The right
plantar response was extensor but there were no other
#5
abnormal meurolo#oal signs*
During the next 4 weeks the vision of the left 
eye deteriorated to l/60(BneXlen) with an increase in # e  
size of the central scotoma# There was striking bilateral 
optic atrophy# Leber* s hereditary optic atrophy was 
diagnosed when it was discovered that his maternal uncle 
had been diagnosed as a case of Leber* s hereditary optic 
atrophy in 1957» &t the age of 36# The patient was 
registered m  blind* % e  sorm vitamin BX2 level was 
150 pg* per ml* (Biglona gracilis method) but other 
laboratory inveetigations were not signifioant#
Bo was treated first with oyanooobalamin 1 mg# 
intra**muBoularly on alternate days for two weeks and then 
with prednieoXone commencing with #  mg# daily reducing to 
5mg# daily over two months, and thereafter at this dosage 
for eight months longer, but the visual acuity remained 
unchanged#
Borne 2 years later, when the superiority of 
hydroxooobalamin ovea? cyanocobalamin in the treatment of
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Hguro I. Graphie repreaentatloR of vlmal px^ogross 
im a patient oufforing from Leher* o hereditary optio 
atrophy treated with hydroxooohalamin* The arrow indioatee 
the time at which the patient was registered blind*
tobaoGO amblyopia mbb realised^ the patient wae treated 
with patenterai hydroxooobalamin 1 mg. daily for 2 weeks 
and thereafter twice weekly# 33efore starting this treatment 
the acuity of the right eye was 2/60 and of the left l/60 
(Snellen)*
After 3 months the visual acuity had improved to 
5/60 in each eye and after 6 months it was 6/60 in the right 
eye and 6/36 in the left* The patient could now read large 
print and was no longer ooneidered regiatrablo as blind*
The progress of the visual defect is shown graphically in 
Figure 6^# 1* (A published account of this case is fcoated 
in Appendix 1% 2).
Members of the following Spanish family have been 
examined m d  treated with hydroxocobalamin* Three of the 
patients have been followed for five months* All the 
members examined belong to the tliird generation (See Fig.6,2)*
III. I* A male aged 34 yoars was examined in October*
I96B* There was a history of sudden bilateral loss of 
vision whilst on a business trip 6 years previously* The
1 7 8
LEBER'S HEREDITARY OPTIC ATROPHY
rO
-o
■  Examined
0  0  Diagnosis confirmed elsewhere 
□  O Not examined — no symptoms
Figure 6j 2# of I»e’ber*3 Bereditsry Optio Atrophy#
ifiewBl loem Mû horn preoaedod hy mi inîlmmiimliMi 
illîiaaa of ono#two daya duration* Ha amokat 20 or- more 
oigarattea i)m day» fha year following the vleaal loaa 
ho had imdergone omnlotomy for ohiaamaX oraelmoidâtia»
The Visual loao waa Bavera and had remained no»
ËKemlnatlon revealed a oorreotod vienai aontty in
the rig h t end leff eyee o f j/iO  (S nellan)i with a x4 low 
vleaal, aid Mb ne#r v is ion  wet Ophtlmlmoaoopio ’’
e^samlnation revealed marked p a llo r o f the optio diooa, w ith  
ehosthing o f the re tin a l vweele a t the iio o  in  each eye»
The oeular media were oloar end the rnaoulaa normal# 
Ikamlnatim of the aentral field of violon revealed a central 
aoetomata# extending to 10^  ^around fixation in the right eye 
and 3^ in the left eye# (Figmre 6$g)# The eootoimta wore 
confirmed hy eta tie perimetry# The Fmmeworth#ffmeell 100 
Mne teet reenlt gave an error of 560 for right eye# 580 
for left eye»
General examination mvealed m  Byctemio or 
neurologloal abnormality# ïj!lootro#'miqephalograpbie 
"ommination revealed a normal tracing» The haemoglobin
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Prüfpunht
LA RA
Name
 -■ asb
Figura 6# J* Oentral area of the visual field in untreated 
heher^B hereditary optic atropî:iy (Patient III# l)#
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concentration was oeruia vitamin B12 306 pg/mlj
serum folate 4*4ng/Bilf a week 4ve result on testing for 
gaatrio parietal cell antibodyç and a «•ve result on 
testing for antibody to intrinsic factor*; the Schilling 
test showed recovery.
%eatment with hydroxocobalamin was comienced 
with 5 daily for I4 days and then reduced to 1 mgm» 
thrice weekly thereafter* After 5 months on this treatment 
there was eubjoctive improvement in visual acuity# not 
confimed on the Bnellen chart# hut confirmed by static 
perimetry which showed a reduction in the sise of the 
scotoma*
III# 6# A male aged 24 years was examined In October# 
196s* There was a history of sudden bilateral loss of 
vision 4 years previously while studying for examinations* 
There was no precipitating illness* He smoked upt^ ards of 
20 cigarettes per day*
Examination revealed a corrected visual acuity 
right eye 8/60# left eye I/60 (Snellen) with x4 low visual
Name r.u. L«uchtdlchte; Fait#: Durchm.: , .M b  \  Z im in  M erid ian :fjW f.. —I— I Pat.
Diagn, :. . V W l  U . . . . .  W T j l t
t i m m -
40
FIxierp.:
Umfeld:
111
6» 4^ Ühowln^ thei in tho etatio
of the left eye before m<l e f t w  5 monthe therapy 
th iiydmxOQobalemin (#^#). There le ahrlnkege In the 
area o f the eootoma* (Patient I I I ,  6)#
aid he vms able to read 15 with either eye# Ophthalmoseopj 
revealed bilateral pallor and atrophy of the optic disco 
with sheathing of the retinal vessels at diso* The 
ocalar media were clear end the maculae normal# Examination 
of the central field of vision revealed a central scotoma 
extending to 3^ from fixation in the right eye and 10^ in 
the left eye# The scotomata were confirmed by static 
perimetry* The Farnsworth Munsell Hundred Hue test result 
gavo an error of 244 for right eye and 5S9 for left eye 
(Fig, 6,5),
General examination revealed no systemic 
neurological abnormality* lleotro*#enoephslographio 
examination revealed a normal tracing* The haemoglobin 
concentration was 1135^ # serum vitamin B12 446 pg/ml* serum 
folate 3*7 ug/ml, a negative result on testing for antibody 
to gastric parietal cells and intrinsic factor* the Bohilling 
test result showed wf& recovery#
Treatment with hydroxocobalamin was commenced with 
5 mgm# daily for 14 days and followed with 1 mgm# three 
v/eehly# After 5 months on this treatment there was a
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Figure 6,5. '^rpioal Farnsworth Muneall 100 Hue chart in 
Leber's Hereditary Optic Atrophy.
1 8 5
, The oorreoted vlswl acuity had 
In the right eye to 3/60 and left oyo to 2/60 
* There Ime boon Improvmmat on otatio porlme^
$4)*
HI# 14# A male ogod 16 yoara wae oxmlned jn #rch, 1969# 
Them wao a &%latory extending over the previous 6 monthm# 
The visual acuity of the rl#kt eye failed first vfithout any 
dieoovorable ophthmMlo oauae# the vieion in the left eye 
deteriorated eoee 3 weeke before exeminatim* An 
ophthalmologist at the patient^ e home town had eoRmenoed 
therapy with eyetemio etoroid (Prodnieolono) &md a mu 
vitamin %>r#a%*ation # which include#
10 olgerettea per day*
al acuity of the right eye was 
1/60 and that of the left eye 6/I8, (Partly) ( % 0llen)# 
Ophthalmoeeopy revealed hyperamia of both optid diaee 
with vaequlor engagement of the upper halves of each dlao# 
Ho vaumlar ehmthing wae observed in either eye# 
Fluoresomeo an^^ograpby confirmed the preemoe of mall 
voooel dilatation of the upper halvee of eaoh optio dioo# 
iYom whioh no leakage of dye ooourred dwing the dye
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The examination of the central fields showed a ohsraoterietic 
central aeotoma in the right eye and a oentro«#oaecal scotoma 
in the left eye* whioh were confirmed by static perimetry#
The Farnsworth Mansell 100 Hue test gave an error score of 
550 with the right eye and $16 with the left eye.
General examination revealed no systemic or 
neurological abnormality* Blectro**enoophalographio 
examination gave a normal tracing* The haemoglobin 
concentration was 182^ 6, serum vitamin concentration was 
nonml* serum folate 5*9 u|^ /ml* a negative result in 
testing for gastric parietal cell antibody, the Schilling 
test result showed 6*9^ recovery*
The patient was treated with the following intensive
régimes*
Day 1* 10 mgm* liydroxooobalamin given as an intravenous 
infusion in 500 ml* saline*
Day 8# 5 mgm. îiydroxoeobalamin given by intramuscular 
Injection*
Day 3* Repeat of the intravenous infusion with lOmgm* 
hydr oxocobalaïîin •
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patientas previous therapy with eyatmlc 
steroid was continue# tlirmghout at the same doee# %
# y  4 the visual aouity of the loft had rlem to 6/9 
(partly) Saollon# an# the therapy was continued with 
hydroxooohalamin 5 mgm# thrloo weekly W t  in opite of ü%io 
the visual aoidLty fell to 6/g6 (6nollm) over the m x t
meké âoso of %#mxooohalmim woe imnnmûâ to 5 :%## 
dally without any additional improvement in violon. Although 
the visual aoWLty fell after the initial improvemont, the 
oboerve# improvement in the visual field has been maintained.
Thla patimt has been etudled in the aoute early 
phase of lober*a hereditary optio atrophy# Hie preemt 
therapy ooneiete of hydroxooobalemin 5 e## daily# Frednieolone 
5 mgm. thrice dally# He M e  been advised to stop smoking#
III# l6* A male aged 14 years was mcamined in October,
19# #  There was a hiotcccy of abmpt lose of vlaion in 
both eyes whmi aged 10 yeara, He had imdorgono wrgery for 
0 mastoMitia at 7 yeara of age# He wan a non#moker# 
Profoeeor l^auelachettl had prescribed male hormone 
injeotione T*:dth no benefit#
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LA RA
Nam e:..............
VISUS
...
6, 6# &e%Gr*8 awMceaitoay (%p%&o ohowdü%& the
pmrlphe^eal vlaiml field befozre (*►) miel aftei?
42cwc3%B#tü*dL ifieauual E&o&tilbjr 
im # 0  right # e  smé Xaft eye of l/êO (Bnellm) aaâ wi th 
&%&#]&)% Tfietwal a&l<& ï%& G%at%a%0GHl !R%)# <3%&brt&Hs3kiK)CHDc%p:lo 
CKKaiüdLncttdLcMü :e<yy&a]Leil iaGKK&&eft g^ allor <)f (>prblo illeats swact 
eWmthlng of the retinal mimolB on the disc in each eye# 
of the visual fields reveàled perlphoml 
ooaetMotim to both colour and white targets and a donee 
absolute scotoma extending to about the fixation point. 
Who Fmmoworth llmeoll 100 Itia teat gave an armr of 1195 
for the right eye and 15# i m  the left eye#
General examination revealed no eyotemio or 
neurological abnomalityi Bleotro encéphalographie 
examination revealed a normal traoin#. %he haemoglobin 
oonocntr&tion wao 1100, eerum vitamin #18 5Ô0 pg/ml, 
serum folate 5#5 ng/ml*, a negative result on testing for 
gaatriô parietal cell antibody #n& antibody to intrinolo 
f&otor; the Schilling tomt reoult Showed 7*9# rooovery.
%eeatment 'With lnydroxocoWlamin waa commenced 
with a dooe of 5 i%m* daily for 14 dsyo and thm oontlnued
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with 1 nigtn* thrice weekly thereafter* At the end of 5 
months there was mhjeotlve visual Improveraeat in visual 
aouity which was not confirmed on the Snellen chart, hut 
was m  static perimetry and there was less oonstxiotion 
of the periphery of his visual field (Fig# 6,6).
Bkaminatlon of these patients for defects in 
vitamin Bis/oyanide relationships was carried out. fha 
relative data are contained in fable 6, 1 and 6* 2* As 
previously reported (Foulds et al 1968c) no significant 
abnormalities were detected in serum vitamin B12 assay, 
or Schilling test results in hober* s hereditary optic 
atropîiy# fhe mean plasma cyanide concentration was 
0i054 micro moles# When only the smokers were considered 
the mean cyanide concentration was 0*045 micro moles#
A similar higher level was found in the smokers, when the 
plasma thiocyanat# concentrations were examined « mean 
2*88 micro moles per 100 mis, 5#18 micro moles per 100 mis* 
for smokers only, and in the urine where the thiocyanate 
concentrations were 5*97 micro molea/lOO mis* urine and, 
3*75 micro molos/lOO mis* urine for the smokers*
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Table 6,1*
LEBER’S HEREDITARY OPTIC ATROPHY - UNTREATED
Age Tobacco
consumption
Plasma
Cyanide
Plasma
Thiocyanate
24 hour Urinary 
Thiocyanate
Thiocyanate
Clearance
Serum
Folate
111, I 35 20 clgs/day 0. 056 3.3 30. 87 0.65 4.4
i n , 6 24 30-40 cigs/ 
day 0. 048 4.4 44.2 0.82 3.7
111, 14 16 10 clgs/day 0. 03 1.85 5.9
111, 16 14 N.S. 0. 001 2.0 23.0 0.79 5.5
Table 6,2,
URINARY EXCRETION OF THIOCYANATE/100 mis. AND RENAL CLEARANCE OF THIOCYANATE WITH TIME
0 6 days 10 days 14 days 6 weeks 5 months
1
111,1 3. 25/0.65 9 .2 /1 .33 9.86/42. 02
111,6 4.25/0 .82 5 .5 /1 .24 10.0 /6 .2
111,14 1 .8 /1 .6 3. 3/3. 05 13. 0/5. 7
111,16 2. 30/0.79 0 .6 /1 ,25 1 .0 /2 .5
Mean Urinary 
Thiocyanate 3. 27 5.1 6. 95
Renal Thiocyanate 
Clearance 0.75 1.27 16.91
- - -  - ~-------
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Am demonstrated in the patients suffering 
from tobacco amblyopia there is a rise in the urinary 
excretionj and a rise in the renal clearance for 
thiocyanate, on treatment with hydro:^ooabalamin* The 
mean urinary thiocyanate was found to be 5*27 micro moles 
per 100 mle# of urine and the clearance for thiocyanate 
to be 0*75 mis* per minute prior to treatment# On giving 
hydroxooobalamin by injection at a dose of 5 mgm# daily 
for 2 weeks fallowed by 1 mgm* thrice weekly, the mean 
urinary excretion rose to 5*1 micro moles per 100 mis# of 
urine after 10 days, end to 6*95 micro moles per 100 mis* 
of urine after 5 months therapy* There was a similar rise 
in the renal clearance for thiocyanate from 0*75 mis* per 
minute to 1*27 mis# per minute after 10 days, and 16*91 
mis* per ailnute after 5 months* The rise in both the 
urinary concentration of thiocyanate and the renal clearance 
of thiocyanate was more marked In those patients who smoked, 
from figure 6,7, It om% be observed that the urinary 
excretion of thiocyanate rises with time on treatment as 
does the renal clearance of thiocyanate* As far as the 
patients have been followed up neither factor has reached 
its peak* These results contrast with results for urinary
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LEBERS HEREDITARY OPTIC ATROPHY  
THIO C YA N A TE EXCRETION and THIOCYANATE CLEARANCE on THERAPY
(M e a n  of 3 patients)
U r i n a r y  T h i o c y a n a t e  
M i c r o  m o l e s  / 2 4 h r s .
R e n a l  C l e a r a n c e  
mis./min.
100-
5 0 “
R e n a l  c l e a r a n c e  
Uri nary excretion
T i m e  In M o n t h s
15
-10
- 8 
-6 
- 4  
-2
Plgmme 6» 7* ■ AlWmtloa la uaylnary eaceration of 
thlooyaaate (#) aad of rmal olomzaaoo of thlooyaimte 
In optlo atmpi##
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obtained in # m  tobaaao aablyopia patienta 
whoae thiooyanato «Korotlon raaohed a peak aome tvro mokB 
after the emmenoemeat of therapy#
II. &8E
Th0 0stmolBM.on haWean theae two oomlttionw hao 
Wen reoo0niee& for eome time* flms Leiehmsn (19S5H) found 
10 mamplea of a#leonlm% pmmloiomB maemla in hi# review 
of 75 patienta eufforing from tohaooo amhlyopia^  and Heaton 
et a% (1958) 2 e%amplea in their analpiie of 13 tohaoeo 
m%blyopia patiente* fhe latter authors further felt that 
patiente with the retrohulhar neurltie of pemloione anaemia 
who emoked ooiiM equally be deaorlbed ae suffering from 
tobaooo amblyopia, fhie theme was farther amplified end 
confirmed by WmmBu mû Heaton (1961)# Heiahman (1951) 
was of the opinion that tobedoo amblyopia and the retrobulbar 
neuritle of pemloloue anaemia oouM oo-exiat and Oohen (1936) 
end Moàlpine and Goldsmith (if51) fmnd optio atrophy ae the 
prwentimg elgn of perniolowe anaemia#
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dallemêer Dmborough (1957) produced 
miâm00 that there is a **pra*pWAicioue anaemia*^  etato 
in which there ie laboratory evidonoo of pomioiouo m & m i a  
(&#e, 8ohlorhydria$ poor absorption of vitamin low or 
low mmuX serum vitamin B18 oonoeatration) without anaemia# 
mû wldoh prooedea the anaemia by an interval of years 
(fewt I92&)* Patients fitting this pre"*pemioiom anaemia 
at&ta were ifoimi both by hoiiilman (1$%) and Heaton et al 
(195®) iu their studies#
Turner (1940) noted #mt the development of 
amblyopia in pernioiow anaemia was not related to the 
degree of amemia# but was pmalbly related to the smoking 
habit of the patient# Adame at al (1967) and fonlcls et al 
(1968e) reported exmploa of amblyopia in non^emohore. Of 
the 5 patients reported by IRmldn et al (19680) all m m  
female#
In this p%*eomt analysis of 65 patients Buffering 
from tobacco amblyopia 11 patiente m m  found to anffer 
from Addisonian pemleioua ammla# dlognoeim Wing baaed 
on anaemia (haemoglobin leas then lOQm^)# megaloblastic
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arythopoaala Im marrow examination eerum vitam in BIB 
oowentration ^110 pg/ml^  oirouXatiBg antibody to gaeirio 
parietal celle# aohlorhydria# end a Schilling toat result 
of <6 recovery# In a further 11 patients evldenoe of the 
‘■^ pre'^ parnloicme anmemin" atato without anaemia was found#
Of tho80 patienta 1 subsequently proved to have a gaotrio 
oaz'oinomm and 4 had undergone previous gaetrlo or Intestinal 
ourgory# %u# slightly more than tl of the patienta in tliia 
analyela eWwod evl&enqe o f overt o r weult pernloloum
fhe patienta mfferlng f m m  Addieonian powJloioue 
anaemia were Hon# 1#Y,8*13#17*27#B9,33#36#90 md 57# and 
included the only female patient in the analyala who smoked 
oigarottea (those In #e**pre^pornlolouo anamia"* otato were 
Moa# 6,18#80*%3#85,44#46,48,56,98,65*
Hone showed the retinopathy of pomlolous anaemia 
and ofhthalmoeaopy revealed p a llo r of the optlo diaoe.
lEaminatioE of the visual field# revealed the oentro-oaeoal 
sootom of tobacco amblyopia and the emmlnatlon of the 
colour aenao showed a grooa distwhanoe* Several patienta
1 9 7
Mil bem diagaosed m  suffering from pomiolouo ememla 
initially end h M  the visual defect oatogorieod subseqiimtly*
fho olinloal details of three of the oaeee merit 
mention IndivitioBily# ftieae m:# two obbbb of tobaooo 
amblyopia ocowwihg In patienta # m m  to have pernloious 
mmmia and whose vision failed to Improve on traatraant with 
oyanoooMlamln in apite of a mtimi to normality of the blood 
pioture# In each oaae there was a prompt Improvement in 
vision wtoi tmatmemt m m  ehmmgeë to %#ifoxoooh$lamlm* The 
third patient aatuaXly developed tohaooo amblyopia while on
with oymiocobalamin for permloioua anaemia ant who 
only vision when the treatment was changed to
hydimooohalamin.
Q flTBt.i patient (Claeo Ho#X) was a man of 56 
years of age who smoked 1 os# of tobacco per week as 
oigarettss# He was a vegetarian# When first seen he had 
a visual soulty of 5/60 with the right eye and 5/6O with 
the left eye# Examination of the visual fields revealed 
the oharaat'èrietio ohanges of tobaoeo amblyopia* Jle was not 
anaemia (haemoglobin 14 g/lOO ml# PGV 45) hut the serum SI a
198
level warn lose than 8$ the folate being normal
(11 Bmg/ml)# of the eternal marrow rmroaled
megalohleetlo oryt&nropooolm# There warn a hletamlne imt 
aohloTl'jydrla# an aWomal Qohllllng toot snd eerolo^
showed the preeowe of antlhodiee to gaetrlo parietal oeXXs* 
^amlnatlm of #e fünûl ehotmd aom^ # degree of optlo atrophy 
and the patient admitted thot Me vlalom had bom poor for 
at least ntm mom### #rea$mmt with oyanooohalemln 1000 uga# 
dally for one week wee etarted mâ thle was followed 1:y §00 ug# 
fortnightly for six months# Bomohlmtlo orythropooBia was 
reetoreâ imt tlM viaml acuity mmalmd unaltered sM the 
patient* a treatment mm therefore changed to hydroxooobalamln 
1000 ttgt Again there was a rapid Improvement
in vla&on# particularly of the right eye# which within a 
month hai improved to 6/M mal has continue# to improve 
reaoMng 6/6 in six months# fhe vicioa In the left eye 
liarj boon slower to respond# improving from B/6Ü to 6/18 over 
the course of six months# fhc pmgreae of the visual clef set 
la each of these oasw 1# mcorded in figure 6,0*
file ^ G'orid patient (Claae io#T) a male agcâ fl years# 
smoked 2 o%# of pipe tohaooo per week# Hie visual aoulty 
when first seen was lees thai% 6/60 with either eye nnd there
i#
VISUAL ACUITY 
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on Cyanocobalamin 
on Hydroxocobalamin
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DURATION of TREATMENT (months)
20
6f ##
of qyo
m  of viamal Improvement
wao a éofeot of tobawo amblyopia
% 0  patient wao 
POV Ê4#5) O M  was
/.Vi gf*u
ifmm to be 
ÿ wv^«wkwu*aotlo memfow, 
positive aerology for gaaWlo pmzletal oe&l oatlbodles# 
6ohllllmg^ toot 3#7^0# '^aatmmt witb parenteml
0ytiK)0Obalai«lm 1000 %a* once weekly for one month was 
iBitituted am# was followed by 1000 %a* onoù par fortml#t 
for eemm momth# when the doae wa# redneed to 500 mg@* at 
Intervale of three weeka# On this treatment the blood 
ploture ret%#%ed rapidly to normal# Imt the vieiml amrity 
whioh initially improved over a period of tm months# from 
leas than 6/60 to 6/60 in eaoh eye# did not improve farther* 
After one year on oyanooobalamin treatment was ohmged to 
hydro%:oeObal8min (1000 mge# twlee per week), There was am 
almost immediate improvement in viaual amity, Within two 
weeks the vision had impmvmd to é/$6 with the right #e m  
6/24 partly with the left# and the vision has contlnned to 
Improve eimoo then reaching 6/gf with the right eye ©mtl 6/l
eye in #1% montho.
m&0 Iw* a male
.!01
VISUAL ACUITY 
(Snellen)
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Figure 6#9* Oraphio representation of visual acuity of right 
and loft eye whilst on treatment with eygmooohalamin and 
later hydroxooohalamin* Patient Ho, 56.
pipe smoker# of 51 years of age, smoked one half to three 
quarters of an otmoe of tohacoo per week. In May, 1966, he
sustained a contusion injury to the hack of his head and
following this noted a proptosis of the left eye without 
eechymosls# He was admitted to hospital where h# was 
found to have pernicious anaemia and treatment with 
oyanooohalamin was started (lOOO ug* daily for one week 
followed by 250 ugo# weekly for one month, when the dose
was reduced to 250 ug* fortnightly. Four weeks later the
dose was further reduced to 250 ug# monthly). On this 
treatment the blood pictwe returned rapidly to normal.
His proptosis however increased and he developed diplopia.
In July 1966 he was admitted to the Glasgow Institute of 
Neurological Sciences where he was found to have 6 mm. of 
left proptosis, slight blurring of the optic disc in the 
left eye and a bilateral depression of the centro-*oaeoal 
area of the visual fields to a small red target, suggestive 
of early tobacco amblyopia. At that time the viemal acuity 
was normal in eaoh eye* In August I966 an exploration of 
the left orbit was carried out, a biopsy showing a non* 
specific orbital granuloma* Following this procedure the 
proptosis disappeared and has not recurred. In October 1966
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3 error aaore nhilet on 
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the vimml aooity v;ae noted au 6/9 p a rtly  w ith the r l^ h t 
eye tmd 6/18 with the le f t .  Four mcmtho la te r he was 
OGoa aipAn and the vleual aoaity in  Um rig h t ey© wso 
recorded ao 6/24 pa rtly  while the vi.3ioa in  the lo f t  eye had 
falXon to 6/60# Bie reading vio lon wao groooly impaired 
and the visual fie ld s  ohowed groB$ contro^oaeoal Xoeo with 
dense ielando o f oootoma typ ica l o f tobacco aabl^ 'Opia#
There wao no peripheral IOO0 of visual field; the right 
optic fliao appeared normal but the left was cllghtly pale# 
The patient was transferred to our care for further 
iv:).vo0tlgation xému It was fou.nd that # m  visual acuity !iad 
fallen to g/60 (coxwctod) with either eye, the reading 
acuity in the right eye being M24 and in the loft B48#
There visa a groao defect of colour discrimination* the 
l%3mev;orth Huneell 100 Hue score for tho right eye being 
7969 a partial taiviorrhai^ hy oa the left aide raeking colour 
vision tooting ia this eye difficult. Boring all the time 
that the patients vi,Bion had been d.ettml ora ting* trcatïsïont 
with parentorml oymiooobalamiu had been maintained and the 
patioat continued to smoke#
Treatment with Ip/droxocobalemin lOQD ug. daily was 
Otar tod and j^ithin throe days tlio visual acuity in the right
eye which had hmn 2/60 improved to 6/24 p a r t l y One 
week after the oomwmoement of treatment the visuel acuity 
in the right eye had Improved to 6/12* euhaetpentXy 
fluctuating during the eucoeedlng week between 6/l0 and 
6/24# fwo weeks after the oommenoement of therapy the 
left tarsorrhaphy was divided. fhe eourao of the visual 
acuity for each eye in shown in Flg»6*9 where it will bo 
B m n  that over a period of four moBtha the visual acuity 
in the right eye improved to 6/9 and in the left to 6/18 
partly* There waa a ooinoident improvement in colour 
diaorlmination which is shown graphically in Fig*6,10*
These patients illustrate the incffaotlve value of 
cyanocobalamin in the tremtmont of pernicious anaemia 
accompanied by visual disturbance# They further eupport 
the view that Îîydroxooobalamiîi should replace cyanocobalamin 
in the treatment of pernloioue anaemia* particularly If the 
patient is a smoker*
206
fh© hypotheale that inter connected dleturbsnoee
of oyanide/vitamin 112 metabolism may be oonoerned in the 
pathogenesis of tohaoeo amllyo%)la* - the retrobulbar wtLeltla 
of peamioieao anaemia*^ Maar’e hereditary optic atrophy 
and certain tropical neurologloal syndromes apparently 
associated with a high oyanlcie intake# ^ is si^pported by the 
investigations of Smith (I96I) Wilson (I95^a)#. Montgomery
(1965) Wilson and hangman (I966)# Monekoseo and Wilson '
(1966)# freeman (196?)#-Ohlaholia et al (196?) and Osnntokim 
et al (1969).
Observations apparently provi.dlng # direct link 
between smoking and vitmaln B12 metabolism are few, They 
inoludei-**
I, Thera may be a slight or moderate inoreas# in 
eyanooobalamin In the plasma of some heavy smokers,
(Lindstrand et al 1966),
2* The finding that a larger proportion of norm
ao?
vitamin B12 is extraotable in the absence of added 
cyanide in smokers than in non-smokers# (Smith 1961)*
5* The finding of a negative correlation between 
plasma cyanide and total serum B12 concentrations#
(Matthews et al 1969* Wilson and Matthews I966)*
4. The urinary excretion of vitamin B12 is 
increased in smokers# and is assooiated with an increase 
in vitamin B12 excretion and a relatively low serum vitamin 
B12 concentration (Wilson and Matthews 1966) #
The findings contained in this thesis are 
presented to amplify and strengthen the theory underlying 
the aetiology of tobacco amblyopia and related conditions - 
namely a disturbance in the cyanide / vitamin Bl2 relationship 
and the following new facts may be emphasised#
(a) The concentrations of serum vitamin BX2 in 
tobacco amblyopia are reduced when compared with the 
concentrations in non-amblyopio smokers and non-smokers#
(b) There is a positive correlation between 
tobacco intake# on the one hand and serum vitamin B12 
concentrations# and vitamin B12 absorption on the other# 
in subjects suffering from tobacco amblyopia#
2 0 8
(o) There are reduced concentrations of 
thiocyanate in the blood of tobacco amblyopes which 
undergo elevation in response to therapy with hydroxocobalamin.
(d) A rise in the renal excretion of thiocyanate in 
tobacco amblyopia occurs in response to therapy with 
hydroxocobalamin •
(e) The elevation of the thiocyanate concentration 
in the blood and urine is also found in patients suffering 
from Leber’s hereditary optic atrophy who are treated by 
hydroxocobalamin..
(f) Changes in the renal clearance of thiocyanate 
observed in tobacco amblyopia, Leber’s hereditary optic 
atrophy and non-amblyopic smoking subjects, receiving 
hydroxocobalamin can only be explained by the renal tubular 
epithelium being a site of production of thiocyanate*
If the intestinal absorption of vitamin 112 is 
reduced to such a degree that the daily metabolic turnover 
rate or lose of vitamin B12 (approximately 2.55 ug per day, 
Heinrich I968) is no longer compensated for, only the 
vitamin B12 pools in the storage organs and tissues can be
as ô source for the matsbollo vitamin 'B12 roquirommt. 
Tille situation results in a progressive depletion of the 
vitamin B12 ooenayme body stores * which ia refleoted in a 
réduction of the vitamin #12 oonomtrationa in the eerm 
rniâ urine and am inoreased methyl melomato urinary exoretlon#
Following manifestation of the biochemical vitamin 
Bit defioienoy aymptoms# the morphological and olimioal 
eymptoms of Bit avitamlnoeio oam become menifeot (#$#2*1)
There is ample evidmoa by other authors miâ in 
this thesis that, in general, tobaooo amblyopia patienta have 
a lower m m m  vitcmia B12 concentration than do noit-aablyopio 
amokera, though in only 18^ was the cmmm concentration 
found to be pathologically low* â aignificant proportion 
of the tobaeoc amblyopes showed, in addition a defective 
absorption of radioactive labelled vitamin Big,
It Ima boom shown that cases of tobacco aort)lyopia, 
whether overtly vitamin Big deficient or not, recover vision 
on treatment with îaydroxooobGlamln, even if smoking is 
oontinuod (Ohioholm et al Igë?)* From this alone it ie
P A T H O G E N E S I S  of V I T A M I N  D E F I C I E N C Y
Anti vitamin compounds
Nutritional vitamin B 
deficiency
Relative & absolute 
intrinsic factor deficiency
Malabsorption Syndrome ■
Ileitis or 
Ileum resection
Increased vitamin B
Fall in serum Vit. B^g 
concentration
I Depletion of Vit. B. g  I 
I body stones J
requirements
T
Reduced urinary 
Vit. Bj^ g excretion
B. 2  coenzyme 
denciency
+
Increased urinary 
excretion of methyl­
malonic acid and 
Propionate
Necrological disorders 
Optic atrophy 
Subacute combined 
degeneration
Megaloblastic
anaemia
Vit. B^g deficiency 
psychosis
Fi||UM 7,1, Summary of vitamin Big dofioleuoy#
evident that in these patients, although there may he 
no apparent vitamin B12 defioienoy, there must he a 
relative deficiency of vitamin B12 itself or some active 
vitamin B12 analogue*
The development of tohacoo amblyopia, however, 
cannot be merely the consequence of a high cyanide intake 
in the presence of vitamin B12 depletion, for the correlation 
between tobacco consumption and serum vitamin B12 
concentration is not very close* In addition, examination 
of a number of patients with Addisonian pernicious anaemia 
who were also heavy smokers, has shown no discoverable 
disturbance of visual function. If vitamin B12 deficiency 
and heavy tobacco consumption were the sole factors in the 
production of the amblyopia# such patients would inevitably 
develop the condition*
The results do not reflect the view that tobacco 
consumption may depress vitamin B12 absorption* There is 
no statistical difference in the serum vitamin B12 
concentration of smoking and non-smoking subjects and there 
is- no correlation between tobacco intake and serum vitamin
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B12 concentration in healthy pipe amokera* (Only in the 
amblyopic patient do the intestinal absorption and serum 
concentrations of vitamin 312 vary directly with tobacco 
intake). It would seem from the results that depressed 
absorption of vitamin 312 as shown by the Schilling test 
or low serum concentrations of vitamin 312, is an 
Independently determined factor of aetiologioal significance 
in relation to the development of tobacco amblyopia,*
It is well recognised that patients suffering 
from tobacco amblyopia show a high incidence of systemic 
disease, especially of those diseases known to be associated 
with abnormalities of vitamin 312 metabolism* Even in 
patients with a normal capacity for absorbing vitamin 312, 
the serum vitamin 312 iéf often low, and the results suggest 
that there is often a dietary insufficiency, which is further 
reflected by the finding of low serum concentrations of other 
factors such as folic acid.
The therapeutic effect of hydroxocobalamin in 
these diseases is difficult to explain and requires 
examination of the known detoxication mechanisms for cyanide.
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1* O^aniâe is oom’bined with inorganlo sulphur 
iu the liver to form thiooyanate. This reaction is 
cateljsed by the enzyme thiocyanate*^oyanide sulphur 
transferase* (Hhodanese, EC* 2*8.1,!,)
2. Cyanide may react directly with 3 mereapto - 
pyruvate to yield thiooyanate and pyruvate* This reaction 
is catalysed by the enzyme 3 mereapto pyruvate ^ cyanide 
sulphur transferase* The 3 mereapto pyruvate is obtained 
by transamination of l*-oysteine,
3* Cyanide is known to react spontaneously with 
cystine to yield cysteine and either 2 •<- imino 4 - thiazolidine 
carboxylio acid, or B^thiocyanoalanine* little is known of 
the further reactions of 2-imino, 4 thlazolidine carboxylic 
acid, but B - thiocyanoalanine after deamination will yield 
thiooyanate and pyruvate*
4* Incorporation into the carbon « one metabolic 
pool and subset^uent excretion as carbon dioxide or synthesis 
into formate, allantoin, choline etc*
3* Direct union with hydroxocobalamin to yield 
cyanocobalamin *
The therapeutic effect of hydroxocobalamin has 
been shown to bring about a rise in the thiooyanate
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ooaoontration In the blood and urine, Somewhat elmllar 
changes have been shown to occur-also In patienta suffering 
from the optic neuropathy of pernloioua anaemia, and Leber*s 
hereditary optic atroplsy on the came treatment* It would 
be naive to ' aasume that the therepeutio effect of 
hydroxocobalamin is merely its union to form eyanocobalamin,
88 £!mlth (196§) has shown that the amount of cyanide 
removable by each moans is very small* It would eeem 
unlikely also, that hydroxocobalamin was acting m  a '*carrier" 
for oysnidei as the cyanide cobald bond Is stable, and 
cyanocobalamin is metsbolically inactive and is excreted 
unchanged in the m:^ lne* (Smith I960)* * â more ratioïial 
consideration would be that therapeutic hydroxocobalamin 
replenishes the depleted adenosyi coenzymo vitamin B12 
stores necessary for the preparation of a suitable sulphur 
donox’ for the conversion to thiooyanate of cyanide*
Dietary sulphur is ingested aa protein containing 
the sulphur amino acids, cystine, cyatein© and methionine*
Such sulphur containing amino acids are utilised in the 
syntheeis of tissue protein such as hair, insulin, 
glutathione, B mercapto^ethanolmnine and taurine and some
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ï'igïœe 7,2* Bummary of known Oyatoine jroaotiona,
8 1 6
are degraded to urea and sulphate# The ooheme is 
outlined in Figure 7, 3 from v/hloh it can be seen that 
neoeaaary aubatratea for the oonvex'alon of cyanide to 
thiocyanate are made available# Both ooenzymo vitamin 
:B12 and .folate are nadeaaary for the aucceaaful preparation#
Failure to detoxify cyanide may ooour in aavoral 
ways. Loea of liver parenchymal cells will interfere with 
the conversion of cyanide to thiooyanate due to diminished 
available rhodaneee, time 'explaining toxic amblyopia in 
patients with oimzhoBlB in whom the serum vitamin Big 
concentration is often high#
hack of ooensyma Big will interfere with the 
conversion of methionine to cysteine rnià this may be a 
factor in cases of optic neiïropatîiy of pernicious anaemia# 
Such patients would b# expected to show a high concentration 
of folio acid in the serum., as has been • ahomu*
Malnutrition will interfere with the preparation 
of a sulphur donor by dietary deficiency of vitamin B12, 
folic acid and the necessary proteina# Such patients will
2 1 7
show low ooncontrationa of vitamin Big and folio aoid 
in their serum. Oeuntohim et al (1969) have ouggested 
that dietary defiolanoy of cyotlno is oritioal in tropical 
nut3?itional neuropathy#
Vllleon (1963) has suggested that in Leherfs 
hereditary optio atx'ophy there is an enzymic dafiplenoy 
which prevents the conversion of oymiide to thiooyanate#
If this is 00, it is difficult to explain the rise in 
thiooyanate found in the body fluids of patients suffering 
from this condition on treatment with hydroxoeobalamis^# 
Although in general patients suffering from Leber*e 
herciditary optic atrophy show normal serum concentrations 
of vitamin B12 and normal vitamin B12 absorption (FouMo 
at al 19680), there may be a defect in the preparation of 
the suitable sulphur donor either before or after the point 
at which ooenzyme B12 is utilised#
Direct combination with cyanide or replenishing 
coenzyme B12 stores may be functions of hydroxocobalamin, 
but neither explain the observed alteration in renal 
clearance of thiooyanate found in patients whilst on
aia
treatment with hydroxocobalamin*
It is proposed that therapeutic hyd'rozooobalûKin 
may affect the tubular resorption of thiooyanate, or 
altemmtlvely the tubular* epithelium may be the site of 
extra hepsvtie couverelon of cyanide to thiooyanate* Such 
renal tubular mechaniame concerned in the active x»eabeorption 
of thiooyanate i'rom the glomerular filtrate, or active 
accretion of thiooyanate Into the renal tubulec, may have 
been "poisoned" by the abnormally high concentrations of 
cyanide and became corrected by the removal of cyanide on 
therapy with hydroxocobalamin* However, the renal clearance 
values for thiocyanate in untreated tobacco amblyopia and 
Leber*8 hereditary optic atrophy were not abnormal when 
compared with the values found by Btoa (1957) in healtîay 
emokera*
It eeema more probable that the tubular epithelium 
of the kidney la in fact a site for the conversion of 
cyanide to thiocyanate* This thiooyanate partly diffuses 
into the blood stream and partly la secreted into the renal 
tubulaa* Such a meohaniam votxld require not to be dependent
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on rhodaneae aa it has been demonstrated that on chronic 
cyanide exposure, rhodanese activity becomes lost, (Sorbo 
1951» Schlevelbein et al I969) but would be an alternative 
and little used pathway, present in both healthy smokers 
and tobacco amblyopes*
The possible source of the thiooyanate would be 
from the imlon of mercaptopyruvio acids with cyanide or the 
degradation of thiocyanopyruvic acid following on the 
oxidative deamination of B thiocyanoalanine in the kidney*
An alternative reasoning would be contained in 
the proposal that cyanide combines with a body constituent 
to form a vitamin B12 antagonist* Smith (l9&3) shows 
evidence that monocarboxylic acids act as antagonists to 
vitamin Bl2 action* The union of cyanide with cystine has 
been shown to produce 2-imino^4*^thiazolidinecarboxylio acid, 
a monocarboxylic acid* This aoid then blocks the coenzyme 
action of vitamin B12 in the formation of thiooyanate*
By simply raising the amount of available coenzyme B12 this 
competitive Inhibition is overcome*
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